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Genetic factors, stressors operating over the life course, and various aspects of 
social context have been shown to play a role in the etiology of depressive symptoms. 
However, empirical studies that investigate environmental and genetic factors, as well as 
their interactions, remain rare. First, traditional genetic analysis methods were employed 
to investigate the genetic determinants of depressive symptoms at the single-nucleotide 
polymorphism (SNP) level, incorporating different approaches to analyzing longitudinal 
outcomes (baseline measure, measures averaged over exam visits, and a repeated 
measures); secondly, state-of-the-art genomic region-level analysis methods were utilized 
to identify genomic regions associated with depressive symptoms; and finally, genomic 
region by environment (G x E) analysis methods were used to examine of the extent to 
which individual- and neighborhood-level social exposures modify the genetic effects of 
depressive symptoms. All analyses were performed both within and across multiple 
ethnicities (African, European, Hispanic, and Chinese Americans). This work includes 
evidence that incorporating longitudinal measures (through the averaged or repeated 
measures approach) results in smaller p-values and an increase in the number of single-
nucleotide polymorphisms (SNP) reaching genome-wide suggestive level, as well as both 
genomic-region determinants of depressive symptom scores and modification of those 
regions by social environments at both an individual- and neighborhood-level (chronic 




important contribution to life sciences in several ways: first, this is the first analysis that 
incorporates novel methods with depressive symptom outcomes; second, through the 
investigation of the association of genetic variants and depressive symptoms across 
multiple ethnicities; third, through a detailed comparison of how longitudinal data can be 
used to define a mental health phenotypes in the context of genetic studies; and finally 
through the use of both individual- and neighborhood-level interactions with genetic 
information at both an individual SNP level and a region level. Replicating these initial 
findings in other studies will help motivate efforts to reduce depressive symptom burden 







Genetic factors, stressors operating over the life-course, and various aspects of 
social context (including neighborhood environments) have been proposed to play a role 
in the etiology of depression. However, empirical studies investigating the joint effects of 
these factors as well as their interactions remain rare. Using datasets collected by the 
Multi-Ethnic Study of Atherosclerosis (MESA), SNP Health Association Resource 
(SHARe) Project, and the associated MESA Neighborhood Ancillary Study, which 
includes extensive social and psychosocial assessments, I conducted a novel investigation 
of the extent to which individual- and neighborhood-level social exposures interact with 
genetic predispositions to affect levels of depressive symptoms in population-based 
samples.  
1.1.1 Goal 
My goal was first to investigate the association of single nucleotide 
polymorphisms (SNP) with depressive symptom scores in a longitudinal setting to 
elucidate genetic predictors of depression across four ethnicities (African American, 
European American, Chinese American, and Hispanic American); second to test whether 
regions around the most strongly associated SNPs (lowest p-values) from meta-analysis 




depressive symptom scores within and across ethnicity; and third to determine whether  
any observed genetic effects are modified by individual-level or neighborhood social 
environments in a large, population-based epidemiologic study with detailed measures of 
social contexts. A detailed analysis plan can be found in Figure 1. These analyses were 
undertaken with specific attention to population stratification and gene- and SNP-level 
inference within a repeated measures frame work. This dissertation has several major 
strengths, including the availability of detailed social environment measures available in 
MESA, which have been previously linked to depression in the same sample;[1] the use 
of novel methods to evaluate gene-level associations;[2, 3] and the use of a large 
population-based multiethnic sample with multiple waves of data, allowing for 
longitudinal analyses. This dissertation takes advantage of a unique dataset, and 
contributes to the intersection of the fields of genetic, social and psychiatric 
epidemiology. 
1.2 Aims 
Aim 1: Investigate genetic associations with depressive symptoms scores using genome 
wide association studies (GWAS) within and across four ethnicities contrasting different 
methods of incorporating repeated outcome measures. Compare these results to 
previously published GWAS on depressive symptoms. 
 
Aim 2: To conduct meta-analysis across ethnicities to further define genomic regions and 






Aim 3: To investigate whether social context (chronic burden, social support, or 
neighborhood index score) modifies genetic risk of depressive symptom score for those 
genomic regions identified in Aim 2. If any significant associations are discovered, 
follow up regional analysis with individual SNP-level analysis for each SNP by 
environment interaction within the region. 
 
1.3 Background and public health significance  
1.3.1 Depression 
Depression is one of the most common mental illnesses and is characterized by 
feelings of guilt, disturbed sleep or appetite, poor concentration, low energy, persistent 
sadness, and loss of interest among other symptoms.[4] Depression is expected to rank 
second among the leading contributors of disease burden by 2020, according to the World 
Health Organization; it is also expected to be the second largest cause of disability after 
heart disease by the same year.[5] It was estimated that the economic burden of 
depression was around $83 billion dollars per year as of 2000.[6] Depression – 
specifically, major depressive disorder (MDD) – is characterized by the presence of the 
majority of the above symptoms, for a duration of at least two weeks.[7] The prevalence 
of MDD in adults 18 and over in the United States is higher than any other DSM-IV 
mental disorder, with a lifetime prevalence of 16.6% and 12-month prevalence of around 
6.7%.[8] Rates of subclinical depression vary based on sample definitions, with 
community sample rates between 8.4 and 9.9% and primary care patient rates of 5 to 




impairment and increased use of health services, as well as higher degrees of morbidity, 
poorer social functioning, and poorer quality of life than those without depression.[11-13] 
Though MDD is characterized as a dichotomous trait, depression exists on a 
continuum with different levels of severity and duration. Binary phenotypes of depression 
are usually based on questionnaire data, such as the CES-D, or even a particular number 
of endorsed symptoms from the Diagnostic and Statistical Manual (DSM) for mental 
illness.[7] The CES-D consists of 20 items and includes items on depressed mood, 
feelings of worthlessness, hopelessness, loneliness, sleep disturbance, loss of appetite, 
concentration problems and psychomotor retardation (see Appendix 1 for full CES-D 
inventory). The scale is a sum of the 20 items (items rated from 0 to 3) and ranges from 0 
to 60. Internal consistency was initially reported as 0.90 (Cronbach’s alpha).[14]  
MDD is a diagnostic convention applied to the very extreme end of the depressive 
continuum[15] and is characterized as a dichotomous measure, differentiating between 
cases and non-cases.[16-18] Often, a cutoff of 16 is used for the CES-D to distinguish 
individuals in the “normal” range from those considered to be “probable cases.”[19] The 
CES-D has a sensitivity and specificity for MDD that has been reported anywhere in the 
range of 64%-90% and 70% - 93% respectively.[16, 20-22] The positive predictive value 
from the CES-D (the proportion of true cases among those exceeding the cutoff) for 
MDD is around 30%.[20, 21, 23] The binary nature of these measures, however, gives 
minimal information about those who do not present with MDD, who often do not report 
extreme events in the numbers that would lead to a diagnosis of MDD.[24]  
While other instruments exist that could provide a more valid assessment of 




Inventory[26]), these instruments often require a trained interviewer or clinician to 
administer. The CES-D can be self-administered and taken in a very short amount of 
time. Symptoms assessed on the CES-D are among those on which a diagnosis of clinical 
depression is based.[14] 
Depressive symptoms, which are measured on a continuous scale, are thought to 
have similar patterns of risk factors to MDD, suggesting that MDD and depressive 
symptoms share a common origin.[27] Due to the hypothesized shared etiology between 
MDD and depressive symptoms, the paucity of literature on MDD risk factors and the 
relative lack of established risk factors for depressive symptoms, information from risk 
factors for MDD was used to inform investigation of depressive symptoms in MESA and 
HRS – noting that the outcome in this dissertation, CES-D score, represents depressive 
symptoms, not depression. 
1.3.2 Depression and environmental exposures 
1.3.2.1 Individual-level social exposures 
 Any environmental, social, or internal stimulus that requires an individual to 
change his or her usual behavior pattern can be referred to as a “stressor” or “stress.”[28] 
Reactions from these perceived “stressors” can often lead to a state of physiological or 
emotional arousal that can be considered a “stress reaction.” Over time, stressors can 
accumulate, resulting in the decreased ability of an individual to cope or readjust his or 
her behaviors. This can lead to depletion of physical or psychological resources, and thus 




Social stress theory often encompasses two broad basic principles: exposure to 
stressors and vulnerability to stress.[32, 33] Figure 2 presents a heuristic model of 
stressors included in this dissertation within the framework of existing social stress 
theory. Many studies have documented associations between social and psychosocial 
exposures and depression or depressive symptoms at an individual-level. Specific 
exposures that have been investigated include adult socioeconomic position (SEP), 
measured using education, income, and wealth (e.g. [34-38]); individual-level stressors, 
such as chronic burden  (e.g. [29, 39, 40]); and social support (e.g. [41, 42]). I 
investigated chronic burden, which represents exposure to a set of potential stressors. To 
examine differential exposure to stressors, I included adult SEP measured by a summary 
index (including education, income, and wealth) in the region-level and interaction 
analyses. Personal and social resources, particularly social support, can reduce 
vulnerability to stress, and so social support is also included as a individual-level social 
environment as a measure of susceptibility to stress.  
Socioeconomic predictors 
Many leading causes of ill health in the United States and other countries are 
associated with SEP. Often, the least affluent suffer a disproportionate share of disease 
burden, including depression.[43] Major depressive disorder and greater depressive 
symptomatology have been found to be more prevalent at lower levels of SEP in several 
studies.[37, 38]  
The Alameda County Study (ACS) has published several articles highlighting the 
relationship between SEP and disease, including depression.[44-46] The ACS is a 




health and well-being in approximately 7,000 adults from Alameda County, 
California.[47] Data from this study has demonstrated a graded relationship between 
SEP, measured by education or income, and prevalent and incident depression.  
In the accompanying Figure 3, adapted from Everson, et al. 2002,[43] the 
prevalence of depression, defined as having five or more symptoms based on an 18-item 
self-report questionnaire, is almost half that in men and women with a high school degree 
or more (12%) compared to men and women who have not obtained a high school 
education (21%).[48] Better educated groups have lower prevalence of depression 
compared with those who have only nine to 11 years of education.  
When income is the primary measure of SEP, the same pattern can be seen, with 
11% of higher income respondents experiencing depressive symptoms compared with 
19% of lower income respondents.[48] Evidence from earlier studies using the ACS data 
has also shown relationships between SEP and incident depression. Participants with less 
than nine years of education who were not depressed at the start of the study were nearly 
twice as likely to become depressed over the subsequent nine years of follow-up relative 
to those with a high school education or more (odds ratio (OR) = 1.86, 95%CI = 1.36-
2.55).[49] 
Many other studies have shown pronounced socioeconomic gradients in 
depression. For example, Figure 4 compares findings from four different studies 
highlighting the relationship between SEP and tertiles of depressive symptoms (adapted 
from Everson, et al 2002[43]). This figure shows the proportion of respondents within 
each education tertile (low, middle, or high, defined in each study by number of years of 




composed of exceedingly diverse participant bases and so the demonstrated gradients are 
particularly remarkable because they demonstrate consistency across the four unique 
study populations (Consumers Survey, Detroit Study, Alameda Study, and the Kuopio 
Study).[43] The Consumers’ Survey included 1,423 randomly sampled men and women 
from the contiguous 48 states using random-digit-dialing.[50] This sample is weighted to 
be representative of the US population by age, race/ethnicity and gender. African 
Americans were oversampled in the Detroit study, which was conducted in 1995 and 
included 1,139 participants from a three-county region surrounding Detroit, 
Michigan.[51] The final sample included approximately equal numbers of Europeans and 
African Americans, and was collected to explore attitudes, psychosocial characteristics, 
behaviors, and health.  
The ACS study was intended to represent the demographic makeup of Alameda 
County, California, in 1965, when the study commenced.[47] The study population 
includes 78.9% Europeans, 12.4% African Americans, and 3.9% Hispanics (with 4.8% 
categorized as “other” racial/ethnic groups or not identifying with a single racial/ethnic 
category) aged 17 – 94 years in 1965. The Kuopio Ischemic Heart Disease Risk Factor 
Study included 2,682 men between ages 42 and 60 when the study began (between 1984 
and 1989) from the Kuopio region of eastern Finland. All participants in this study are 
European.[52]  
Despite such a diverse range of study populations, the socioeconomic gradient 
persists. I incorporated the theory generated from this broad literature by using data from 




genes/gene-regions, to depressive symptoms using education, income, wealth, and 
childhood SEP measures. 
Stressors 
 According to social stress theory, low SEP increases the risk of depression, in 
part, by increasing exposure to chronic and acute stressors. I focused on one measure of 
chronic stress: chronic burden. A majority of research supporting relationships between 
stress and depressive episodes has been based on episodic stressors, or discrete events 
having a beginning and an end, that have negative or undesirable content (e.g.[29, 53, 
54]). On the other hand, chronic stress has been inconsistently defined and comparatively 
less studied.  
Early studies investigating chronic stress and depression defined chronic stress as 
“ongoing difficulties lasting at least four weeks” and found that depressed subjects were 
more likely to have experienced either an ongoing difficulty or at least one severe life 
event prior to the onset of depression.[29, 40] These earlier studies often did not 
differentiate between the effects of chronic and acute stress.[55] Other research has 
reported that continuing adverse conditions, such as poverty, medical disabilities, and 
lasting marital discord are associated with risk of depression.[29, 56-58] Researchers 
have also found an association with depression when chronic stress is defined as the 
continued absence of social support (e.g.,[59]).  
The development of a chronic stress profile covering domains such as intimate 
relationships, close friendships, family relations, finances, and the health of self and 
family members in the past six months found that chronic stress increased depression in 




to suggest that chronic stress (defined as stress ongoing for more than 12 months) is a 
stronger predictor of depressive symptoms than acute stressors.[62] Chronic stress is an 
important area in need of further study, with implications in the association between 
individual stressors and depression. In this dissertation, I utilized an index of chronic 
burden as a proxy for individual-level social environment stressors. 
Stress buffers 
 Low SEP may also increase the risk of depression by decreasing access to stress-
buffering resources, such as self-esteem and social support.[32] Much research on social 
support and its association with depression was published in the 1970s and 1980s. 
Though the meaning, nature, and measurement of social support have been debated in the 
literature, there has been movement to identify several distinct types of components of 
support.[63] Some of these components include structural aspects of relationships (e.g., 
living alone), frequency of social contact, participation in social activities, and 
involvement in social networks. In a conceptual analysis, the four most frequently used 
defining attributes of social support included emotional, instrumental, informational, and 
appraisal. Social networks, social embeddedness, and social climate were all identified as 
antecedents of social support.[64, 65]  
One of the most robust relationships between social support and depressive 
symptoms in late life has been found with perceived emotional support.[41] A 
community study in Hong Kong found that impaired social support, (including network 
size, network composition, social contact frequency, satisfaction with social support, and 
instrumental-emotional support) and depressive symptoms were associated in bivariate 




or depressive symptoms in longitudinal studies. In a community-based study of 
Australians, poor social support was predictive of the number of depressive symptoms at 
follow-up, three to six years after baseline measurements.[66] Additionally, insufficient 
social networks predicted the incidence of major depression in a sample of 875 non-
depressed elderly people over a three-year follow-up.[67] Measured social support 
indices within MESA are used as a measure of vulnerability to stress in this dissertation. 
Both the chronic burden and social support constructs are consistent with aspects of 
proximal determinants of depression using the social stress model.[32] 
1.3.2.2 Neighborhood-level social exposures 
It has been postulated that neighborhood contextual characteristics may be related 
to mental health outcome over and above the effects of individual characteristics. A large 
number of studies have documented associations of various features of neighborhood 
environments with depression or depressive symptoms (reviewed in [68, 69]). The 
neighborhood constructs investigated have included general measures of neighborhood 
SEP, as well as more specific measures of chronic stressors (including violence, disorder, 
and aesthetic quality) and measures of neighborhood social cohesion/social support. Mair 
et al, 2008, evaluated 45 observational studies published between January 1990 and 
August 2007.[70] Studies included sample sizes ranging from 117 to 56,428, adult 
populations, children or teenagers, the elderly, mixed ethnic/racial groups, African-
American-only, and Mexican-American-only studies. These studies also included 
metropolitan or urban areas, non-urban areas, different depression measures, different 
study designs, and differing definitions of neighborhood. Review of these studies showed 




neighborhood characteristics and depression or depressive symptoms after controlling for 
various individual-level characteristics. Common covariates in these studies included age, 
race/ethnicity, gender, marital status, education, and income.[1, 70] A more recent study 
using the MESA data, not included in the review by Mair et al, 2008, found that key 
features of the environment including lower levels of social cohesion were significantly 
associated with depressive symptoms.[1, 68] Here, I describe the evidence for including 
neighborhood predictors in the context of depression and depressive symptoms in the 
context of social stress theory. 
Potential neighborhood stressors may include residential stability, deprivation, 
violence, disorder, and aesthetic quality. Depressive symptoms were found to be 
associated with residential stability (β (SE) = 0.72 (0.27)) after controlling for individual-
level characteristics in 3,442 elderly individuals living in urban areas of the U.S.A. where 
census tracts are defined as the neighborhood.[71] Depressive symptoms were also 
associated with neighborhood-level measures of deprivation (OR for highest vs. lowest 
fifth 2.4 (1.28 to 4.48)), lack of social support (OR = 2.51 (1.75 to 3.61)) and self-
reported stress (OR = 10.42 (6.29 to 17.28)) in a model adjusting for all these 
characteristics plus social capital, receiving means-tested benefits, and having three or 
more kids 5 years of age or younger. This study was conducted in 2005, and investigated 
846 mothers of young children living in deprived areas of Nottingham in the U.K., using 
British enumeration districts.[72] A study assessing neighborhood problems (too much 
traffic, excessive noise, trash and litter, smells, smoke) and using participant-defined 
neighborhoods reported that subjects in the top quartile of neighborhood problems were 




= 4.8 (2.4 to 9.5)), in adults living with asthma in northern California.[73] Another study 
found that being environmentally dissatisfied and living in neighborhoods with 
transportation problems were associated with increased levels of depressive symptoms. 
This study sampled 725 adults aged 55 and older from four metropolitan counties in 
Alabama and used the census tract as the definition of neighborhood.[74]  
Though several studies found associations between neighborhood stressors and 
depression, some did not. Using census tract-defined neighborhoods, investigators 
conducting a study of 2,109 non-institutionalized people ages 65 and older in New 
Haven, Connecticut, found no association between racial/ethnic heterogeneity, residential 
stability, service density (services promoting social engagement, providing care, and 
undesirable amenities), and depressive symptoms.[75] Another study included in the 
review found no evidence for an association between neighborhood measures and 
depressive symptoms. This study involved 2,998 adults ages 65 and older in North 
Carolina and investigated racial/ethnic heterogeneity, residential stability, and 
neighborhood age structure. None of the factors was significantly associated with 
depressive symptoms conditional on census tract random effects, either before or after 
adjustment for individual characteristics.[76] 
Certain aspects of neighborhoods can be thought of as buffering the effects of 
exposures on depression, such as social cohesion. An association between neighborhood 
cohesiveness and higher levels of depressive symptoms in adolescent and early adult 
females was reported. In the same study, neighborhood cohesiveness for adolescent 
males was noted. This study included 372 youth from the first and second waves of the 




strong, prospective association between negative perceived neighborhood characteristics 
and subsequent depressive symptoms, after adjusting for baseline depression (β = 0.28, p 
< 0.01), was found in a sample of residents of high-drug-use areas in Baltimore, 
Maryland, using participant defined neighborhoods.[78, 79]  
Another study found that having limited social supports within a neighborhood 
was associated with increased levels of depressive symptoms. This study sampled 725 
adults aged 55 and older from four metropolitan counties in Alabama and used the census 
tract as the definition of neighborhood.[74] In another study, adolescents’ perception of 
ambient hazards (β (SE) 0.022 (0.008)) and negative social cohesion (β (SE) -0.122 
(0.032)) were both associated with depression symptoms in 877 adolescents from Los 
Angeles County using clustered census tracts as the neighborhood.[80] Simons et al, 
2002, reported an association between community ethnic identification (β = -0.392, p-
value = 0.04) and prevalence of discrimination (β = 0.313, p-value 0.04) with depressive 
symptoms, after controlling for individual- and community-level characteristics in a 
sample of 876 African-American children ages 10 to 12 in Georgia and Iowa.[81]  
Incident depression/depressive symptoms, which can provide much stronger 
evidence of a causal effect of neighborhood on depression, has been assessed in several 
studies (reviewed in [70]). These studies defined incident depression as all subjects who 
did not have depression or presented with symptoms less than a certain cutoff at baseline, 
but who had depression or were above the cut-off at follow-up. Incident depression was 
associated with socioeconomic status[82], living in an impoverished area[83], and 
neighborhood disadvantage[84] in samples of New York residents, Alameda and Oakland 




Though many studies found associations between social support and social 
cohesion, some studies failed to replicate these findings. Simons et al, 2002, found no 
association between community cohesion and depressive symptoms after controlling for 
individual- and community-level characteristics in a sample of 876 African-American 
children ages 10 to 12 in Georgia and Iowa. Neighborhoods were defined as “community 
groups,” which were made up of census block group areas from cluster analysis.[81] 
Despite this finding of no association, much of the evidence in the literature supports 
some association between neighborhood social cohesion and depression. 
Using the literature and available measures of neighborhood characteristics, I 
have included neighborhood safety, aesthetic quality and social cohesion as 
neighborhood dimensions included in the neighborhood index score. These measures 
stem were created with validated scales from an ancillary study of non-MESA 
participants residing in the same neighborhood as members of the MESA cohort. In using 
these measures and by aggregating responses across several respondents, I have reduced 
variability from individual subjectivity and measurement error and also circumvented 
same-source bias.[85] More details are presented in the individual sections. 
1.3.3 Genetic mechanisms of depression 
Genetic effects 
The heritability (proportion of variation attributable to genetic factors) of 
depression as assessed by twin studies is estimated at around 30 to 50%.[86] Despite 
evidence for heritability of depression, the identification of vulnerability genes has not 
been as successful as it has been for many other complex disorders, such as obesity. Due 




of depression. Many genetic factors have been investigated, including candidate genes 
and SNPs, but little to none has been replicated to any acceptable level.  
 
Interaction effects 
Several different theories have been invoked in the analysis of mental health 
genes and the environment, including (but not limited to) gene-environment correlation 
(rGE)[87], Diathesis-Stress model (i.e. vulnerability genes)[88], and Differential 
Susceptibility (i.e. plasticity genes)[89, 90]. rGEs are different from G x E interactions in 
that rGE explains why individuals with certain genetic predispositions to exhibit 
sensation-seeking behaviors affiliate with individuals who are more likely demonstrate 
the same behaviors[91], while G x E would explain why individuals with a certain 
environmental exposure would lead to a specific phenotype only in individuals with a 
particular genotype.  
Gene-environment correlation is broken down into three categories: passive gene-
environment correlation (referring to the association between the genotype a person 
inherits from their parents and the environment in which that person is raised), evocative 
gene-environment correlation (also known as “reactive”, referring to the association of an 
individual’s genetically predisposed behaviors and other people’s reactions to those 
behaviors), and active gene-environment correlation (also known as “selective”, referring 
to the relationship between an individual’s genetically influenced behaviors and the 
environmental exposures that an individual selects)[87, 92].  
The prevailing framework has been that of the Diathesis-Stress model.[88] This 




behavioral/temperamental or genetic – are disproportionately affected negatively by a 
particular environmental stressor leading to the manifestation of a psychopathological 
condition, such as depression.[93] Previously depression literature consistent with this 
theory has included environments of child maltreatment, negative life events and even 
parental discipline (e.g. [94-96]) and their interaction with genetic profiles.  
Differential Susceptibility is a more recent framework of G x E interactions 
focusing on the idea that not only are some individuals more susceptible to negative 
environmental exposures, but those very same individuals may respond more positively 
to environmental support and enrichment, included the absence of a negative 
environment. Much literature to date has not explicitly investigated genes and 
environments in the context of this model – mostly by focusing only on negative 
environments and failing to measure the positive (excepting the absence of adversity) and 
investigating only a small range of psychological and behavioral outcomes, again 
focusing on negative psychopathologies.[93] However, there is a paucity of literature that 
supports this hypothesis, even if not explicit in the conclusions of the authors (e.g. 
.MAOA—Physical abuse—Mental health problems,[97] 5-HTTLPR—stressful life events 
–depression symptoms[98]). Belsky and Pluess (2009)[93] outline several evidentiary 
criteria for determining differential susceptibility; (1) applying a conventional statistical 
criteria for evaluating an interaction, where interactions where regression lines do not 
cross are excluded, (2) evaluating the association between the environment and outcome 
(if they are related, then Diathesis Stress models are suggested), and (3) demonstrating 




susceptible subgroup is both significantly different than zero and significantly steeper 
that the non- (or less) susceptible subgroup. 
 These models are not necessarily mutually exclusive and evidence of one or more 
may be present in a study.[99] These different models may suggest that there is a 
profound influence of genes and the environment on epidemiologic and genetic 
parameters, including increased susceptibility to negative environments for certain 
genotypes. This can enhance our understanding of the pathways of risk leading to the 
occurrence of depressive symptoms in the general population. In the context of public 
health and in particular for depressive illness, risk-prevention efforts have tended to focus 
on behavior modification. Recognizing that risk for depression by be driven by genetic 
factors and modified by environments presents a complex paradigm for designing and 
testing intervention strategies for the future. 
This dissertation exploits these theories by including environments that assess not 
only the negative end of an environmental spectrum, but also the positive end – and not 
only in terms of the absence of adversity.  
1.3.3.1 Individual-level social and genetic predictors of depression 
In recent years, there has been an upsurge of research literature showing the 
etiology of different types of psychopathology to be linked to both genetic and 
environmental factors working together in complex ways.[100-102] Though researchers 
have long known that both genetic and environmental risk factors independently 
contribute to the development of psychopathology, only recently has attention been 
focused on exploring how genes and environmental factors work in concert.[103, 104] 




psychiatric genetics research (a) by showing a direct linear relationship between a gene 
and a disorder, (b) by showing the relationship between genes and disorders through an 
endophenotype, which is a heritable neurophysiological, biochemical, endocrinological, 
neuroanatomical, or neruopsycholocical antecedent of a disorder,[106] and (c) finally by 
showing a gene-environment interaction approach. True genetic and environmental 
effects can be obfuscated when gene-environment interactions are ignored, which can 
lead to false negative results and can be an explanation for inconsistent findings in the 
literature.[107] 
 G x E in psychiatric genetics have been reported for disorders such as attention 
deficit/hyperactivity disorder (ADHS), schizophrenia, substance use disorders, and 
depression (reviewed in [108]). Individual-level environmental outcomes include 
stressful life events, childhood maltreatment, institutional deprivation, stress, acute 
injury.[108]  The most prominent and widely cited example of an individual-level G x E 
interaction in depression is that of Caspi et al, 2003.[95] This study used stressful life 
events and genetic variation in the promoter region of the serotonin transporter gene (5-
HTTLPR) as the environment and genetic factors, respectively. Findings implicated a 
polymorphism (short allele) in the promoter region of the serotonin transporter gene, 
which predicted depression in interaction with major stressors (stressful life events 
(SLE)). This was the first study to identify a specific genetic locus ass ociated with 
depressive reactions to stressful life events.[95, 104] 
 After the initial findings of Caspi et al, 2003[95] a number of studies were 
undertaken to attempt to replicate the findings. Two meta-analyses of the 5-HTTLPR x 




concluding that there was no evidence of overall interaction between this variant and 
environments studied. However, these meta-analyses were limited to a selection of the 
literature due to strategical decisions about inclusion/exclusion criteria and 
methodological constraints. Inconsistencies in the findings from individual studies could 
be due to several reasons such as different definitions of outcomes, different study 
designs (longitudinal, cross-sectional , case-control, etc.),  and varied exposure 
measurements.  A more recent meta-analysis has included more current research 
(including studies investigated in the two previous reviews) and found strong evidence 
that the 5-HTTLPR locus moderates the relationship between stress and depression (meta-
analysis p = 0.00002).[111]  This meta-analysis also stratified results by two integral 
sources of variation in individual studies: stress assessment methods (questionnaires, 
objective, and interviews) and stressor types (childhood maltreatment, stressful life 
events, and specific medical conditions).  This meta-analysis concluded that studies with 
very defined stressors (childhood maltreatment and medical conditions) were more likely 
to find significant gene by environment interaction effects compared to those studies with 
more generally defined stressors – particularly those using interview or objective 
assessment measures.[108]  Several other genetic regions (COMT, TPH, and 5-HTR2a) 
have be identified through biological pathways (such as the hypothalamic-pituitary 
adrenal axis) as being potential regions of interest in the development of depression, 
though currently polymorphisms in these regions have failed to show interactions with 
SLEs.[112] Only one GWAS analysis of MDD has found a genome-wide significant hit 
[113], whereas a mega-analysis of all GWAS studies of MDD [114] has not found a 




to expect several genome-wide hits if MDD behaved similar to diabetes or 
schizophrenia[115]. Hence, depression risk may need a different approach. This 
dissertation builds on previous literature by using questionnaires to evaluate interactions 
between well-defined individual-level stressors (chronic burden and social support) and 
genetic regions with depressive symptoms.  
1.3.3.2 Neighborhood-level social and genetic predictors of depression 
 Most G x E studies have focused on individual traits or characteristics as the “E,” 
or environmental, factor in the interaction. Very few studies have investigated 
neighborhood-level, or distal environments (particularly measures of social environment) 
when it comes to G x E studies. Despite the lack of literature on G x “neighborhood E” 
studies, many health-related outcomes have been associated with neighborhood-level 
environments. Existing literature remains limited in the range of contextual factors that 
have been considered in G x “neighborhood E” studies of depression. 
Of note are differences between the use of objective and subjective measures of 
neighborhood-level social environments. A recent meta-analysis compares studies with 
objective versus subjective measures of the environment and concludes there is a 
systematic relationship between method of environmental assessment and the results of G 
x E studies with the length variant of the serotonin transporter.[109] This meta-analysis 
further states that all studies involving objective measures to assess stress replicated the 
G x E interactions either fully or in part, whereas non-replications relied on self-report 
measures.[109]  
 G x “neighborhood-E” interaction studies are exceedingly rare in depression, and 




and social environment were detected in adolescent boys based on their residence in 
public versus privately owned house, with no significant interaction findings in 
adolescent females, despite other variables (e.g., traumatic conflicts in the family) 
showing significant G x E interactions exclusively in females.[116] Uddin et al, 2010, 
noted that the 5-HTTLPR “sl” genotype conferred protection against depressive 
symptoms in adolescent females, independent of county-level social context (measured 
by county-level proportion of households receiving public assistance), though in 
adolescent males, the same genotype only conferred protection against depressive 
symptoms within the context of county-level deprivation.[117] 
There is a large gap in the G x E literature in which studies of interactions 
between whole genes or gene regions (not individual loci, as have been investigated 
previously) and individual- or neighborhood-level social environment could greatly 
advance the field. MESA provides us the opportunity to use objective measures of 
neighborhood social environment to obtain a more robust measure of environment. In 
addition, new statistical methods allow us to investigate whole gene/gene-region 
interactions in the context of G x E interactions, both at the individual- and 

















Figure 3 Prevalence of depression by levels of education and income: Alameda County Study, 1965 






Figure 4 Prevalence of depressive symptoms by education in four epidemiological studies. Education 
categories defined within each study 
 
Data from the Kuopio Study represent hopelessness rather than overall depressive symptoms. Adapted 





Figure 5 Approaches to psychiatric genetics research.  
 
a | The gene-to-disorder approach assumes direct linear relations between genes and disorder. b| The 
endophenotype approach replaces the disorder outcomes with intermediate phenotypes. c | The gene– 








II. Study population and descriptive statistics 
2.1 The Multi-Ethnic Study of Atherosclerosis 
The Multi-Ethnic Study of Atherosclerosis [118] is a longitudinal study supported 
by the National Heart, Lung, and Blood Institute (NHLBI) designed to identify risk 
factors for subclinical atherosclerosis. The MESA cohort was recruited in 2000-2002 
from six Field Centers: Baltimore MD (Johns Hopkins University Field Center); Chicago, 
IL (Northwestern Field Center); Forsyth County, NC (Bowman Gray Field Center); Los 
Angeles, CA (UCLA Field Center); New York, NY (Columbia Field Center); and St. 
Paul, MN (University of Minnesota Field Center). Participants were 45-84 years of age 
and free of clinical cardiovascular disease at baseline. At each site a probability sample of 
approximately 1100 participants was selected at each site to represent specific 
populations. At baseline the MESA cohort included 6814 men and women, with 38.5% 
non-Hispanic whites, 27.8% non-Hispanic African-Americans, 22% Hispanics, and 
11.8% Chinese. Participants attended a baseline examination (2000-2002) and three 
additional follow-up examinations approximately 18-24 months apart. At each clinic 
visit, participants completed a series of demographic, personal history, medical history, 
access to care, behavioral, and psychosocial questionnaires in English, Spanish, or 
Chinese. These visits included three measured of depressive symptoms using the Center 
for Epidemiologic Studies Depression (CES-D) scale. Overall, cohort follow-up has been 




were: exam 1 (n=6,814), exam 2 (n=6,239, 92%), exam 3 (n=5,946, 89%), exam 4 
(n=5,704, 87%).  
Since MESA’s primary hypotheses relate to determinants of subclinical 
cardiovascular disease, certain exclusion criteria were applied (Table 1). Institutional 
Review Board approval was obtained at each of the six MESA centers where participants 
were seen for clinical exams. 
2.1.1 Depressive symptoms 
MESA uses an instrument widely accepted for assessment of depressive 
symptoms in the general population, the CES-D scale.[14] The CES-D is advantageous in 
such a large sample due to the quickness with which it can be completed (5-10 minutes) 
and that it has been translated and validated into several languages. Depressive symptoms 
were measured in MESA participants at baseline and at two follow-up visits using the 20-
Item CES-D Scale.[14] Higher CES-D scores represent more/more severe depressive 
symptoms. The first follow-up visit including an assessment of the CES-D (exam 3) was 
3-4 years after baseline, and the second 4-5 years after baseline, at exam 4.  
2.1.2 Anti-depressant adjustment  
 Rather than removing individuals taking anti-depressant medication and losing 
valuable genetic information, CES-D scores were adjusted for treatment effect using a 
similar algorithm used for adjustment of blood pressure for persons taking anti-
hypertensive medications.[119] Since response to anti-depressant medication is highly 
variable and information on compliance to medication is not always available in 




scores. First, CES-D scores of anti-depressant users are right-censored. That is, the CES-
D score while on anti-depressant medication is lower than the score while not taking anti-
depressant medication. Second, participants with low depressive symptoms scores 
respond less to anti-depressant medication than persons with high depressive symptom 
scores, on average.  
 The algorithm for adjustment of anti-depressant use was run separately for 
multiple factors: gender, race, and exam period, on a total of 6,438 individuals. The 
nonparametric imputation algorithm replaces the CES-D score of a person using anti-
depressants with the mean depressive symptom score for all persons taking anti-
depressants with the same or higher depressive symptom score. This method has recently 
been used in a large depressive symptom GWAS consortium.[120] Anti-depressant use 
was defined at each exam by self-reported monoamine oxidase inhibitor (i.e. 
isocarboxazid, phenylzine, tranylcypromine), tricyclic anti-depressant (i.e. amitriptyline, 
doxepin, nortriptyline) and/or non-tricyclic anti-depressant (i.e. citalopram, escitalopram, 
fluoxetine, sertraline) use coded as yes/no. Descriptive statistics on depressive symptom 
scores and anti-depressant use for each ethnicity for participants not on anti-depressant 
and also for those on anti-depressant medication both before imputation and after 
imputation are available in Table 2. Since those who had missing information on anti-
depressant use were not significantly different on exam-specific mean CES-D scores than 
those who did not take anti-depressants (exam 1: p-value = 0.5955, exam 3: p-value = 
0.1476, exam 4: p-value = 0.1103), individuals with missing information on anti-
depressants were classified as “0 – not taking anti-depressants” for imputation purposes. 




power. Missing information on anti-depressant use was observed on two participants 
from exam 1, 91 participants from exam 3, and 167 participants from exam 4. The 
distribution (histogram and box-plots) of CES-D for each exam, for those missing anti-
depressant use compared to those with no anti-depressant is shown in Figure 6-Figure 9. 
The distribution of CES-D in this sample is skewed right, with the majority of values 
being less than 10. The distributions of CES-D scores are broken down by race and 
phenotype (baseline, averaged, repeat measure) as well as by log-transformation status. 
The (CES-D scores + 1) were log transformed to improve consistency with linear 
regression assumptions after anti-depressant imputation for use in MESA.  
2.1.3 Genetic data 
All genotype collection and laboratory analyses were done by MESA. MESA 
provides genotypes to the SNP Health Association Resource (SHARe) Project. DNA 
isolated from whole blood or packed cells are frozen at –70
o
C.  The DNA extraction and 
purification method uses sodium dodecylsulfate cell lysis followed by a salt precipitation 
method for protein removal using commercial Puregene® reagents (formerly Gentra 
Systems, Inc., Minneapolis, MN 55447; currently Qiagen Instrument Service, 
Germantown, MD 20874).  DNA is quantitated using the NanoDrop Spectrophotometer 
(NanoDrop Technologies, Wilmington, DE).  Quantitation by Picogreen analysis 
(Molecular Probes, Eugene, OR) is also available.  A mean yield of 200 µg or 40 µg 
DNA/mL packed cell is obtained, and DNA is of high quality (mean purity 
A260/280=1.77) and high molecular weight as determined by gel electrophoresis.  
Approximately one million SNPs were typed using the Affymetrix Genome-Wide 




<95% and individual level call rate <95%, and monomorphic SNPs were removed. The 
IMPUTE 2.1.0 program was used in conjunction with HapMap Phase I and II 
CEU+YRI+CHB+JPT as the reference panel (release #22 - NCBI Build 36 (dbSNP 
b126)) for African American, Chinese and Hispanic participants, and HapMap Phase I 
and II - CEU as the reference panel (release #24 - NCBI Build 36 (dbSNP b126)) for 
Europeans to increase the number of available SNPs to approximately 2.5 million 
markers per each ethnicity. Genotyping was completed by Affymetrix in September 2009 
and released on dbGaP in February 2009. 
To account for population substructure, ethnic-specific principal components 
were taken from the genome-wide data. Principal components (PC) were computed 
through the MESA SHARe project by the Wake Forest analysis team. The PCs were 
computed on 8,227 individuals who self-reported ethnicity: 2,590 African Americans, 
2,174 Hispanics Americans, 2,686 European Americans, and 777 Chinese Americans. 
PCs were computed separately in each self-reported ethnic group. The Wake Forest 
analysis team excluded the 23,428 SNPs that were already flagged in the data that was 
downloaded from dbGaP. They also removed 6,849 SNPs in genomic regions that have 
been shown to harbor long range linkage disequilibrium (LD), as these regions have been 
shown to influence the choice of PCs. Each ethnicity was adjusted for population 
substructure through the top four ethnic-specific PCs as proposed previously in MESA 
and elsewhere.[121, 122] 
For the baseline and averaged phenotype genetic information, genotype 
probabilities were converted to dosages within the PLINK platform using command-line 




repeated measures analyses, probabilities were converted to dosages using R 
software.[125] Dosages were used for the GWAS analyses in Aim 1. Since the PLINK 
package models the minor allele (which is not always the coded allele), and the GEE 
models the coded allele, the sign of the beta estimates for the results from the GEE 
models have been reversed if required (+ to –, or – to +) to allow for consistency across 
models. 
2.1.3 Environmental data 
2.1.3.1 Individual-level social environment  
Two dimensions of individual-level social environment, chronic burden (CB) and 
social support (SS), were investigated in this dissertation. The CB scale was available at 
exam one and exam three.[118, 126] The summed “yes” responses for the CB scale were 
calculated for the following questions: ‘have you experienced ongoing health problems 
(self) greater than six months’; ‘has someone close to you experienced ongoing health 
problems greater than six months’; ‘have you experienced ongoing job difficulties greater 
than six months’; ‘have you experienced ongoing financial strain for greater than six 
months’; and ‘have you experienced ongoing relationship problems greater than six 
months’. If an individual’s response to any of the five aspects of the individual exam’s 
CB was missing, the exam-specific CB score was set to missing. 
 To capture the longitudinal aspect of CB, the scores from exams one and three 
were averaged for each individual. If an individual was missing either CB value, then the 
averaged CB was calculated from the existing measure. To increase the sample size, the 
average CB score was set to missing only if the measure was not calculated on both 




specifically (African, European, Chinese, and Hispanic Americans) is shown in Table 
3(a). For analyses, CB was mean centered to aid in interpretability. Higher values of CB 
score indicate a higher chronic burden (i.e. more burdens). The distribution of chronic 
burden, averaged over exams one and three is shown in Figure 10. 
 The emotional social support scale in MESA is composed of six questions on a 
five-point Likert scale (1 = “none of the time” to 5 = “all of the time”), and measured at 
exam one and exam three.[118, 127] The questions measured SS by asking whether 
‘someone available to listen to you’; ‘someone available to give you advice’; ‘someone 
available to show you love and affection’; ‘someone available to help with daily chores’; 
‘someone available to provide emotional support’; and ‘sufficient contact with someone 
you can confide in’. If any of the component items were missing, then the score was set 
to missing for that exam.  
 To capture the longitudinal aspect of social support, the SS scores from exams 
one and exam three were averaged together within an individual. If a participant was 
missing either exam-specific SS measure, then the averaged SS was calculated from the 
existing measure. Only if both SS measures were missing was the averaged value set to 
missing. The distribution of averaged SS for the overall sample and for each race 
specifically (African-, European-, Chinese-, and Hispanic-Americans) is shown in in 
Table 3(b). For analysis, SS was mean centered to aid in interpretation. Higher scores 
indicate more social support. The distribution of chronic burden, averaged over exams 
one and three is shown in Figure 11. 
 For the overall sample, the correlation between CB and SS is significantly 




and range from -0.26 and -0.29 (European: -0.29, p < 0.0001; African: -0.27, p < 0.0001; 
Chinese: -0.29, p<0.0001; Hispanic: -0.26, p<0.0001). Though they are correlated, they 
represent two different dimensions of individual-level social environment and are 
analyzed in separate models.  
Preliminary race-specific linear models for the association between depressive 
symptoms and social environment, both unadjusted and adjusted (adjusting for age, sex, 
adult socioeconomic position and individual-level social environment) are displayed in 
Table 4 and Table 5. The CB and SS scores were included in separate models. Averaged 
chronic burden score was significantly associated with averaged depressive symptom 
score in each ethnic group in both the unadjusted and adjusted models (p-value < 0.0001 
in all models; Table 4). Averaged social support was significantly associated with 
averaged depressive symptom score in each ethnic group in both the unadjusted and 
adjusted models (p-value < 0.0001 in all models; Table 5). These models support the 
need to investigate these factors in interaction with genes. 
2.1.3.2 Neighborhood-level social environment 
This dissertation uses three dimensions of neighborhood social environment: 
aesthetic quality (AQ), safety (SF), and social cohesion (SC) measured with a 1-mile 
radius as the definition of neighborhood. The 1-mile neighborhood radius around 
individual respondents was selected after examining Pearson’s correlations, linear models 
and clustered mixed models for the 1-mile and conditional empirical Bayes (CEB) 
neighborhood estimates for each MESA exam with CES-D measures (one, three, and 
four), and averaged across all three of the exams for the separate neighborhood 




characteristics. Evidence of significant, strong correlation between the CEB and 1-mile 
measures and significant association between depressive symptoms and each measure 
were used to determine if 1-mile measures would be appropriate for analysis. Since the 
correlation between the CEB and 1-mile measures was strong (>0.70) the 1-mile 
measures were used for analyses. The 1-mile neighborhood buffer is also consistent with 
the neighborhood definition of 1-mile from the Health and Retirement Study (which is 
being used as a replication sample in future analyses), which aids in interpretation and 
comparability across the two studies. 
The longitudinal scales for these measurements were created using the MESA 
Neighborhood Survey embedded within the MESA survey conducted at exam one, the 
MESA Neighborhood Activities Survey (MESAN) conducted at exams two and three, 
and MESA exam five (MESA5). Each MESA participant self-reported information about 
their neighborhood for these scales. Additionally, scales utilized information from a 
random sample of people in the 1-mile radius where MESA participants were living 
using the Community Survey (CS). The community surveys were conducted between 
January 2004 and August 2004 for the Baltimore, New York, and Los Angeles sites 
(CS1), between August 2006 and February 2008 for the New York and Los Angeles sites 
(CS2), and August 2011 and May 2012 for all six of the MESA study sites (CS3). See 
Table 6 for a timeline of surveys. 
These combined scales were created for the 1-mile neighbors using only questions 
that were common between MESA, MESA5, CS1, CS2, and CS3. The respondent’s own 
answer was not included in the crude means estimates. The neighborhood measures 




collection periods and allow for time-varying neighborhood information. The scales 
created from MESAN+CS1 are linked to exams one and three while the neighborhood 
scales created from MESA5+CS3 and are linked to exam four.  
Neighborhood measures were linked with individual MESA participants through 
address data. The address data is compiled for each month starting in 2000 and ending in 
January 2012 which coincides with the time the MESA study exams 1 – 5 were collected. 
Only MESA participants who agreed to participate in the neighborhood study are 
included in these analyses. Addresses were geocoded using a 5-foot offset from major 
roadways either using a batch process sending addresses directly to TeleAtlas to geocode 
(addresses added in 2007) or using EZ-Locate software at the University of Michigan 
(addresses added in 2010 or later). After geocoding, the neighborhood level data was 
linked to the addresses within a 1-mile buffer by matching each participant of the survey 
within 1 mile based on the latitude/longitude of the address. 
We have used measures pooling all MESA and CS data into crude means. Per 
MESA recommendation, when choosing which scales to include, I performed sensitivity 
analysis excluding neighborhoods where scales were based on less than five neighbors. 
The neighborhood scales and all preliminary analyses were calculated using SAS 9.2. 
SAS and all other SAS Institute Inc. product or service names are registered trademarks 
or trademarks of SAS Institute Inc., Cary, NC, USA.[128] 
In creating the neighborhood scales, “Don’t Know” or “Refused” values were set 




were reverse coded so that questions reflected better social outcomes with increasing 
scores. The original coding and which questions were reverse-coded is shown in Table 7. 
The correlations between the averaged neighborhood measures and the 
neighborhood index score (NIS) are shown in Table 8. All correlations were significantly 
greater than zero, with p-values <0.0001. The smallest correlation between the NIS and 
an averaged neighborhood dimension was with the SC score (r = 0.67).  
The model information from adjusted neighborhood dimension mixed models 
predicting depressive symptom score are presented in Table 9. Using the neighborhood 
summary score allows us to obtain a more reliable estimate, combining all the 
neighborhood dimensions into one value. Additionally, we are avoiding the issue of 
colinearity in our final models.  
The distributions of each component score (AQ, SF, SC), averaged over exams 
one, three, and four is shown, paneled by race, in Figure 13-Figure 15 along with the 
combined neighborhood index score in Figure 16. The index score was created by 
averaging the 1-mile means for the three variables across the three exams by 
neighborhood dimension and then averaging the three averages. If any one of the nine 
variables (AQ exam one, three, and four; SF exam one, three, and four; or SC exam one, 
three, and four) was missing then the index score is set to missing. The index score was 
then mean-centered by the overall mean to aid interpretability. Higher index scores 
indicate “more positive” overall neighborhood environments, such as a high degree of 
SF, good AQ, and/or good SC. The index scores range from 2.34 to 4.58 (mean centered 




analysis sample includes 5,023 total individuals (2,047 European Americans, 559 
Chinese Americans, 1,391 African Americans, and 1,026 Hispanic Americans) and is 
presented in Table 10.  
2.1.4 Covariates 
Information on age (in years), gender (male/female) and ethnic group was 
obtained from all MESA participants at baseline. Ethnic group was characterized using 
participants’ responses to questions modeled on the Year 2000 Census. Participants were 
classified as Hispanic, non-Hispanic white, Chinese and non-Hispanic black. These 
ethnicities will be referred to as Hispanic American (HA), European American (EA), 
Chinese American (CA), and African American (AA). Study sites included Baltimore 
MD (Johns Hopkins University Field Center); Chicago, IL (Northwestern Field Center); 
Forsyth County, NC (Bowman Gray Field Center); Los Angeles, CA (UCLA Field 
Center); New York, NY (Columbia Field Center); and St. Paul, MN (University of 
Minnesota Field Center). For the baseline analyses and the averaged analysis, baseline 
age, sex, ethnic group and study site were used. For the repeat measures analyses, age 
and study site were treated as time-varying, while sex and ethnic group were obtained 
from baseline. 
Adult socioeconomic position (ASEP) was used in aims two and three. Since 
several measures of ASEP were available (measuring different dimension of 
socioeconomic position), we summarized indicators into an ASEP score. The methods 
are based on previous work and combine information on income, education, and wealth 
(ownership of a home, car, land/property or investments).[129, 130] Income was defined 




collapsed from the original 13 categories in MESA. At the baseline examination, highest 
level of education completed was reported and for these analyses operationalized into 
four categories (completed high school or less, some college but no degree/technical 
school certificate, associate or bachelor’s degree, or graduate/professional degree). The 
four wealth indexes included: (1) whether the participant, or their family, had investments 
such as stocks, bonds, mutual funds, retirement investments, or other investments 
(yes/no), (2) whether the participant owned their home (yes/no), (3) whether the 
participant owned a car (yes/no), (4) whether the participant owned land or another 
property that was not their primary residence (yes/no). To create the summary score for 
ASEP, the individual measures for income, education and wealth were summed (income 
variable (0 – 3, low to high), education (0 – 3, low to high), and for each wealth indicator, 
a single point was added). The ASEP score ranged from 0 – 10, with higher scores 
indicating greater ASEP (Figure 17).   
2.1.5 Analysis data set and descriptive statistics 
 There are 8,227 individuals in the MESA genotype database. After removing 
participants with missing genetic data, depressive symptom score, or covariates used for 
analysis (Aim 1: age, sex, site, top four ethnicity-specific principal components), we had 
an analysis sample size of 6,335 (EA: 2,514; AA: 1,603; CA: 775; HA: 1,443) 
individuals. For aims two and three, the sample size was further reduced removing 





2.2 Health and Retirement Study 
HRS is a dynamic cohort, national panel survey and includes measures collected every 
two years on more than 22,000 Americans over the age of 50 in multiple race/ethnic 
groups. It is the largest, most representative longitudinal study of Americans over age 50. 
HRS began collecting data in 1992 using a probability sample with oversamples of 
minorities. HRS is supported by the National Institute on Aging (NIA U01AG009740) 
and the Social Security Administration. The baseline HRS cohort consists of people who 
were born in 1931 through 1941 and were household residents of the contiguous United 
States in the spring of 1992, and their spouses or partners at the time of the initial 
interview in 1992 or at the time of any subsequent interview. The HRS is an ideal sample 
for joint analysis because HRS participants are roughly the same age as MESA 
participants, both samples are multi-ethnic, and both studies have similar measures of the 
outcomes and environments of interest. The HRS study contains several different facets 
including a core survey,[131] a psychosocial leave-behind participant questionnaire 
(LBQ),[132] and genetic data.[133]  
2.2.1 Depressive symptoms  
Depressive symptoms were measured in HRS participants at multiple follow-up visits 
using the 8-Item CES-D Scale. Each self-respondent was asked the following questions 
with ‘yes’ or ‘no’ response options: 1) Much of the time during the past week, I felt 
depressed; 2) I felt everything I did was an effort; 3) My sleep was restless; 4) I was 
happy; 5) I felt lonely; 6) I enjoyed life; 7) I felt sad; 8) I could not “get going”. The total 
number of “yes” responses to questions 1, 2, 3, 5, 7, and 8, and the “no” responses to 




to 8 (Figure 18). Since there were no assessments of anti-depressant medication in HRS, 
the scores were not adjusted for medication use. 
2.2.2 Genetic data 
Over 16,000 HRS respondents were genotyped in 2006 or 2008 using the Illumina 
Human Omni-2.5 Quad beadchip methodology to collect information on ~2.5 million 
SNPs .[133] Samples originated from either buccal swabs (collected in 2006) in phase I 
or from saliva samples (collected in 2008) in phase II. Though these phases were 
genotyped separately, the data was clustered and called together. Genotyping was 
conducted by the Center for Inherited Disease Research (CIDR) at Johns Hopkins 
University. Individuals with missing call rates >2%, SNP with missing call rates <85%, 
chromosomal anomalies, and first degree relatives in the HRS were removed from the 
database before posting to dbGaP. The genotyping data is consistent with build 
37/hg19.[134] Respondents who consented to provide DNA samples and answered at 
least one of the CES-D8 assessments were used in the analysis.  
All HRS respondents who provided DNA samples and completed at least one 
CES-D8 depressive symptom assessment (N = 10,163) were used in the analyses. Nearly 
10,000 members of this sample responded to the CES-D8 items on five or more interview 
occasions between 1993 and 2010. 
2.2.3 Covariates 
Age (in years) and gender (male/female) were assessed for all HRS participants at 
the first exam for which they had a valid measure of CES-D8. The first exam for which a 




Genetic ancestry in HRS was identified through principal component analysis on 
genome-wide SNPs calculated across all participants. The final European American 
sample included all self-reported non-Hispanic whites that had PC loadings within ±one 
standard deviations for eigenvectors 1 and 2 in the PCA of all unrelated study subjects. 
The final African American sample included all self-reported African Americans within 
two standard deviations of all self-identified African Americans for eigenvector 1 and ± 
one standard deviation for eigenvector 2 in the PCA of all unrelated study subjects.  
2.2.4 Analysis data set and descriptive statistics 
 There are 12,507 individuals with phenotype information in dbGaP. After 
removing individuals with missing information on phenotype, genotype, or the covariates 
of interest, the final analysis subset for HRS consisted of 10,163 individuals. Of those 









Table 1 Exclusion criteria for the Multi-Ethnic Study of Atherosclerosis[118] 
Age younger than 45 or older than 84 years 
Physician-diagnosed heart attack 
Physician-diagnosed angina or taking nitroglycerin 
Physician-diagnosed stroke or TIA 
Physician-diagnosed heart failure 
Current atrial fibrillation 
Having undergone procedures related to cardiovascular disease (CABG, angioplasty, valve replacement, pacemaker or 
defibrillator implantation, any surgery on the heart or arteries) 
Active treatment for cancer 
Pregnancy 
Any serious medical condition which would prevent long-term participation 
Weight >300 pounds 
Cognitive inability as judged by the interviewer 
Living in a nursing home or on the waiting list for a nursing home 
Plans to leave the community within five years 
Language barrier (speaks other than English, Spanish, Cantonese or Mandarin) 









Table 2 Depressive symptoms by ethnic group, imputed and non-imputed for each exam, MESA 
 EA CA AA HA Total 
 n (%)                       n (%)                       n (%)                       n (%)                       n 
Exam 1      
No anti-depressant use 2214 (87.58) 756 (97.55) 1613 (96.07) 1363 (94) 5,946 
CES-D [mean (sd)] 6.48 (6.45) 6.1 (6.42) 7.16 (7.15) 9.17 (8.65)  
Anti-depressant use 314 (12.42) 19 (2.45) 66 (3.93) 87 (6) 486 
CES-D before imputation [mean (sd)] 10.36 (8.81) 8.05 (10.67) 11.95 (10.59) 13.7 (11.3)  
CES-D after imputation [mean (sd)] 18.56 (7.46) 16.05 (10.31) 20.92 (8.75) 23.76 (8.23)  
Exam 3      
No anti-depressant use 2185 (86.43) 761 (98.19) 1616 (96.25) 1365 (94.14) 5,927 
CES-D [mean (sd)] 6.38 (6.58) 6.00 (7.01) 6.81 (7.05) 9.27 (9.15)  
Anti-depressant use 343 (13.57) 14 (1.81) 63 (3.75) 85 (5.86) 505 
CES-D before imputation [mean (sd)] 10.84 (9.19) 8.36 (8.85) 13.1 (11.34) 13.87 (10.68)  
CES-D after imputation [mean (sd)] 19.35 (7.58) 14.57 (7.97) 22.99 (8.36) 22.95 (7.71)  
Exam 4      
No anti-depressant use 2184 (86.39) 764 (98.58) 1608 (95.77) 1356 (93.52) 5,912 
CES-D [mean (sd)] 6.91 (6.8) 5.98 (6.67) 6.94 (6.49) 9.19 (8.93)  
Anti-depressant use 344 (13.61) 11 (1.42) 71 (4.23) 94 (6.48) 520 
CES-D before imputation [mean (sd)] 11.34 (9.29) 11.55 (11.29) 13.51 (11.76) 16.56 (12.49)  
CES-D after imputation [mean (sd)] 19.91 (7.55) 19.92 (7.66) 23.88 (8.58) 27.03 (10.21)  
* CES-D scores were imputed within each race and gender separately, within each exam separately. EA: European American, CA: Chinese 










Table 3 Descriptive statistics of averaged chronic burden and averaged social support by race and for the overall MESA sample 
  N Mean Standard  
Deviation 
Minimum Maximum 
(a) Averaged Chronic Burden      
Overall 5967 1.06 1.02 0 10 
European Americans 2520 1.10 1.02 0 5 
Chinese Americans 774 0.65 0.82 0 4.5 
African Americans 1664 1.17 1.09 0 5 
Hispanic Americans 1445 1.06 1.01 0 5 
(b) Averaged Social Support           
Overall 6421 24.15 4.86 6 30 
European Americans 2524 24.06 4.94 6 30 
Chinese Americans 775 23.86 4.31 6 30 
African Americans 1672 24.27 4.73 6 30 











Table 4 Race-specific linear models predicting averaged depressive symptom score for unadjusted and adjusted linear models 
  African American European American Chinese American Hispanic American 
  Beta Std Err p value Beta Std Err p value Beta Std Err p value Beta Std Err p value 
Intercept 1.54 0.03 <.0001 1.60 0.02 <.0001 1.41 0.04 <.0001 1.79 0.03 <.0001 
Averaged Chronic Burden 0.31 0.02 <.0001 0.33 0.02 <.0001 0.40 0.03 <.0001 0.32 0.02 <.0001 
Intercept 1.95 0.14 <.0001 2.11 0.13 <.0001 1.05 0.23 <.0001 1.87 0.14 <.0001 
Age 0.00 0.00 0.41 0.00 0.00 0.15 0.00 0.00 0.62 0.00 0.00 0.96 








  ASEP -0.06 0.01 <.0001 -0.07 0.01 <.0001 0.04 0.01 0.00 -0.06 0.01 <.0001 
Averaged Chronic Burden 0.27 0.02 <.0001 0.30 0.02 <.0001 0.38 0.03 <.0001 0.31 0.02 <.0001 










Table 5 Race-specific linear models predicting averaged depressive symptom score for unadjusted and adjusted linear models 
  African American European American Chinese American Hispanic American 
  Beta Std Err p value Beta Std Err p value Beta Std Err p value Beta Std Err p value 
Intercept 3.45 0.09 <.0001 3.60 0.08 <.0001 3.83 0.15 <.0001 3.78 0.10 <.0001 
Averaged Social Support -0.06 0.00 <.0001 -0.07 0.00 <.0001 -0.09 0.01 <.0001 -0.07 0.00 <.0001 
Intercept 4.05 0.16 <.0001 4.08 0.13 <.0001 3.23 0.24 <.0001 3.86 0.16 <.0001 
Age -0.01 0.00 <.0001 -0.01 0.00 <.0001 0.00 0.00 0.14 0.00 0.00 0.08 








  ASEP -0.06 0.01 <.0001 -0.06 0.01 <.0001 0.04 0.01 <.0001 -0.04 0.01 <.0001 
Averaged Social Support -0.06 0.00 <.0001 -0.06 0.00 <.0001 -0.09 0.01 <.0001 -0.06 0.00 <.0001 





Table 6 Timeline of MESA surveys 
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 
 MESA1  
 MESA NS  
 MESA 5 







Table 7 Neighborhood scales common questions for Social Cohesion, Aesthetic Quality and 
Neighborhood Safety, MESA 
Scale Component Question 
Social Cohesion (higher 
score is better cohesion) 
SocCo1 People around here are willing to help their neighbors – 
Reverse coded 
 SocCo2 People in my neighborhood generally get along with each 
other – Reverse coded 
 SocCo3 People in my neighborhood can be trusted – Reverse 
coded 
 SocCo4 People in my neighborhood share the same values – 
Reverse coded 
Aesthetic Quality (higher 
score is better Aesthetic 
Quality) 
AeQual1 There is a lot of trash and litter on the street in my 
neighborhood. 
AeQual2 There is a lot of noise in my neighborhood. 
AeQual3 My neighborhood is attractive – Reverse coded 
Safety (higher score is 
more safety) 
Safe1 I feel safe walking in my neighborhood day or night – 
Reverse coded 
Safe2 Violence is a problem in my neighborhood. 
Original coding for all components is 1=Strongly Agree, 2=Agree, 3=Neither Agree Nor Disagree, 











Table 8 Pearson's correlations between averaged neighborhood measure and neighborhood index 
score 
Simple Statistics 
Variable N Mean Std Dev Minimum Maximum 
NIS 4754 0.00 0.33 -1.30 0.95 
Averaged 
aesthetic quality 
4846 3.70 0.42 2.17 5.00 
Averaged safety 4848 3.67 0.42 2.00 5.00 
Averaged social 
cohesion 
4761 3.56 0.25 2.42 5.00 







 NIS 1 0.95 0.91 0.88 
 Averaged 
aesthetic quality 
  1 0.77 0.84 
 Averaged safety     1 0.67 
 Averaged social 
cohesion 
      1 
 NIS: Neighborhood Index Score,  

















Table 9 Parameter estimates for log transformed (CES-D score + 1), standard errors, and p-values for adjusted mixed-models, for each separate 
neighborhood dimension and for neighborhood index score 
 
Aesthetic Quality Safety Social Cohesion Neighborhood Index Score 
Effect Beta SE P Beta SE P Beta SE P Beta SE P 
Intercept 2.89 0.13 <.0001 2.88 0.14 <.0001 3.04 0.19 <.0001 2.54 0.08 <.0001 
Age -0.01 0.00 <.0001 -0.01 0.00 <.0001 -0.01 0.00 <.0001 -0.01 0.00 <.0001 
Female 0.16 0.02 <.0001 0.16 0.02 <.0001 0.17 0.02 <.0001 0.17 0.02 <.0001 
Male (ref)     (ref)     (ref)     (ref)     
EA -0.01 0.03 0.8731 -0.01 0.03 0.7111 -0.01 0.03 0.8323 0.00 0.03 0.9263 
CA -0.31 0.04 <.0001 -0.32 0.04 <.0001 -0.34 0.04 <.0001 -0.32 0.04 <.0001 
AA -0.09 0.03 0.0084 -0.11 0.04 0.0017 -0.10 0.04 0.0062 -0.10 0.04 0.0042 
HA (ref)     (ref)     (ref)     (ref)     
ASEP -0.05 0.00 <.0001 -0.05 0.00 <.0001 -0.05 0.00 <.0001 -0.05 0.00 <.0001 
Neighborhood Value 
AQ -0.09 0.03 0.0038                   
SF       -0.09 0.03 0.008             
SC             -0.14 0.05 0.0091       
NIS                   -0.13 0.04 0.0019 
ASEP: Adult socioeconomic position, AQ: Aesthetic Quality, SF: Safety, SC: Social Cohesion, NIS: Neighborhood Index Score, EA: European, CA: 









Table 10 Mean centered summary neighborhood index score, combined sample and race-specific 
  N Mean Std Dev Minimum Maximum 
Overall 5023 3.63 0.34 2.34 4.58 
Overall (MC) 5023 0.00 0.34 -1.29 0.95 
European (MC) 1979 0.13 0.29 -1.19 0.95 
Chinese (MC) 543 0.06 0.24 -0.87 0.82 
African American (MC) 1239 -0.09 0.34 -0.77 0.83 
Hispanic (MC) 993 -0.18 0.33 -1.30 0.92 



















Figure 6 Distribution of CES-D score by exam for those with missing anti-depressant use (missing 












Figure 8 Distribution of CES-D score, raw and log-transformed, by ethnicity averaged across exams 







Figure 9 Distribution of CES-D score, raw and log-transformed, by ethnicity for repeated measures 

















































Figure 16 Distributions of neighborhood index score, averaged over Exams one, three, and four, 















Figure 18 Distribution of CES-D score, raw and log-transformed, by ethnicity, averaged across 








III. Comparative genome-wide association studies of depressive symptom phenotype 
in a repeat measures setting by ethnic group in the Multi-Ethnic Study of 
Atherosclerosis 
3.1 Introduction 
Major Depressive Disorder (MDD) is the most prevalent mental disorder in the 
United States [7]. The lifetime prevalence of MDD is approximately 16.6% with a 12-
month prevalence of approximately 6.7% in US adults aged 18 and over [8, 135].  MDD 
is associated with high morbidity [136-138]. It is estimated that the heritability of MDD 
is in the range of 31% to 42%, indicating a strong genetic contribution to disease 
etiology.[139, 140] 
Though several linkage studies of MDD have been performed, only a single locus 
has been identified in the 17q-31 chromosomal region [141, 142]. Genome wide 
association studies (GWAS) have also had limited success in identifying new associated 
loci. Nine GWAS on MDD have been published to date [9-13, 136, 139, 143, 144] as 
well as a meta-analysis of the nine GWAS that included almost 19,000 European 
unrelated individuals [114]. Only one loci reached genome wide significance in 
individual studies[113], but this loci was not significantly associated with MDD in the 
meta-analysis [114]. Meta-analyses of genetic predictors of MDD are currently consistent 





pathways (such as TPH2, HTR2A, MAOA, COMT) have rarely been identified/replicated 
as predictors of MDD in GWAS [136, 145-147]. 
It is possible that measurement error in the assessment of MDD could be 
contributing to the largely null findings. Depressive symptoms exist on a spectrum, 
varying in both severity and duration. The ability to detect genetic predictors of 
depression may be enhanced by analyzing depressive symptoms quantitatively [148], 
rather than applying cutoffs or defining disorders such as MDD at the extreme of the 
continuum [15]. Depressive symptoms are often measured using the 20-item Center for 
Epidemiologic Studies Depression scale (CES-D). Because depressive symptoms may 
vary over time in relation to a variety of circumstantial factors, repeated measures of 
depressive symptoms may provide a better characterization of an individual’s phenotype 
than a single measure, thus increasing power to detect underlying genetic predictors.  
The Multi-Ethnic Study of Atherosclerosis (MESA) was recently part of a 
discovery sample for a cross-sectional GWA study of depressive symptoms conducted by 
the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) 
consortium [120]. This GWAS focused on a single measure of depressive symptoms (as 
assessed by CES-D) in individuals of European descent. Though no loci reached genome-
wide significance in the discovery sample (composed of 34,549 individuals), one of the 
seven most significant SNPs had a suggestive association in the replication sample 
(rs161645, 5q21, p = 9.19x10
-3
). This SNP reached genome-wide significance (p = 
4.78x10
-8
) in overall meta-analysis of the combined discovery and replication samples (n 
= 51,258) [120]. Important limitations of this GWAS include the reliance on a single 





study improves the characterization of the phenotype through the incorporation of 
repeated measures of depressive symptoms over time and extends the GWAS to multiple 
ethnicities. 
 We use longitudinal data on depressive symptoms collected over a 9 year period 
in MESA to conduct GWAS on depressive symptoms in four race/ethnicities. We also 
contrast different approaches of incorporating the repeated measures into the GWAS: (1) 
analyzing a single time-point measure (baseline), (2) averaging measures over time, and 
(3) conducting a repeated measures outcome analyses. Finally, we jointly analyze 
repeated measures GWAS results from MESA and the Health and Retirement Study 
(HRS) in an overall meta-analysis for European Americans and African Americans to 
increase our power.  To our knowledge, there have been no GWAS of repeated measures 
of depressive symptoms measured over time in individuals of multiple race/ethnicities.   
 
3.2 Methods 
3.2.1 Discovery sample 
MESA is a longitudinal study supported by NHLBI with the overall goal of 
identifying risk factors for subclinical atherosclerosis [118]. The MESA cohort was 
recruited in 2000-2002 from six Field Centers: Baltimore, MD (Johns Hopkins University 
Field Center), Chicago, IL (Northwestern Field Center), Forsyth County, NC (Bowman 
Gray Field Center), Los Angeles, CA (UCLA Field Center), New York, NY (Columbia 
Field Center), and St. Paul, MN (University of Minnesota Field Center). MESA 





baseline. At each site a probability sample of approximately 1,100 participants was 
selected through a variety of population-based approaches. At baseline the MESA cohort 
included 6,814 men and women, with 38.5% non-Hispanic whites (EA), 27.8% non-
Hispanic African Americans (AA), 22% Hispanics (HA), and 11.8% Chinese (CA). 
Participants attended a baseline examination (2000-2002) and three additional follow-up 
examinations approximately 18-24 months apart. At each clinic visit, participants 
completed a series of demographic, personal history, medical history, access to care, 
behavioral, and psychosocial questionnaires in English, Spanish, or Chinese. Depressive 
symptoms were assessed using the Center for Epidemiologic Studies Depression scale 
(CES-D) at exams 1, 3 and 4. The total number of participants and the corresponding 
response rates (of participants alive) were: exam 1 (n=6,814), exam 2 (n=6,239, 92%), 
exam 3 (n=5,946, 89%), exam 4 (n=5,704, 87%). After removing participants with 
missing genetic data, depressive symptom score, or covariates used for analysis, we had 
an analysis sample size of 6,335 (EA: 2,514; AA: 1,603; CA: 775; HA: 1,443) 
individuals. The total number of individuals with one, two or multiple repeated measures 
can be reviewed in Table 11. Institutional review boards at each site approved study 
protocol.  
3.2.2 Depressive symptom score 
Depressive symptom score was assessed using the 20-item CES-D Scale [14]. The 
CES-D was developed by the Center for Epidemiologic Studies for use in general 
population surveys [14, 19]. The CES-D has an excellent internal consistency 
(Cronbach’s alpha = 0.90) [14], and is designed to assess depressive symptoms at a 





sum of the 20 items, ranging from 0 to 60. If more than 5 items were missing, the CES-D 
score was not calculated. If 1-5 items were missing, the scores were summed for 
completed items, dividing the sum by the number of questions answered and then 
multiplying by 20. There were 5,178 participants with three measures of CES-D, 507 
with two measures, and 650 with only baseline CES-D measures, for a total of 6,335 
participants with 17,198 observations. The CES-D scores were log-transformed to 
improve normality. 
 Anti-depressant use was defined as taking any or multiple of the following 
medications: Selective Serotonin Reuptake Inhibitors (SSRIs), Monoamine Oxidase 
Inhibitor (MAOI), Tricyclic anti-depressant, and/or Non-tricyclic anti-depressant other 
than MAOI. Anti-depressant use was assessed at each exam and corrected CES-D scores 
were estimated for each exam.  A total of 7.6%, 7.9% and 8.1% of persons were on anti-
depressant medications at exams 1, 3 and 4, respectively. We corrected for anti-
depressant use with methods previously described [120]. Briefly, assuming that the 
depression score is lower in treated than in untreated participants, and that participants 
with high depression scores, on average, respond less to their medication than persons 
with lower depression scores, we used a nonparametric imputation algorithm to adjust for 
the treatment effect. Separately for men and women and within each ethnicity separately, 
we replaced CES-D score for a person using anti-depressants with the mean depressive 
symptom score of all persons using anti-depressants with greater or equal CES-D scores. 
This method is based on an algorithm previously used to adjust blood pressure for 
persons on antihypertensive medication [119]. We chose not to exclude participants 





depressive symptom scores and thus add value to genetic studies. To improve normality 
consideration for the outcomes, baseline, averaged and repeated measures CES-D (adding 
one point to all values) were log-transformed after adjustment for anti-depressant use. 
3.2.3 Genotyping 
MESA is a participating study in the SNP Health Association Resource (SHARe) 
Project. About one million SNPs were genotyped using the Affymetrix Genome-Wide 
Human SNP Array 6.0. The IMPUTE 2.1.0 program was used in conjunction with 
HapMap Phase I and II reference panels (CEU+YRI+CHB+JPT, release 22 - NCBI Build 
36 for African-, Chinese- and Hispanic-American participants; CEU, release 24 - NCBI 
Build 36 for European Americans) to increase the number of available SNPs to 
approximately 2.5 million markers. We accounted for population substructure by 
including the top four ethnicity-specific principal components (estimated from genome-
wide data) as adjustment covariates in all analyses, as proposed previously by MESA 
investigators and elsewhere [121, 122].   
3.2.4 Joint Sample 
We used the Health and Retirement Study (HRS) as a joint sample to be 
combined with MESA GWAS results in a meta-analysis [149]. These two studies have 
comparable participants, and similar measures of phenotype. The HRS surveys a 
representative sample of more than 26,000 Americans over the age of 50 every two years 
starting in 1992. HRS data includes information on depressive symptoms measured with 
a short form of the CES-D, the CES-D8. The CES-D8 includes a subset of eight items 
from the full 20-item CES-D [14]. The depression score for each participant was 





symptom score ranges from 0 to 8. Participants missing two or more of the eight items 
were excluded from the analyses. The Institutional Review Board at the University of 
Michigan, where the study was conducted, approved study protocol before data 
collection. The depressive symptom phenotype for MESA was constructed form the full 
20 items available while the HRS depressive symptom phenotype was calculated from 
the 8 available items. 
Over 12,000 HRS participants were genotyped for about 2.5 million SNPs using 
the Illumina Human Omni-2.5 Quad beadchip. Genotypes were imputed for European 
Americans and African Americans using MACH software (HapMap Phase II, release 
#22, CEU panel for European Americans and CEU+YRI panel for African Americans). 
We accounted for population substructure by including the top four ethnicity-specific 
principal components (estimated from genome-wide data) as adjustment covariates in all 
analyses. There were 10,163 HRS participants after removing those with missing 
outcome, covariate or genetic information. A total of 507 had only one measure of CES-
D8, 34 had only two measures, and 9,982 had three or more CES-D8 measures, for a total 
of 72,273 observations. 
3.2.5 Genome-wide association analysis 
We contrasted GWAS results using different approaches to incorporate the time-
varying phenotypic data:  using a single (baseline) measure, taking the average across 
exams, or conducting a repeated measures analysis that accounts for correlation of 





Baseline and averaged GWA studies were analyzed using a one-step linear 
regression approach, adjusting for age, sex, site (in MESA) and the first four genome-
wide principal components, stratified by race in PLINK v.1.07 [123, 124]. The analytic 
approach and included covariates are consistent with previous GWAS [119, 120]. Each 
SNP was analyzed separately, using SNP dosages, in an additive genetic model. 
Below are the linear models used in the baseline: 
                  
and averaged GWA analysis:  
   ̅                
Where    is the log-transformed depressive symptom measure (baseline CES-D) and  ̅   
is the averaged CES-D over all available time points for individual i, X is a vector of 
covariates: age at baseline, sex, site at baseline (for MESA), the top four ethnic-specific 
principal component loadings for individual i, and SNP is the dosage values for a 
particular SNP for individual i. 
For the repeated measures, we used generalized estimating equations (GEE) to 
account for within-individual correlations between repeated CES-D measures [150]. 
Advantages of the repeated measures analysis include improved characterization of a 
time-varying phenotype and greater power than afforded by a single outcome measure. 
We did not include a time indicator, since there was no significant time effect across 
exams for MESA participants. Below is the generalized estimating equation model 





                       
      
        
            
         
Throughout the dissertation:                       
For a given depressive symptom measure y (log-transformed within each exam), yit is the 
t
th
 measure (i.e., depressive symptom score measure at exam 1, 3, or 4) for participant i. 
The identity link function is used to describe the variance of     as a function of the 
mean, where     is the marginal mean of yit. The vector X represents time-invariant 
covariates including sex and top four principal components for individual i, measured at 
baseline. Time-varying covariates, represented by Z are age and site for individual i at 
time t. Within the ‘geepack’ package in the R software, we used an exchangeable 
(compound symmetric) correlation structure, represented as       .[151, 152]. 
3.2.6 Comparison of p-values across phenotype approach 
To examine whether p-values from GWAS in MESA were consistent in rank 
across the three analysis approaches (baseline, averaged across exams, repeated 
measures), we calculated Spearman’s correlations between the ranks of p-values (for 
SNP-phenotype associations for baseline versus averaged, baseline versus repeated 
measures, and averaged versus repeated measures) for the set of SNPs within ethnic 
group. Spearman’s correlation is defined as: 
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Where x is the rank for individual SNP l for a given approach j, and y is the rank for 
individual SNP l for a given approach k, where j ≠ k. Rank ties or value duplicates are 
assigned a rank equal to the average of their positions in the ascending order of the 
values. We would expect that the test statistics corresponding to the averaged versus 
repeated measures approach would be highly correlated due to the definition of these two 
phenotypes.  
3.2.7 Meta-analysis  
To increase statistical power to detect SNP association, we performed a fixed-
effects meta-analysis combining results across all four ethnicities within the MESA study 
for each of the three phenotype definitions (baseline, averaged, repeated measures), 
weighting by sample size. In order to further investigate consistency of associations 
across different studies we also conducted a meta-analysis for European Americans and 
African Americans (separately) across the MESA and HRS studies for the repeated 
measures phenotype. We use only the African American and European American 
samples due to the availability of a large enough sample size for these two ethnicities in 
HRS. For the analysis that includes both MESA and HRS, the repeated measures 
phenotype was selected to allow for maximum power. All meta-analyses were performed 
using METAL [153].  
3.3 Results 
3.3.1 Descriptive statistics 
Descriptive statistics for the MESA and HRS samples are presented in Table 12. 





at baseline is 62.2 years and approximately 40%, 25%, 12%, and 23% are of European-, 
African-, Chinese-, and Hispanic-American self-reported ethnicity, respectively.  
In MESA, the mean baseline depressive symptom score ranged from 6.3 (standard 
deviation (SD): 6.6) in the Chinese subsample to 9.9 (SD: 9.22) in the Hispanic 
subsample out of a possible score of 60.  CES-D scores in this sample tended to increase 
slightly over time so that average scores across visits tended to be higher than baseline 
scores for all ethnicities, except in the Chinese sample which decreased slightly over 
time. The intraclass correlation (within-person correlation) across all exams for which an 
individual had a valid CES-D score (up to three time-points) ranged from 0.44 in African 
Americans to 0.60 in European Americans.  
The HRS analysis sample contains 10,163 respondents, with 8,652 European 
Americans (85%) and 1,511 African Americans (15%). The HRS sample is 41% male 
with an average age at baseline of 58 years. The CES-D8 depressive symptom score in 
HRS EA and AA participants increased, though negligibly in EA participants, over time. 
The intraclass correlation for the HRS participants across exams was 0.48 for the EA 
participants and 0.51 for the AA participants.   
3.3.2 Ethnicity-specific association analysis in MESA 
Table 13 shows the number of SNPs, minimum p-value of the adjusted 
association between SNP dosage and outcome, and the genomic-control inflation factor, 
lambda, for each ethnicity in MESA and HRS. Quantile-Quantile (QQ) plots and 
Manhattan plots for all GWA analyses is shown in Appendix 14-Appendix 20) The 





by ethnicity [154], is very close to 1.0 for all analyses, indicating that the potential 
confounding effect of population structure is adequately adjusted. One SNP reached 
genome-wide significance in the Hispanic subset in the baseline CES-D approach in the 
intronic region of the MUC13 gene (rs1127233, 3q22.1, p-value = 2.73x10
-8
). This gene 
has previously been linked to cancer pathogenesis (e.g. [155-164]) but has not been 
implicated in any psychiatric disorders. There were no other genome-wide significant hits 
in any of the ethnicities for any of the modeling approaches. There were, however, 
unique (LD R
2
 < 80%) genome-wide suggestive (5x10
-8
 < p-value ≤ 5x10
-6
) hits in each 
ethnicity for each of the modeling approaches: baseline CES-D (EA n=9; AA n=7; CA 
n=1; HA n=10), averaged CES-D (EA n=6; AA n=9; CA n=2; HA n=4), and repeated 
measures CES-D (EA n=11; AA n=11; CA n=4; HA n=11) (Table 13). For all ethnicities 
the majority of the p-values decreased in size from the averaged to the repeated measures 
CES-D analysis (EA: 50.7% 95%CI (50.6, 50.8), AA: 51.1 (51.0, 51.1), CA: 51.7 (51.6, 
51.7), HA: 50.6 (50.6, 50.7). Additional results (presented in Table 14) show the number 








) for the baseline and 
averaged approaches. In general, more SNPs were implicated at lower p-values in the 
averaged approach than in the baseline approach. This, in combination with an increase 
in the number of SNPs at the genome-wide suggestive level from the baseline to the 
repeated measures analysis, indicates greater power with the repeated measures analysis. 
3.3.3 Sensitivity Analysis 
In order to examine whether correction for anti-depressant use influenced results, 
sensitivity analyses were conducted by excluding participants using anti-depressants. 





as ranked by p-value (i.e. the 10 SNPs with the smallest p-values and with ethnicity-
specific minor allele frequencies greater than 5% and linkage disequilibrium (LD) R
2
 < 
80%) in each ethnicity for analyses based on the repeated measures. Results were 
consistent with the original analyses. 
3.3.4 Comparison of results across approaches 
To compare association results between the different versions of the CES-D 
scores, we plotted the p-values from each pair of SNPs for the baseline CES-D score 
compared to the averaged CES-D score phenotype (Figure 19), the baseline CES-D score 
compared to the repeated measures CES-D score (Figure 20), and the averaged CES-D 
score to the repeated measures CES-D score (Figure 21) within each of the four 
ethnicities in MESA. Each panel shows the -log10 p-value from the two approaches in 
comparison with an x = y line overlaid, for each of the four ethnicities. The x = y line 
represents perfect concordance between p-values in the two approaches. For all four 
ethnicities, the Spearman’s rank correlations between the baseline versus averaged CES-
D phenotype and between the baseline and repeated measures CES-D phenotypes ranged 
between 0.46 and 0.57. The correlations between p-values for the averaged versus 
repeated measures CES-D phenotype were higher. The European sample had the highest 
correlation (0.92), while the Chinese subset had the lowest (0.85) (Table 15).  
3.3.5 Meta-analysis across ethnicities in MESA 
The results from the three meta-analyses performed within MESA and across 
ethnicities for the baseline, averaged and repeated measures CES-D scores are presented 
in Table 16. For every unique (LD R
2
 < 80%) SNP with a p-value <1x10
-6
, we present the 





meta-p-value, direction of effect, and closet gene within ±50kB of the SNP. The meta-
analysis only included SNPs with ethnicity-specific minor allele frequency (MAF) > 
0.05. The MAF was calculated within ethnicity using only participants from the MESA 
study. Thirteen SNPs reached the genome-wide suggestive threshold in these meta-
analyses (baseline n=3; averaged n=5, repeated measures n=3). The smallest p-value we 
observed was in the repeated measures meta-analysis on chromosome 2, (rs41379347, 
2q32.2, p-value = 1.81x10
-7
). This SNP was only present in the Chinese- and Hispanic-
American subsamples (with MAF > 0.05). This SNP is in the intronic region of the 
STAT1 gene, IFN-γ transcription factor signal transducer and activator of transcription 1, 
previously implicated as a tumor suppressor [165, 166]. This SNP has not been 
previously linked to depressive symptoms. 
3.3.6 Joint-analysis across studies 
Results from the joint-analyses for the European and African Americans, 
separately, across the MESA and HRS studies are presented in Table 17. While no SNP 
reached the genome-wide level, eight SNPs (EA n=3; AA n=5) satisfied the suggestive 
threshold for significance. In European Americans, the smallest observed p-value was on 
chromosome 4 (rs6842756, 4q35.1, p-value = 6.54x10
-7
) located within the ENPP6 gene, 
which is expressed primarily in the kidney and brain and has not been implicated in any 
disorders or diseases [167]. In African Americans, the smallest observed p-value was on 
chromosome 20 (rs2426733, p-value = 2.07x10
-6
) located downstream of the RBM38 
(20q13.31) oncogene. RBM38 encodes an RNA binding protein found to regulate MDM2 





identified in genetic studies of depressive symptoms or any other psychiatric disorders 
[165, 167]. 
3.3.7 Consistency with previous GWAS on depressive symptom scores 
There has been one published GWAS conducted on depressive symptom scores 
[120]. This GWAS found one genome-wide significant hit in overall meta-analysis of 
51,258 European-ancestry individuals (rs161645, 5q21, p = 4.78x10
-8
). In our baseline 
CES-D phenotype meta-analysis across ethnicities within MESA, this SNP had a p-value 
of 0.067, in the averaged CES-D phenotype GWAS a p-value of 0.006, and in the 
repeated measures GWAS a p-value of 0.008. The overall direction of effect was 
consistent with the published GWAS for EA, AA, and HA, though the direction of effect 
was reversed for CA. The SNP was present in all four MESA ethnicities. In meta-
analyses performed across the MESA and HRS studies (for European and African 
Americans), the p-values for this SNP were 0.951 and 0.113 respectively. The direction 
of effect in HRS EA was opposite that of MESA EA, though the HRS-specific SNP 
association was not significant (p-value = 0.48). 
 
3.4 Discussion 
This study uses genome-wide association studies of depressive symptoms in a 
longitudinal framework and across ethnicities to find common variants for depressive 
symptoms. We include a joint-analysis sample for European and African Americans that, 
when combined with the MESA sample, composed of 16,498 individuals. We found one 





CES-D approach (rs1270666, 2q32.2, p-value = 2.73x10
-8
). This is a novel finding in the 
depressive symptom genetic literature. Though power to detect genetic variants of 
depression has been shown to increase when assessing depression quantitatively — as 
opposed to using a dichotomous definition or cutoff point [24] — we did not find any 
variants that reached genome-wide significant levels in the European-, African- or 
Chinese-American, ethnicity-specific GWAS, across ethnicity meta-analysis for any 
ethnicities, or across study meta-analysis for the European and African Americans. 
However, we did find several novel variants at a genome-wide suggestive level, 
particularly in the repeated measures analysis. This increase in the number of SNPs found 
at the genome-wide suggestive level is a reflection of the increase in the power to detect 
genetic variants using a repeated measures method. 
This is the first genome-wide association study, to the authors’ knowledge, to 
investigate depressive symptoms in a longitudinal setting across four different ethnicities. 
A previously published GWAS on depressive symptoms identified a SNP (rs161645) 
associated with a large sample of European-ancestry participants measured at a single 
time point. It is important to note that European Americans from MESA were used in the 
discovery sample for the previously published GWAS. Our analysis provides support for 
the association of this SNP with depressive symptoms not only in MESA European, but 
also in African, Chinese, and Hispanic Americans.  
Our analysis suggests that there may be benefits to using a repeated measures 
analysis in GWAS of phenotypes that may change over time.  Longitudinal data is 
increasingly available from prospective cohorts. A more complete characterization of 





of complex traits. Though we did find evidence of increased power (the number of 
independent genome-wide suggestive regions and the percent of SNPs decreasing in p-
value from averaged to repeated measures depressive symptom score - Table 13), the 
computational time and computing resources to analyze longitudinal data using a repeat 
measures approach can be large. Baseline models ran in SNPTEST approximately two to 
four hours per ethnicity for all 22 chromosomes on four nodes compared to the repeated 
measures models running at roughly three days for one chromosome, for one ethnicity, 
on one node. However, the benefits of using repeated measures outweigh the drawback in 
time to perform the analysis.  
The MDD GWAS literature to date includes nine GWAS of MDD, with only one 
genome-wide significant result [113]. We did not find a significant association with 
depressive symptoms for the SNP that has reached genome-wide significance in MDD 
GWAS, nor did we find SNPs within previously hypothesized candidate genes that met 
criteria for genome-wide or genome-suggestive significance. One potentially important 
reason for this is that despite the CES-D correlating strongly with depression and having 
been used in hundreds of studies, the CES-D is not a diagnostic tool like the Composite 
International Diagnostic Interview (CIDI). The CES-D only measures depressive 
symptoms over the past week. The MESA study exams were spaced approximately 12 – 
24 months apart (the HRS surveys 24 months apart). It is possible that failure to capture 
changes in depressive symptoms between the assessments introduced measurement error 
in the phenotype. Nevertheless, the use of multiple measures is a major improvement 





We included only common variants (those with ethnicity-specific MAF > 5%) in 
our analysis. One reason we may not have found any significant genetic variants of 
depressive symptoms is that we did not investigate rare variants or copy number variants 
that were not part of the genotyping panel or imputation used in these studies. New 
methods for analyzing rare variants or SNP sets, such as Sequence Kernel Association 
Testing (SKAT), are being developed and applied and may help to further elucidate 
genetic predictors of depressive symptoms at a gene-level and across ethnicities [3]. 
Individual SNPs and variants differ in frequency across ethnicities leading to differences 
in power to detect genetic effects. However, genes themselves do not differ across 
ethnicities and form a more natural unit of analysis and inference. Additionally, it is 
possible that multiple SNPs with small effects, working in concert, could affect 
individual susceptibility to depression and depressive symptoms [170]. Further, no 
interactions (gene-gene or gene-environment) were evaluated in these analyses. 
Interactions could play an important role in revealing the pathogenesis of depression and 
depressive symptoms. 
Combining genetic information across multiple ethnicities can result in false-
positive findings from admixture within genetically distinct populations. In our analyses, 
we used ethnicity-specific principal components to account for admixture within each 
ethnic group and filtered initial GWAS results by ethnicity-specific minor alleles. The 
meta-analysis software accounts for both magnitude and direction of effect when 
combining information across studies (in this case different ethnicities) which is 
especially appropriate when studies contain differences in ethnicity, phenotype 





Identifying genes that are associated with depression has tremendous potential to 
transform our understanding and treatment of depression. Utilizing longitudinal measures 
in GWA studies for depressive symptoms allows researchers to get a better picture of 
depression over the life-course. Though this study did not find any gene variants that 
reached genome-wide significance in the repeated measures approach, it provides a first 
step in examining depressive symptoms in different longitudinal settings and also across 
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Table 11 Number of participants with one, two or multiple repeated measures, MESA and HRS 











EA 2514 183 (7.3%) 158 (6.3%) 2173 (86.4%) 7018 
CA   775 84 (10.8%) 73 (9.4%) 618 (79.7%) 2084 
AA  1603 209 (13%) 133 (8.3%) 1261 (78.7%) 4258 
HA   1443 174 (12.1%) 143 (9.9%) 1126 (78%) 3838 
Total 6335 650 (10.3%) 507 (8%) 5178 (81.7%) 17198 











EA  8652 27 (0.3%) 107 (1.2%) 8518 (98.5%) 62073 
AA  1511 7 (0.5%) 40 (2.6%) 1464 (96.9%) 10200 
Total 10163 34 (0.3%) 147 (1.4%) 9982 (98.2%) 72273 






















n = 6,335 n = 10,163 
 
EA AA HA CA 
 
EA AA 
n=2,514 n=1,603 n=1,443 n=775 
 
n=8,652 n=1,511 




      Baseline CES-D 8.0 (7.8) 7.6 (7.6) 9.9 (9.2) 6.3 (6.6) 
 
1.2 (1.8) 1.2 (1.8) 
Averaged CES-D 8.7 (7.4) 7.8 (6.7) 10.2 (8.5) 6.2 (5.6) 
 
1.2 (1.3) 1.9 (1.6) 
Age 62.6 (10.2) 62.2 (10.1) 61.4 (10.3) 62.4 (10.4) 
 
58.4 (8.8) 56.8 (8.2) 
Sex (%) 




       Baltimore, MD 20.1 30.1 0 0 
 
- - 
Chicago, IL 20.9 16.1 0 35.4 
 
- - 
Forsyth County, NC 21.8 26.5 0.2 0 
 
- - 
Los Angeles, CA 5.3 8.9 38.4 64.3 
 
- - 
New York, NY 8.3 18.4 29.9 0.3 
 
- - 
St. Paul, MN 23.6 0 31.5 0 
 
- - 
Anti-depressant Use (%) 12.2 3.8 5.8 2.5   - - 
Intraclass correlation 
     Repeated Measures CES-D 59.7 44.1 57.1 57.4   47.7 50.5 
1
Multi-Ethnic Study of Atherosclerosis,
 2
Health and Retirement Study,
 3
CES-D measured as 20-item sum in MESA and as 8-item sum 









Table 13 Minimum p-value from GWAS of baseline, averaged, and repeated measures of CES-D
1





   


























MESA AA 2559964 2.05E-07 7 1.01 6.64E-07 9 1.00 1.63E-07 11 1.01 
 
EA 2269552 1.33E-07 9 1.01 8.26E-07 6 1.00 6.04E-07 11 1.01 
 
CA 1943213 2.48E-06 1 0.99 1.42E-06 2 1.00 2.71E-07 4 1.02 
 HA 2285460 3.85E-08 10 1 1.61E-06 4 1.00 9.25E-07 11 1.01 
HRS AA 2678868 -  - -  - 2.07E-06  1.01 
  EA 2393700 -  - -  - 6.54E-07  1.04 
1
Center for Epidemiologic Studies – Depression, 
2
Multi-Ethnic Study of Atherosclerosis, 
3
Health and Retirement Study, 
4
Number of unique 
(independent) SNPs LD R
2
 < 0.80, filtered at ethnicity-specific minor allele frequency < 5%, genome-wide suggestive (5x10
-8















Table 14 Comparison of the number of SNPs significant at four α thresholds for the baseline and averaged approaches 
 
AA EA CA HA 
 
Baseline Averaged Baseline Averaged Baseline Averaged Baseline Averaged 



















 2 (0.08) 8 (0.30) 1 (0.04) 5 (0.19) 0 (-) 0 (-) 0 (-) 21 (0.85) 
p-value < 1x10
-5
 32 (1.29) 19 (0.71) 44 (1.67) 30 (1.25) 18 (1.25) 2 (0.13) 27 (1.04) 116 (4.69) 
p-value < 1x10
-4
 297 (11.99) 235 (8.82) 263 (9.98) 210 (6.94) 100 (6.94) 90 (5.89) 207 (7.98) 350 (14.14) 
p-value < 1x10
-3
 2146 (86.64) 2404 (90.17) 2328 (88.32) 2326 (90.47) 1324 (91.82) 1435 (93.98) 2361 (90.98) 1989 (80.33) 
Total
b
 2477 2666 2636 2571 1442 1527 2595 2476 
b




Total=total number of SNPs with p-values < 1x10
-3
 









Table 15 Spearman’s correlation coefficients (rs) and 95% confidence intervals for paired p-values in Multi-Ethnic Study of Atherosclerosis 
  
Baseline vs averaged  
CES-D score 
Baseline vs repeated 
measures  
CES-D score 





rs, (95% Confidence 
Interval) 
rs, (95% Confidence 
Interval) 
rs, (95% Confidence Interval) 
MESA AA 0.53, (0.53, 0.53) 0.54, (0.54, 0.54) 0.88, (0.88, 0.88) 
 
EA 0.54, (0.54, 0.54) 0.57, (0.57, 0.57) 0.92, (0.92, 0.92) 
 
CA 0.48, (0.48, 0.48) 0.46, (0.46, 0.47) 0.85, (0.85, 0.85) 
 
HA 0.54, (0.54, 0.54) 0.56, (0.55, 0.56) 0.88, (0.88, 0.88) 








Table 16 Meta-analysis results
1
 across ethnicities in MESA
2
 (p-values < 1x10
-5
) for each depressive symptom approach  












 8 rs2440212 97270629 A 0.66 4.47 7.73E-06 ++++ (GDF6) 
 9 rs13440434 131953827 A 0.87 -4.50 6.79E-06 ---- (GPR107) 
 10 rs7087469 54339854 A 0.13 4.76 1.93E-06 ++?+ - 
 13 rs9560521 89457392 A 0.13 4.69 2.69E-06 ++++ (LINC00559) 
 16 rs8046816 71863525 A 0.47 4.53 5.92E-06 ++++ - 
 20 rs17215529 3923402 A 0.85 4.79 1.66E-06 ++?+ RNF24 
Averaged 
 1 rs3100865 2795967 T 0.49 4.44 9.02E-06 ++++ - 
 2 SNP_A-1966287 191577187 T 0.89 -4.58 4.57E-06 ??-- STAT1 
 2 rs7602149 114357038 T 0.84 -4.57 4.78E-06 --?- LOC728055 
 2 rs13001068 182706602 A 0.92 4.50 6.95E-06 ?+?+ (PDE1A) 
 7 rs697521 16730681 T 0.13 -4.74 2.12E-06 --?- BZW2 
 8 rs7350109 60753909 A 0.81 -4.50 6.88E-06 --?- - 
 11 rs1448128 121291660 C 0.24 -4.58 4.61E-06 ---- - 
 22 rs5760767 23696411 T 0.50 4.58 4.62E-06 ++++ (TMEM211) 
Repeated measures 
 1 rs11590206 145665933 A 0.16 -4.72 2.33E-06 ---- (GJA5) 
 2 SNP_A-1966287 191577187 T 0.89 -5.22 1.81E-07 ??++ STAT1 
 2 rs7602149 114357038 T 0.84 -4.62 3.83E-06 ++?+ LOC728055 
 4 rs13139186 96637940 T 0.90 -4.48 7.44E-06 ---- UNC5C 
 4 rs233976 104823918 A 0.21 4.47 7.75E-06 ?+++ TACR3 
 7 rs11771332 86539742 A 0.81 -4.48 7.45E-06 ?-?- (KIAA1324L) 
 9 rs2211185 1332721 T 0.77 4.55 5.42E-06 ++++ - 
 18 rs2728505 21474070 A 0.55 -4.47 7.84E-06 ---- - 
  22 rs5760767 23696411 T 0.51 4.54 5.68E-06 ---- (bA9F11.1) 
1
filtered at ethnicity-specific minor allele frequency of 0.05, where the SNP was present in at least two ethnicities, LD R
2
 < 80%, 
 and heterogeneity p-value ≥ 0.1 
2
Multi-Ethnic Study of Atherosclerosis;  
3
Order corresponding to direction positions: African, European, Chinese,  
Hispanic American; 
4















 (p-values < 1x10
-5
) for each depressive symptom approach within ethnicity 















 1 rs10776776 114384683 T 0.55 4.73 2.30E-06 ++ (SYT6) 
 1 rs1417303 235193008 T 0.59 -4.43 9.46E-06 -- LOC440737 
 2 rs4629180 101454802 A 0.83 -4.51 6.41E-06 -- (LOC731220) 
 2 rs6711630 126534599 T 0.93 4.58 4.70E-06 ++ 
  7 rs10249133 12514004 T 0.39 -4.47 7.67E-06 -- (LOC100133035) 
 8 rs17067630 3661853 A 0.85 4.70 2.57E-06 ++ CSMD1 
 11 rs11036016 40661316 A 0.80 4.68 2.94E-06 ++ LRRC4C 
 15 rs4551976 49264445 T 0.63 -4.45 8.48E-06 -- (CYP19A1) 
 16 rs365962 85267450 C 0.69 -4.53 5.83E-06 -- (LOC101928614) 
 20 rs2426733 55454729 A 0.40 -4.75 2.07E-06 -- (RBM38) 
European American 
 1 rs12031875 71357685 A 0.82 4.81 1.54E-06 ++ ZRANB2-AS2 
 4 rs6842756 185341452 A 0.92 4.98 6.54E-07 ++ ENPP6 
 6 rs6941340 16145531 T 0.48 -4.47 7.95E-06 -- 
  9 rs11794102 111772109 A 0.91 4.54 5.70E-06 ++ PALM2-AKAP2 
 13 rs6492314 110267411 C 0.28 -4.75 2.00E-06 -- 
  16 rs12921740 20219533 T 0.51 -4.55 5.44E-06 -- (GP2) 
 
18 rs2612547 41290709 A 0.83 4.47 7.94E-06 ++ SLC14A2 
1
filtered at ethnicity-specific minor allele frequency of 0.05, where the SNP was present in at least two ethnicities, LD R
2
 < 80%, and heterogeneity p-value ≥ 
0.1; 
2
Multi-Ethnic Study of Atherosclerosis;  
3
Health and Retirement Study  
4
Order corresponding to direction positions: African, European, Chinese, Hispanic 
American; 
5




Figure 19 Comparison of p-values for genome-wide association studies for baseline CES-D score 





Figure 20 Comparison of p-values for genome-wide association studies for baseline CES-D score 





Figure 21 Comparison of p-values for genome-wide association studies for averaged CES-D score 







Associations of genetic regions with depressive symptom scores across ethnic group 
groups in the Multi-Ethnic Study of Atherosclerosis 
4.1 Introduction 
Multiple genes are posited to be involved in disorders of highly complex 
pathophysiology such as mental health disorders. While examining single nucleotide 
polymorphisms (SNP) through genome-wide association studies (GWAS) is an important 
first step in identifying genetic risk factors for depressive symptoms, SNP-set based 
analyses may help us better understand the association between genetic variants and 
complex phenotypes by identifying genetic regions that are associated with the phenotype 
across different ethnicities).[171] Because relevant variability in a given genetic region 
may be indexed by different SNPs in different ethnicities, the failure to perform gene-
region analyses may result in underestimates of the effects of genetic variability on the 
phenotype. For example, there have been a number of conditions  (e.g., bipolar disorder, 
coronary artery disease, hypertension, Parkinson’s, amyotrophic lateral sclerosis, Crohn’s 
disease, rheumatoid arthritis, types I and II diabetes, and age-related eye disease) for 
which analyses of genetic regions identified important genetic predictors whereas 
traditional SNP analyses did not.[172] The authors of this study identified genes in a 
single cohort, and confirmed via meta-analysis for multiple cohorts, suggesting that these 




Though we have been studying mental health disorders for decades and have 
characterized the basic epidemiology of depression and depressive symptoms, we have 
yet to discover a proverbial genetic “smoking gun” through GWA studies of SNPs. 
Further, we have not been able to identify genetic variants that are associated with 
depressive symptoms across multiple ethnicities, likely due to different ancestry-based 
patterns in population stratification and differences in linkage disequilibrium (LD) 
patterns.[173-175] This results in different “tag SNPs” that are associated with the causal 
variant(s) appearing in different ethnicities and could lead to what appear to be 
inconsistent (or non-replicated) SNPs across ethnicities.  
I have established that a depressive symptom phenotype over time in a repeated 
measures approach is beneficial over a single-time point (baseline) measure in GWAS in 
terms of power. However, well-developed and validated methods of analyzing SNP sets 
using repeated measures have yet to be implemented in genetic association studies. 
Therefore, in this chapter, results from averaged depressive symptom scores GWAS are 
used to take our level of inference from SNPs to sets of SNPs to help identify genetic 
regions across ethnicities that may be associated with depressive symptoms.  
 
4.2 Methods 
4.2.1 Previous GWAS 
This study is based off of analysis performed on data from the Multi-Ethnic Study 
of Atherosclerosis. This study and methods are described extensively in chapters II and 
III. Briefly, MESA is a longitudinal study supported by NHLBI consisting of individuals 




samples and were included in the MESA SHARe project are included in this analysis. 
These analyses were performed in African Americans (AA), European Americans (EA), 
Chinese Americans (CA), and Hispanic Americans (HA). 
The outcome of interest, depressive symptom score, was assessed using the 20-
item CES-D Scale[14], adjusted for anti-depressant use and averaged over all exams for 
which the measure was administered. The ethnicity-specific GWA studies for averaged 
depressive symptom score were conducted using a linear model, adjusted for age at 
baseline, sex, site at baseline and the top four ethnicity-specific principal components. 
SNPs were analyzed as dosages in the SNP-based GWAS using an additive genetic 
model.  
4.2.2 Covariates 
Age, sex and study site were assessed at the MESA baseline exam. There were a 
total of 6,335 MESA participants included in the averaged depressive symptom GWAS 
(AA 25%, EA 40%, CA 12%, HA 23%). Average age (standard deviation) for the AA, 
EA, CA, and HA sub-samples was 62.2 (10.1), 62.6 (10.2), 61.4 (10.3), and 62.4 (10.4) 
years, respectively. Slightly less than half of each ethnicity was male (AA 48.0%, EA 
46.4%, HA 49.3%, CA 49.7%). Participants were ascertained from six study sites 
(Baltimore, MD; Chicago, IL; Forsyth County, NC; Los Angeles, CA; New York, NY; 
and St. Paul, MN).[118] Ethnicity-specific principal components were used to adjust for 
population stratification.  
Adult socioeconomic position (ASEP) was included as an additional covariate to 
assess any residual confounding over the adjustment for ancestry through the inclusion of 




different dimensions of socioeconomic position), indicators were summarized into an 
ASEP score. The methods are based on previous work and combine information on 
income, education, and wealth (ownership of a home, car, land/property or 
investments).[129, 130] Income was defined in four categories (<$25,000, $25,000–
39,999, $40,000–74,999, or +$75,000). At the baseline examination, highest level of 
education completed was reported and for these analyses operationalized into four 
categories (completed high school or less, some college but no degree/technical school 
certificate, associate or bachelor’s degree, or graduate/professional degree). The four 
wealth indexes included whether the participant: (1) had investments such as stocks, 
bonds, mutual funds, retirement investments, or other investments (yes/no), (2) owned 
their home (yes/no) (3) owned a car (yes/no) and (4) owned land or another property that 
was not their primary residence (yes/no). To create the summary score for ASEP, the 
individual measures for income, education and wealth were summed (income variable (0 
– 3, low to high), education (0 – 3, low to high), and for each wealth indicator, a single 
point was added). The ASEP score ranged from 0 – 10, with higher scores indicating 
greater ASEP.  
4.2.3 Region selection 
 Regions for analysis were selected by first ranking the 5,000 SNPs with the 
lowest p-values from the averaged depressive symptom GWAS (filtered at ethnicity-
specific minor allele frequency (MAF) > 0.05) within each ethnicity. Once those SNPs 
were identified, the union of the SNPs (nSNP = 19,932) was obtained, and each SNP was 
analyzed in a fixed-effects meta-analysis across the four ethnicities using METAL, 




differences in LD structures across the ethnicities with different tag SNPs for the causal 
variant(s) emerging in each ethnicity, and that there were almost 2.5 million imputed or 
genotyped SNPs analyzed within each ethnicity. The sheer number of analyzed SNPs 
reduces the probability that the same SNP would be in the top 5,000 in two ethnicities. 
From the meta-analysis results, SNPs were retained if they had MAF > 0.05 in more than 
one ethnicity (nSNP = 18,645). SNPs were ranked by lowest p-value (by meta-analysis p-
value: P(1) ≤ P(2) ≤ … ≤ P(nSNP)) and the top 100 meta-analysis SNPs (P(1) – P(100)) were 
identified.  
Starting with the SNP with the lowest meta-analysis p-value (P(1) – referred to as 
the index SNP), a SNP set region was defined including all SNPs (not only SNPs in the 
meta-analysis) within a 20 kilobase (kb) region up and downstream of the index SNP 
(eliminating any SNPs in the meta-analysis top 100 in this region from being an index 
SNP of a second region). The 40kb total region was selected to conservatively capture the 
average size of a linkage disequilibrium (LD) block. In EA and AA populations, average 
LD, calculated by r
2
, declines to approximately 0.15 - 0.25 at a distance of 40kb.[176] 
We continued this process until all regions were identified from the top 100 SNPs from 
meta-analysis (nregions = 47). It is possible that regions overlap slightly if the index SNP of 
regioni and the index SNP of regionj (i ≠ j) are more than 20kb but less than 40kb away 
from each other. This occurred five times (regions [3, 4], [5, 6], [7, 8], [27, 28, and 29], 
[41, 42]). 
4.2.4 Sequence Kernel Association Testing (SKAT)  
 SKAT was performed for each SNP set region for each ethnicity separately. 




mixture of chi-squared distributions under the null hypotheses that can be evaluated 
explicitly and used as a reference distribution to compute the P-values. Genetic main 
effects are tested by: 
 ̅        
     
       
Where  ̅   is the log-transformed, averaged depressive symptom score corresponding to 
individual i,    is an intercept term,    is a vector of non-genetic covariates (age, sex, 
study site, PC1 – 4, and ASEP),    is a matrix of best-call genotypes (0 = no copies of the 
coded allele, 1 = one copy of the coded allele, 2 = two copies of the coded allele). The 
coded allele is the same for all ethnicities. Measurement error    follows any distribution 
with mean zero and variance   . The vector of regression coefficients for the covariates 
is represented by  , and   is a vector of regression coefficients for the p observed gene 
variants in the region. A primary assumption of SKAT is that each   ,  j = 1, …, p 
follows an arbitrary distribution with mean zero and variance     . The weights,   , are 
specified as the MAF in this analysis. Testing         is equivalent to testing      
 . Since this analysis is only concerned with the effects of common SNP variants, not the 
effects of rare variants or epistatic effects, the analysis is implemented using a linear 
kernel. Results with significant p-values indicate that there is at least one non-zero beta in 
the region. The variance-component score statistic is 
    ̅   ̂     ̅   ̂  





 MetaSKAT allows for the meta-analysis of SNP set-level results across cohorts, 
in this case ethnicities.[177] To allow for heterogeneity across studies, MetaSKAT 
assumes effect sizes of markers in different studies are independent and follow a common 
distribution. The meta-analysis SKAT test statistic is: 
               ∑∑   
    
 
 
   
 
   
 
Where j is a specific variant and m is the total number of variants in a region, K is the 
number of cohorts (ethnicities),    
  is the marker-specific weight (a function of MAF of 
SNP j) and    
  is the score statistic of the j
th
 variant in linear regression model. This test 
assumes the effect sizes of markers in different studies are independent and follow a 
common distribution. Individual-level genotype data were used, with an unweighted 
kernel (weights.beta = c(1,1)), and allowing for ethnicity-specific MAFs. 
4.3 Results 
The information about each region is presented in Table 18. The index SNP, 
chromosome, region start and stop position (kb), coded allele, the ethnicity from which 
the SNP was discovered, MAF, minor allele (MA), and p-value for the discovery 
ethnicity, and the p-value from the averaged CES-D meta-analysis are described. There 
were nine index SNPs originally from the African-American GWAS, 17 index SNPs 
from the European-American GWAS, four index SNPs from the Chinese-American 
GWAS, and 15 SNPs from the Hispanic GWAS. One index SNP (index SNP 22) was in 




 Out of the 47 regions, 21 had no genes within ±100kb of the index SNP.[178]  
There were 14 regions that lay within (or partially within) a gene, seven regions which 
were in a gene and also had other genes within ±100kb of the index SNP, and five 
regions that were not in genes but had genes within ±100kb of the index SNP. Twenty-
one regions had no genes within ±100kb of the index SNP. 
4.3.1 SKAT 
SKAT and MetaSKAT results are presented in Table 19. This table includes 
ethnicity-specific p-values and the number of markers used in analysis (after non-varying 
SNPs and SNPs with MAF < 0.05 were eliminated) in each region, as well as the across-
ethnicity MetaSKAT p-values. LocusZoom[178] plots for each region is located in 
Appendix 21 – Appendix 67. Plots show p-values from the averaged CES-D GWAS 
plotted against chromosomal position for each ethnicity, for each region, with an overlay 
of the recombination rate in cM/Mb.  
4.3.2 MetaSKAT 
At an α of 0.05 in the ethnicity-specific SKAT analysis adjusted for age, sex, site, 
and ASEP there were twelve regions significantly (α = 0.05) associated with averaged 
depressive symptoms in the AA sub-sample, eighteen regions in the EA sub-sample, six 
regions in the CA sub-sample, and eleven regions in the HA sub-sample. After 
Bonferroni correction for the number of regions (αBonferroni = 0.001), one region (region 
43) in both the AA and CA sub-samples, six regions (regions 1, 17, 19, 26 – 28) in the 




There were no genes within ±100kb of the index SNP for region 1; regions 8, 17, 
19 and 43 fell within the genes PPA2, GPLD1, and MEGF11 respectively. These genes 
are discussed later in this chapter. Regions 26 – 28 are overlapping regions and do not 
have any established genes within ±100kb of the index SNP for any of the three regions. 
Regions seven and eight are overlapping regions near ABCB11 and partially in G6PC2. 
In the MetaSKAT analysis adjusted for age, sex, site, and ASEP, 29 out of 47 
regions were significant at an α of 0.05. Four regions remained significant after 
Bonferroni adjustment (αBonferroni = 0.001): region 19 (located within GPLD1, 6p22.1), 
and regions 26 – 28 (chromosome 8:60733909kb-60850808kb) and two regions, region 
17 (located within PPA2, 4q24) and region 43 (located within MEGF11, 15q22.31) were 
approaching significance (p-value = 1.40 x 10
-3




 In this analysis we have taken results from a GWAS on averaged depressive 
symptom score from four different ethnicities, determined the top SNP sets from the 
GWAS across ethnicities, and examined the SNP-set associations with averaged 
depressive symptom score. The SNP-set association analysis using SKAT resulted in nine 
total significant regions at an αBonferroni of 0.001, one in both the HA and CA, six in the 
EA and two in the HA subsample adjusting for age, sex, site, and ASEP. MetaSKAT 
analysis resulted in four regions (three of which neighbored each other) that were 
significant after Bonferroni adjustment (region 19, p-value 1.71 x 10
-4
; region 26, p-value 
1.17 x 10
-4
; region 27, p-value 9.69 x 10
-5
; region 28, p-value 7.47 x 10
-4
 ) and two 
regions that were marginally significant (region 17, p-value = 1.40 x 10
-3




value 1.18 x 10
-3
). MetaSKAT p-values of all regions, adjusted for age, sex, site, and 
ASEP, ranged from 9.7 x 10
-5
 to 6.6 x 10
-1
.  
4.4.1 Region 17 
One region (17) on chromosome 4 had been previously associated with 
psychiatric phenotypes, though not for depressive symptoms specifically. Though only 
marginally significant at the Bonferroni level when adjusted for age, sex, site, and ASEP, 
region 17 is contained completely within the PPA2 (pyrophosphatase (inorganic) 2) 
gene.[179] Two SNPs in PPA2 have been reported to reach genome-wide significance (p-
value 3.68 x 10
-7
, 5.05 x 10
-7
) in GWAS for clinician-reported illness severity of 
schizophrenia.[180] Additionally, a gene (DKK2) in the chr4q22-q32 area was identified 
based on systematic gene-based screening to be associated with quantitative trait of 
alcohol dependence symptom counts.[181] This region may play a part in mental health 
psychopathologies. Significance in this region is driven primarily by the EA sub-sample, 
which is shown in Figure 22 by the large number of SNPs with small p-values in the EA 
ethnicity. This region was marginally significant (p-value = 0.0014) at the αBonferroni of < 
0.001 after adjusting for ASEP, suggesting that the relationship between the joint SNP 
effect in this region and averaged depressive symptom scores is partially mitigated by 
adult socioeconomic position – which will be investigated further in the subsequent 
chapter. 
4.4.2 Region 19 
 Region 19 is contained completely within the GPLD1 
(glycosylphosphatidylinositol specific phospholipase D1) gene on chromosome 6. Within 




alkaline phosphatase levels (6.0 x 10
-26
, 1.0 x 10
-11
)[182, 183] This gene, or SNPs within 
this gene, has not been found to be associated with depressive symptoms or any other 
psychiatric disorder. Region 19 shows a different pattern of p-values than in region 18 
(Figure 23). While the strongest signal is in the EA ethnicity, there is a cluster of low p-
values in the AA ethnicity near position 24.57Mb. This region remained significant at the 
αBonferroni of < 0.001 after adjusting for ASEP. 
4.4.3 Regions 26 – 28 
 These regions are within a gene desert with no genes within ± 250kb of either side 
of the region. This set of regions includes a strong overall signal of an association with 
depressive symptoms, particularly in the EA ethnicity, though there are also marked 
signals in the CA and HA sub-samples as well (Figure 24). Within each ethnicity, the 
strongest signals in each region are coming from different SNPs (e.g. the smallest p-value 
in EA is not from the same SNP that has the strongest signal in AA). These three regions 
all remained significant at the αBonferroni = 0.001 after adjusting for ASEP.  
4.4.2 Region 43 
This region is located in the MEGF11 gene (multiple EGF-like-domains 11, 
15q22.31).[167] Strong evidence was seen in both the AA and CA ethnicity-specific 
SKAT analysis (AA p-value = 1.70 x 10
-4
, CA p-value = 3.59 x 10
-4
). Variants within this 
gene have been cited as predictors of hemorrhagic stroke and hypertension in Japanese 
individuals,[184, 185] but this region is novel in psychiatric disorders. There is strong 
evidence of an association with averaged depressive symptom scores in both the AA and 




For the regions which were not located in genes, the functionality of the region 
was investigated through the Encyclopedia of DNA Elements (ENCODE). ENCODE 
aims to build a database of functional elements in the human genome, including protein 
and RNA level elements, and regulatory elements that control cells and circumstances in 
which a gene is active.[186, 187] Because this region is in a gene desert, a preliminary 
bioinformatic analysis may provide information on functional elements related to 
enhancer or transcription factor binding in this region. These analyses (Figure 26) reveal 
that this region may overlap with an H3K4Me1 and H3K27Ac histone mark (a feature 
often located near active regulatory elements), several DNase1 hypersensitivity clusters 
(a chromatin accessibility feature common to cis-regulatory sequences), and transcription 
factor binding sites. All of this evidence is suggestive of potential functional 
consequences of genetic variation in this particular region – suggesting that further 
functional characterization is warranted.  
Unlike a previously published GWAS/SNP-set analysis[171] – we did not take 
our top SNPs from our ethnicity-specific GWAS. Rather we selected the top SNPs from a 
meta-analysis across the four ethnicities, since our goal was to find regions associated 
with depressive symptom phenotype across multiple ethnicities. This is the reason we 
may not have seen our strongest signal in a region as that region’s index SNP. It is also 
apparent that there may be effects in only a subset of the ethnicities (e.g. in EA and HA 
only, in CA, HA, and AA only, etc.) as opposed to across all four of our examined 
ethnicities. Future research should consider all combinations of ethnicities in SNP-set 




Using MetaSKAT permitted heterogeneous effects across the ethnicities and a 
reduction in the number of statistical tests performed over individual SNP analysis.  
MetaSKAT allows for the summary of SNP heterogeneity, in terms of direction of effect, 
into a single statistic. That is, a SNP-set could have significant positive effects in one 
ethnicity and significant negative effects in a second ethnicity that could result in a null 
overall effect of the SNP-set using other methods, whereas MetaSKAT would indicate 
that the region was a significant predictor of the outcome. This method allowed us to 
discover genetic signals from a set of SNPs that were not apparent when the SNP-level 
GWAS was performed. Like previously published MetaSKAT analysis on complex 
traits,[171] this method better reflects the biology of the trait because truly associated 
genes likely have variants with differing direction and size of effect in different 
ethnicities. Our results produced an important insight into the genetic association of 
depressive symptoms across multiple ethnicities: there is evidence that different SNPs 
from different ethnicities may be implicating genetic regions that are consistent across 
ethnicities. Our findings (particularly region 19 (Figure 23) and regions 26-28 (Figure 
24)) provide justification for moving out of performing solely individual SNP-based 
GWAS and into adding regional/gene-level analysis when examining a phenotype across 
multiple ethnicities. 
Though regions were chosen using a fairly conservative genetic distance of 
±40kb, regions of true association could be larger or smaller than our selected size. We 
detected regions that overlapped, which may imply larger regions ought to be created 
from these abutting regions. Future research should determine biologically relevant 




approaches (moving windows, LD block refinement, gene-regions, etc.) to elucidate 
genetic regions. 
 No genetic studies to date have examined depressive symptoms at a genetic 
region level, let alone across multiple ethnicities. This chapter represents novel methods 
and findings that advance our ability to examine the variations in multiple regions and 
their associations with depressive symptoms not only within ethnicities but across them 
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Table 18 Region information for the 47 regions 
    
Discovery Ethnicity 
 







MAF MA p-value 
Meta p-value, 
Averaged CES-D 
1 rs3100865 1:2775967-2815967 T EA 0.29 T 3.95E-05 9.02E-06 
2 rs7550557 1:216321556-216361556 A CA 0.05 G 1.07E-03 3.92E-05 
3 rs12711789 2:114307098-114347098 A HA 0.08 A 1.53E-03 1.86E-05 
4 rs7602149 2:114337038-114377038 T HA 0.10 T 1.58E-04 4.78E-06 
5 rs6710525 2:114392038-114432038 A HA 0.08 G 1.35E-03 3.05E-05 
6 rs13425176 2:114413390-114453390 A HA 0.08 C 1.24E-03 2.68E-05 
7 rs519887 2:169469131-169509131 T HA 0.46 C 8.61E-05 3.00E-05 
8 rs853772 2:169502901-169542901 T HA 0.48 T 9.92E-05 4.48E-05 
9 rs12692904 2:169992063-170032063 T EA 0.23 C 1.88E-03 4.06E-05 
10 rs13001068 2:182686602-182726602 A HA 0.06 G 1.06E-04 6.95E-06 
11 rs1569108 2:183196291-183236291 T AA 0.46 C 1.97E-03 5.01E-05 
12 SNP_A-1966287 2:191557187-191597187 T HA 0.11 T 2.97E-05 4.57E-06 
13 rs4389282 2:192565881-192605881 T EA 0.08 T 1.10E-03 4.30E-05 
14 rs6802476 3:151302625-151342625 C HA 0.09 G 1.50E-04 5.01E-05 
15 rs3796972 4:104755240-104795240 A EA 0.32 C 2.02E-06 4.89E-06 
16 rs233976 4:104803918-104843918 A EA 0.17 A 1.90E-04 1.34E-05 
17 rs2726516 4:106545655-106585655 A EA 0.43 A 1.21E-04 3.58E-05 
18 rs13130595 4:177364585-177404585 T CA 0.25 C 2.52E-03 3.93E-05 
19 rs9467173 6:24547252-24587252 T EA 0.46 T 1.02E-03 2.71E-05 
20 rs4626500 7:5353108-5393108 A AA 0.11 A 1.46E-03 1.30E-05 













23 rs11771332 7:86519742-86559742 A HA 0.11 T 1.54E-04 2.52E-05 
24 rs13271255 8:5383703-5423703 T EA 0.11 C 1.39E-03 2.98E-05 
25 rs4273841 8:59034140-59074140 C HA 0.18 G 3.27E-04 1.45E-05 
26 rs7350109 8:60733909-60773909 A EA 0.25 T 6.85E-06 6.88E-06 
27 rs4360284 8:60771439-60811439 C EA 0.26 G 1.25E-05 6.89E-06 
28 rs9643512 8:60810808-60850808 T EA 0.26 T 8.53E-05 2.41E-05 
29 rs1377249 8:78208511-78248511 A AA 0.24 C 1.22E-03 1.97E-05 
30 rs17148529 10:10685682-10725682 T AA 0.14 T 4.94E-04 2.83E-05 
31 rs17620681 10:54883832-54923832 T EA 0.22 C 1.91E-03 1.83E-05 
32 rs1159612 10:85299038-85339038 T AA 0.11 T 1.13E-03 2.87E-05 
33 rs11015985 10:129649308-129689308 T EA 0.21 C 8.33E-04 1.21E-05 
34 rs1448128 11:121271660-121311660 C EA 0.19 C 3.74E-05 4.61E-06 
35 rs1863838 12:9183291-9223291 T AA 0.23 G 3.14E-05 4.84E-05 
36 rs776896 12:39714697-39754697 A HA 0.17 A 1.16E-03 3.20E-05 
37 rs2229774 12:51871812-51911812 A EA 0.07 A 3.30E-04 1.04E-05 
38 rs1765856 13:33802221-33842221 A EA 0.28 G 9.06E-04 2.45E-05 
39 rs9560521 13:89437392-89477392 A EA 0.09 A 1.03E-03 1.92E-05 
40 rs9323096 14:43747537-43787537 A CA 0.09 A 2.98E-03 4.92E-05 
41 rs10149069 14:43786179-43826179 A CA 0.09 G 1.58E-03 2.22E-05 
42 rs3784589 15:29062006-29102006 A EA 0.06 A 2.59E-04 3.89E-05 
43 rs12148583 15:64262685-64302685 A CA 0.47 T 9.93E-06 1.66E-05 
44 rs729650 15:77126365-77166365 T AA 0.11 C 3.68E-04 4.51E-05 
45 rs8046816 16:71843525-71883525 A AA 0.43 C 5.16E-04 3.83E-05 
46 rs2728505 18:21454070-21494070 A HA 0.40 C 5.76E-04 2.27E-05 
47 rs4140486 22:23660087-23700087 A HA 0.20 G 1.73E-03 6.28E-06 
CHR: chromosome, bp: basepairs, MAF: minor allele frequency, MA: minor allele, CES-D: Center for Epidemiologic Sciences – Depression score, AA: African 








Table 19 SKAT and MetaSKAT, fully adjusted 
  SKAT(AA) SKAT(EA) SKAT(CA) SKAT(HA) MetaSKAT 




Region Chr p-value nSNP p-value nSNP p-value nSNP p-value nSNP p-value  
1 1 8.80E-01 18 1.60E-04 19 6.55E-01 20 1.56E-01 22 7.71E-03 - 
2 1 1.98E-01 47 1.93E-01 43 9.86E-02 41 7.43E-01 46 1.96E-01 - 
3 2 2.28E-01 53 7.66E-03 41 1.34E-01 40 6.61E-02 53 4.27E-02 (ACTR3) 
4 2 3.62E-01 43 8.31E-02 35 1.69E-01 33 9.29E-02 43 6.16E-03 ACTR3 
5 2 4.47E-01 38 2.37E-02 32 1.33E-01 32 1.50E-01 38 4.14E-02 ACTR3 
6 2 3.11E-01 50 1.66E-02 44 7.50E-02 41 1.90E-01 50 1.58E-02 ACTR3 
7 2 1.15E-01 76 1.33E-01 63 5.60E-01 56 5.95E-05 75 4.07E-03 (ABCB11) 
8 2 2.22E-01 56 2.70E-01 52 8.09E-01 45 2.93E-04 55 1.35E-02 G6PC2, (ABCB11) 
9 2 1.16E-01 55 7.59E-03 59 1.77E-02 49 3.44E-01 56 3.41E-03 (BBS5) 
10 2 9.34E-01 72 5.36E-02 63 1.70E-01 57 2.13E-02 71 3.36E-02 (PPP1R1C, PDE1A) 
11 2 8.09E-03 58 1.66E-02 57 9.38E-01 49 1.08E-01 55 2.08E-03 - 
12 2 6.09E-01 45 8.56E-01 38 3.51E-01 35 3.40E-03 42 2.11E-01 STAT1, (STAT4) 
13 2 4.04E-01 20 9.69E-02 20 1.24E-01 18 4.84E-01 25 1.72E-01 TMEFF2 
14 3 1.73E-01 93 1.07E-01 89 5.73E-01 89 3.44E-02 94 4.42E-02 - 
15 3 7.40E-01 34 7.65E-03 33 6.92E-01 30 7.25E-02 36 5.16E-01 TACR3 
16 4 6.60E-01 42 1.21E-01 30 6.57E-01 30 1.89E-01 42 1.89E-01 TACR3 
17 4 7.47E-01 57 2.31E-04 54 6.79E-01 45 2.70E-01 57 1.40E-03 PPA2, (EEF1A1P9) 
18 4 4.66E-02 73 2.44E-01 67 1.07E-02 60 2.15E-01 77 3.40E-01 ASB5, (SPATA4) 
19 4 2.50E-02 84 2.88E-04 77 1.34E-01 79 9.36E-01 85 1.71E-04 GPLD1, (MRS2, ALDH5A1) 
20 6 5.03E-02 9 4.43E-01 12 1.41E-01 8 3.01E-02 11 8.19E-02 TNRC18 
21 7 3.07E-01 58 3.00E-02 70 5.11E-01 54 2.24E-02 73 8.12E-03 (BZW2, TSPAN13) 
22 7 1.42E-02 75 1.48E-01 77 5.84E-01 54 7.67E-01 74 6.61E-02 - 
23 7 2.90E-02 48 1.12E-01 49 7.75E-01 42 2.03E-01 47 2.76E-02 KIA13242 
24 7 8.76E-03 129 1.52E-01 120 4.21E-01 97 8.59E-01 127 6.95E-02 - 
25 8 4.09E-01 34 5.92E-01 23 3.25E-01 21 4.88E-02 34 3.25E-01 FAM110B 
26 8 5.31E-02 35 1.62E-04 18 9.04E-02 28 1.15E-01 36 1.17E-04 - 








28 8 5.98E-01 54 5.96E-04 45 3.03E-01 45 4.76E-01 54 7.47E-04 - 
29 8 4.54E-02 65 9.25E-02 60 1.87E-01 56 2.84E-01 65 4.31E-02 - 
30 8 1.17E-02 79 6.54E-01 74 9.12E-01 68 4.25E-01 80 1.39E-01 - 
31 10 8.64E-01 70 4.27E-01 59 4.83E-01 31 8.55E-01 72 6.60E-01 - 
32 10 2.56E-01 69 3.07E-01 71 5.51E-01 65 4.97E-02 69 1.63E-01 - 
33 10 1.04E-01 47 2.07E-02 57 8.17E-01 43 4.29E-01 56 3.25E-02 PTPRE 
34 10 4.40E-03 52 3.02E-02 45 2.55E-01 44 1.11E-01 52 3.23E-03 - 
35 11 5.38E-02 51 2.72E-01 47 5.44E-01 41 3.26E-01 50 1.44E-01 P2P 
36 12 3.36E-01 65 5.20E-01 44 6.21E-01 60 2.34E-01 64 5.28E-01 CNTN1 
37 12 6.30E-01 23 8.44E-02 23 6.80E-01 18 4.79E-01 24 2.77E-01 
ITGB7, RARG, (CSAD, ZNF740, 
MFSD5) 
38 12 4.81E-01 94 3.37E-02 85 2.78E-01 78 2.52E-01 94 4.35E-02 - 
39 13 3.67E-01 51 2.38E-01 49 9.42E-01 37 4.38E-01 50 3.63E-01 - 
40 13 3.86E-01 31 5.08E-02 31 5.32E-03 27 1.57E-01 32 1.02E-02 - 
41 14 8.43E-01 54 4.46E-02 56 4.47E-03 47 2.23E-01 53 3.07E-02 - 
42 14 8.85E-03 33 4.27E-02 32 7.42E-01 29 5.01E-01 34 1.72E-02 TRPM1, MTMR10, (MIR211) 
43 15 1.70E-04 65 3.40E-01 68.00 3.59E-04 63 5.08E-01 68 1.18E-03 MEGF11 
44 15 3.63E-02 35 6.88E-02 32 3.48E-01 30 7.49E-01 37 3.00E-02 RASGRF1 
45 16 1.52E-01 48 3.43E-01 42 2.23E-01 31 2.66E-01 46 2.23E-01 - 
46 18 7.47E-02 52 1.95E-01 44 7.33E-01 44 2.06E-02 53 3.74E-02 - 
47 22 7.34E-01 28 1.10E-01 26 1.08E-02 24 1.09E-02 31 2.31E-02 TMEM211, (SGSM1) 
Models adjusted for age, sex, site, and adult socioeconomic position 
SKAT: Sequence Kernel Association Test, Chr: chromosome, n: number of SNPs in analysis, AA: African American, EA: European American, CA: Chinese 
American, HA: Hispanic American, highlighted p-values are less than 0.05. 
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Figure 22 -log10(p-values) for region 17 (chr4) plotted against genomic position in Mb 
Top SNP in each ethnicity is identified by rs number. AA: African American, EA: European American, CA: Chinese American, HA: Hispanic 









Figure 23 -log10(p-values) for region 19 (chr6) plotted against genomic position in Mb 
Top SNP in each ethnicity is identified by rs number. AA: African American, EA: European American, CA: Chinese American, HA: Hispanic 









Figure 24 -log10(p-values) for regions 26-28 (chr8) plotted against genomic position in Mb 
Top SNP in each ethnicity is identified by rs number. AA: African American, EA: European American, CA: Chinese American, HA: Hispanic 









Figure 25 -log10(p-values) for regions 43 (chr15) plotted against genomic position in Mb 
Top SNP in each ethnicity is identified by rs number. AA: African American, EA: European American, CA: Chinese American, HA: Hispanic 
















V. Interactions of individual- and neighborhood-level social environment with 
genetic factors in the prediction of depressive symptoms in the Multi-Ethnic Study 
of Atherosclerosis 
5.1 Introduction 
While both genetic and environmental factors have been associated with 
depressive illnesses when considered in isolation, complex diseases such as these seldom 
fit into single-factor models. It is likely that characteristics of both internal and external 
environments play a role in modifying genetic associations with depressive symptoms. 
Further, it is plausible that the interactions between genetic factors and these internal and 
external environmental factors may impact disease development. Gene by environment 
(G x E) interactions associated with disease development or morbidity have previously 
been found in both physical and mental disorders, specifically for depressive outcomes 
with genes characterizing serotonin transportation.[95, 117, 188-190] The serotonin 
transporter gene (5-HTT) has been found to interact with environments such as stressful 
life events, proportion of individuals receiving public assistance (county-level), infant 
mortality rates and county-level crime rates, demonstrating that both individual (e.g. 
stressful life events) and external neighborhood (e.g. county-level crime rates) factors 
convey different risks of depression for different genotypes.[95, 117, 188-190] It has 





than single-nucleotide polymorphism (SNP)-disease or gene-disease associations.[111, 
191]  
A major limitation of prior work on gene by environment interactions in 
depressive illness has been the type and quality of the social environment measures 
available. The ability to replicate findings has been shown to differ when environment 
measures are defined objectively versus subjectively. In the context of the serotonin 
transporter gene, a review found that studies involving objective measures assessing 
neighborhood stress replicated G x E interactions either fully or in part, whereas studies 
relying on self-reported measures often did not replicate.[192] Depression has been 
connected to several biological pathways including metabolic pathways (e.g. [193]), 
inflammatory pathways (e.g. [194]), and neurobiological pathways (e.g. [195]). These 
pathways may be activated by external environments – such as chronic burden or 
neighborhood stressors (e.g. [196]) There is need to further investigate G x E interactions 
using larger samples with improved psychosocial and environment measures. This work 
examines gene-environment interactions with depressive symptoms at both individual- 
and neighborhood-level environments, and accounting for depressive symptoms over 
time. 
Using quantitative depressive symptom scores measured with the Center for 
Epidemiologic Studies – Depression scale (CES-D), we investigated interactions between 
variability in selected genetic regions and both individual-level and neighborhood-level 
measures of social environments. The genetic regions for investigation were identified 
based on prior GWAS and SNP-set analyses (chapters III and IV). Environments were 





(2) chronic burden (CB)), and (3) separately as neighborhood-level social factors (an 
index score combining neighborhood social cohesion, perceived neighborhood safety, 
and neighborhood aesthetic quality). 
5.2 Methods 
5.2.1 Outcome 
The outcome of interest, depressive symptom score, was assessed using the 20-
item CES-D Scale[14], appropriately log-transformed to improve normality. CES-D 
score was then adjusted for anti-depressant use[119, 120], and averaged over all exams 
for which the measure was administered. This outcome was selected because it was the 
most powerful approach to capturing the longitudinal nature of depressive symptoms 
while still having methods available to analyze G x E at the gene level (there are 
currently no validated methods for analyzing repeated measures of an outcome at the 
SNP-set level). 
5.2.2 Genes 
 Gene regions are defined using SNP sets identified based on a prior GWAS 
conducted in all four ethnicities (Chapter III). Methods for selecting SNP regions are 
described previously (Chapter IV). Briefly, genome-wide association study (GWAS) 
results, for ethnicity-specific common alleles (minor allele frequency (MAF) ≥ 5%), were 
analyzed across four ethnicities (African (AA), European (EA), Chinese (CA), and 
Hispanic (HA) Americans) using a fixed effects meta-analysis. Top hits (by p-value) 
were then filtered using the following criteria: meta-analysis heterogeneity p-value > 





analysis SNPs were then selected and starting with the SNP with the smallest p-value, a 
region was created around this index SNP including all SNPs within ±20kb. This distance 
was selected so that the region captured the average size of a linkage disequilibrium 
block.[176] If any other SNPs in the top 100 meta-analysis results were in this region, 
they were eliminated from being the index SNP of another region. This method continued 
through the list of top 100 SNPs until all possible regions were created. Some overlap is 
present in regions that had an index SNPi within ±20kb < index SNPj < ±40kb, where i ≠ 
j. A total of 47 regions were created. 
 Any region which had a MetaSKAT p-value (adjusted for age, sex, site, top four 
ethnicity-specific principal components (PC), and adult socioeconomic position (ASEP)) 
less than 0.20 was included in these analyses (see Chapter IV). The threshold of a 
MetaSKAT p-value of 0.20 was selected to allow for the possibility of qualitative 
interaction which could result in a null main effect for the region (for example if the 
genetic variant is positively associated with CES-D in the presence of the environmental 
factor but inversely associated in the absence of the factor resulting in an average null 
effect). A total of 37 regions were included (of 47). Since regions were selected based on 
lowest p-values from the meta-analysis of individual SNPs and averaged depressive 
symptom scores across ethnicities, it is not surprising to have such a large percentage of 
regions with regional genetic effect p-values < 0.20. 
5.2.3 Environment 
 Two individual-level social environments are used in these analyses: chronic 
burden and emotional social support. These measures represent different dimensions of 





exams in MESA (exams one and three) and is based off of the chronic burden scale 
developed for the Healthy Women Study.[126] It is an index of affirmative responses to 
five individual burdens including health (self and others), finances, employment, and 
relationships that were ongoing for more than six months. Within each exam if a 
component score was missing, the overall CB for that exam was set to missing. CB was 
averaged across the two exams for each individual. If either exam was missing, CB was 
created from the existing measure. If both exams were missing, CB was set to missing. 
CB was centered at the overall mean. Higher values of CB indicate higher chronic burden 
(i.e. more burdens).  
 Emotional social support was available at exams one and three of MESA and is an 
index rating six questions on a five-point Likert scale (1 = “none of the time” to 5 = “all 
of the time”). This scale was originally assessed in the Enhancing Recovery in Coronary 
Heart Disease study.[127] These questions included asking if someone was available to 
listen, give advice, show love and affection, help with daily chores, provide emotional 
support, and confide in. Within each exam if a component score was missing, the overall 
SS for that exam was set to missing. If either exam was missing, SS was created from the 
existing measure. If both exams were missing, SS was set to missing. SS was centered at 
the overall mean. Higher scores indicate more social support. 
 Neighborhood social environment is summarized into a neighborhood index score 
(NIS) composed of three dimensions: aesthetic quality (AQ), safety (SF), and social 
cohesion (SC) measured with a 1-mile radius as the definition of neighborhood. A 
previously published study found that these key features of the environment were 





separate neighborhood dimension scales (AQ, SF, SC) pooled information from MESA 
and the Community Survey (CS) to create crude means for the neighborhood dimensions. 
The respondent’s own answer was not included in the crude mean estimates for the 
neighborhood, allowing for more objective neighborhood measures than using the MESA 
participant’s perception of neighborhood dimensions alone. The neighborhood level data 
was linked to the participant’s addresses within a 1-mile buffer by matching each 
participant of the survey within 1 mile based on the latitude/longitude of the address. 
Responses of “Don’t Know” or “Refused” values were set to missing for each of the 
original variables in each of the surveys. Several questions were reverse coded so that 
questions reflected better social outcomes with increasing scores.  
The NIS was created by averaging the 1-mile means for AQ, SF, and SC across 
the three exams by neighborhood dimension and then averaging the three exam-specific 
averages. If any one of the nine variables (AQ exam one, three, and four; SF exam one, 
three, and four; or SC exam one, three, and four) was missing, then NIS is set to missing. 
The index score was then mean-centered by the combined-ethnicity mean to aid 
interpretability. Higher NIS indicates “more positive” overall neighborhood 
environments, such as a high degree of SF, good AQ, and/or good SC. The index scores 
range from -1.30 to 0.95, with a mean of 0 and a standard deviation of 0.33 in the 
combined sample (AA, EA, CA, HA). 
5.2.4 Covariates 
 Covariates include age at baseline exam, sex, study site at baseline exam, top four 
ethnicity-specific PCs, and ASEP. There were a total of 6,335 MESA participants 





23%). Average age (standard deviation) for the AA, EA, CA, and HA sub-samples was 
62.2 (10.1), 62.6 (10.2), 61.4 (10.3), and 62.4 (10.4) years, respectively. Slightly less than 
half of each ethnicity was male (AA 48.0%, EA 46.4%, HA 49.3%, CA 49.7%). Study 
site is the field center from which the participant was interviewed and includes: 
Baltimore MD (Johns Hopkins University Field Center); Chicago, IL (Northwestern 
Field Center); Forsyth County, NC (Bowman Gray Field Center); Los Angeles, CA 
(UCLA Field Center); New York, NY (Columbia Field Center); and St. Paul, MN 
(University of Minnesota Field Center). PCs were calculated using genetic information 
for each ethnicity separately. ASEP is a summary index of income, education, and 
wealth. Income (<$25,000, $25,000–39,999, $40,000–74,999, or +$75,000), baseline 
highest level of education completed (completed high school or less, some college but no 
degree/technical school certificate, associate or bachelor’s degree, or 
graduate/professional degree), and  four wealth indexes (investments (yes/no), home 
ownership (yes/no), vehicle ownership  (yes/no), land/property ownership other than 
primary residence (yes/no)) were summed (income variable (0 – 3, low to high), 
education (0 – 3, low to high), a single point for each wealth indicator). The ASEP score 
ranged from 0 – 10, with higher scores indicating greater ASEP. 
5.2.5 GESAT 
 The GESAT is a variance component score test. For GESAT, the interaction 
model is:  
   ̅           
       
      
       





Where  ̅   is the log-transformed (depressive symptom score averaged across exams plus 
1) for individual i,  Xi is a vector of non-genetic covariates, Ei is the environmental 
factor, Gi is a vector of genetic markers, and Si is a vector of G x E interaction terms. One 
assumes that each of the βj’s, j = 1, …, p, follows an arbitrary distribution with mean zero 
and common variance τ
2
, and that the βj’s are independent. Testing H0: τ
2
 = 0 is 
equivalent to testing H0: β = 0, which tests whether at least one of the interaction terms is 
non zero. Covariates include age, sex, site, top four ethnicity-specific PCs, and ASEP. 
The variance-component score statistic for τ is 
    ̅   ̂       ̅   ̂  
Where S is the vector of G x E interactions for each individual and variant in the region,  
 ̂ is the predicted mean of   ̅ under the null model. 
5.2.6 Single SNP interaction model 
GESAT does not provide SNP-by-environment interaction parameter estimates 
(i.e. magnitude or direction of effect). Gene-level analysis was followed with an 
individual SNP x environment analysis using generalized estimating equation (GEE) 
methods to estimate both the magnitude and direction of each SNP-by-environment 
interaction term in a SNP set when there was evidence of a significant gene-level 
interaction.  
For SNP sets that showed significant evidence of interactions with the 
environments, we estimated the effect of each SNP within the SNP-set, for each ethnic 
group separately using GEE methods following the model below: 
   ̅
  
        





Where  ̅   is the depressive symptom measure averaged across exams and appropriately 
log transformed for participant i. Instead of the model-based estimator of variance, we 
used a sandwich estimator of variance for robustness. MESA encourages the use of 
sandwich based variance estimation. 
 After interaction models for individual SNP x environment models were run, the 
p-values for each SNP across ethnicities were combined using Fisher’s method [197]: 
   
    ∑      
 
   
 
 Where pi is the p-value for the SNP x E interaction for each ethnicity i, and k is the 
number of ethnicities. This statistic follows a chi-square distribution with 2k degrees of 
freedom. Only cases where two or more ethnicities contribute to the statistic were 
included. This method gives an estimate of the overall effect of the SNP x E interaction 
across ethnicities.  
5.3 Results 
5.3.1 Gene-level   
5.3.1.1 Chronic Burden and Social Support 
  Results from all regions for the SNP-set x CB interaction are shown in Table 20. 
Of the 37 regions investigated, seven regions showed significant or marginally significant 
interactions (significant p-value ≤ 0.05, marginally significant 0.05 < p-value ≤ 0.10) 
with CB. Two of these regions had significant or marginally significant interactions in 





0.04; and region 44 chr 15:77126365-77166365: EA p-value = 0.06, CA p-value = 0.09). 
Region 1 has no established genes within ±100kb of the index SNP. Region 44 lies within 
the intronic RASGRF1 (5q31 ras-specific guanine nucleotide-releasing factor 1) 
gene.[167] This gene has previously been associated with myopia (near-sightedness) in 
European and Asian ethnicities,[198, 199] but it is novel in depressive symptoms. 
 Ten regions had ethnicity-specific significant or marginally significant 
interactions (Table 20) with SS. Only one region had a significant SNP-set interaction 
with SS in more than one ethnicity (region 29 8:78208511-78248511: AA p-value = 0.04, 
EA p-value = 0.04). Region 29 does not have any established genes within ±100kb of the 
index SNP. Though there may be no genes near these regions, it does not preclude the 
region from being in a potentially important regulatory area. 
5.3.1.2 Neighborhood Index Score 
 Twelve regions were found to have significant interactions with NIS (Table 21). 
Region 46 (chr 18:21454070-21494070) had significant (p-value ≤ 0.05) interactions in 
three ethnicities (AA p-value = 0.04, EA p-value = 0.03, HA p-value = 0.00). Region 46 
does not have any established genes within ±100kb of the index SNP.  
5.3.2 SNP-level   
Instances where there was evidence of a significant or marginally significant 
region-level interaction (p-value < 0.10) in at least two ethnic groups for any SNP-set x E 
were considered to provide the strongest evidence of cross-ethnicity region-level 
interaction effects. For these SNP sets, individual SNP x E interactions were examined to 





Fisher’s combined p-value) SNP x E interaction for each region showing CES-D at 
quartiles of environment (combined ethnicities) for each genotype (0, 1, or 2 copies of the 
coded allele) were plotted for each ethnicity.  
5.3.2.1 Chronic Burden and Social Support 
 Within the regions identified in the chronic burden (regions 1, 44) and social 
support (region 29) environments, 14 SNP x E interactions reached statistical significance 
(αBonferroni = 0.001 – corrected for the average number of SNPs within a region) in the 
across-ethnicity analysis, all from region 29.  
Plots of the top SNP from each of these regions, for each ethnicity show strong 
evidence of an additive effect for these SNPs in almost all of the ethnicities (Figure 31-
Figure 33). Noting that these graphs do not necessarily provide the most accurate 
reflection of the individual SNP interaction results (environment was modeled as 
continuous and plotted as quartiles), plots continue to show a large difference between 
mean depressive symptoms for the chronic burden quartiles (Figure 31,Figure 32) and the 
social support quartiles (Figure 33). Among all ethnicities, higher levels of the amount of 
chronic burden experienced denoted increases in mean depression scores. In European, 
Chinese, and Hispanic Americans, this increase was steepest for those with no copies of 
the coded allele. In African Americans, highest mean CES-D scores were seen at the 
highest level of chronic burden for those with two copies of the coded allele (Figure 31). 
Similar increases in mean depressive symptoms over the quartiles of chronic burden were 
observed in region 44 (Figure 32). In this region, having two copies of the coded allele 





AA, CA, and EA populations but this genotype was susceptible to higher mean 
depressive symptom scores in the HA sub-sample.  
In the interaction plots for social support quartiles for the top SNP from the 
Fisher’s method meta-analysis show a protective effect of social support for each 
genotype (Figure 33). There is some evidence of interaction in the Hispanic American 
sample. The AA and EA sub-samples showed lower mean CES-D scores with zero copies 
of the coded allele over all levels of social support compared to one or two copies of the 
coded allele. Both the CA and HA samples showed similar decreasing patterns of 
depressive symptoms over the increasing levels of social support; however, no copies of 
the coded allele exemplified higher mean depressive symptoms compared to one or two 
copies. One point to note in these plots is that the CA sub-sample consistently shows 
higher levels of depressive symptoms scores in these environments than the other three 
ethnicities. This can be misleading, as the Chinese sub-sample had the lowest average 
depressive symptom scores of any of the four ethnicities. One reason for the increased 
values in the Chinese sample is that these participants tended to have much more strongly 
skewed measures of environment. Particularly the CA sample had lower levels of 
deleterious individual- and neighborhood-level factors as well as a smaller sample size 
overall. As an example, quartiles of chronic burden in the Chinese sample were (Min: 0, 
Q1: 0, Med: 0.5, Q3: 1, Max: 4.5) whereas in the combined ethnicity the quartiles were 
(Min: 0, Q1: 0, Med: 1, Q3: 1.5, Max: 5). The combined ethnicity quartiles were used to 





5.3.2.2 Neighborhood Index Score 
 Region 46 had 24 SNP x E interactions that reached significance. The lowest p-
values in this region were for rs4800653 (p-value 1.47 x 10
-6
) and rs1840444 (p-value 
7.65 x 10
-6
). A complete listing of the ethnicity-specific sample sizes and p-values, and 
Fisher’s chi-square, degrees of freedom, and p-value for cross-ethnicity comparison for 
each region can be found in Appendix 68 - Appendix 71. 
 The interaction figures for rs4800653 for each ethnicity reveal evidence of a 
statistical interaction (Figure 34). In of all the ethnicities, having more copies of the 
coded allele is associated with higher mean depressive symptom averages in areas with 
low NIS scores (indicating less safe, less cohesive, and/or less aesthetically pleasing 
neighborhoods). Conversely, having more copies of the coded allele (while deleterious in 
low NIS areas) is protective in areas with high NIS scores (indicating safer, more 
cohesive, and/or aesthetically pleasing neighborhoods). 
5.4 Discussion 
 These analyses used novel methods (GESAT[200]) to elucidate SNP set x social 
environment interactions associated with depressive symptoms, averaged across exams. 
Using three different environments, two at the individual-level (chronic burden and social 
support) and one at the neighborhood-level (neighborhood index score), four genetic 
regions had significant G x E associations with depressive symptoms. Investigating these 
associations at the SNP level and combining across ethnicity provided striking evidence 






In these analyses we assumed an additive effect for each SNP; that is, for every 
additional copy of the coded allele, the mean response (averaged depressive symptom 
score) increases (or decreases) linearly. However, it is likely that the additive model may 
not be the best-fitting model for every variant within a region. Additional testing with 
different genetic effect assumptions is warranted to better estimate the true genetic effects 
of these variants on depressive symptoms.  
The method used to test interaction effects for genetic marker sets, GESAT, is 
computationally efficient, robust, and has several advantages over traditional SNP x 
environment analysis. In particular, this method has been shown through simulation and 
real data applications to be a more powerful method over others (e.g. weighted sum 
statistics[201], cohort allelic sum tests[115], or C-alpha test[202]). GESAT allows for 
covariate adjustment and can test common variants through the use of an unweighted 
linear kernel. Since our analyses filtered out any rare variants (MAF < 0.05), this option 
is particularly important. GESAT also does not assume that all variants will produce 
effects of similar direction and magnitude by allowing the variance of an individual 
variant to differ from a mean of zero. Finally, GESAT allows for a test of biologically 
meaningful regions rather than individual SNPs that may vary in distribution across 
ethnicities due to evolutionary patterns and may not be functional genetic variants.[173-
175] Unfortunately, GESAT does not yet allow for testing of phenotypes over time in 
repeated measures models, accounting for correlation between measures on the same 
individual. The extension of GESAT to allow for repeated measures modeling would 
greatly enhance the ability to detect genetic effects for phenotypes that are better 





The Encyclopedia of DNA Elements (ENCODE) aims to build a database of 
functional elements in the human genome, including protein and RNA level elements, 
and regulatory elements that control cells and circumstances in which a gene is 
expressed.[186, 187] Because regions 1, 30, and 46 all presented as being in gene deserts 
(that is, there were no genes within ±100kb of the index SNP), ENCODE was used to 
determine if potential functional elements exist in these regions. 
5.4.1 Region 1 
 Region 1 (chr1:2,775,967-2,815,967) lies on the q arm of chromosome one. There 
is preliminary evidence of an overlap with an H3K4Me1 histone mark (regions often 
located near active regulatory elements), several DNase1 hypersensitivity clusters (a 
chromatin accessibility feature common to cis-regulatory sequences), and several 
transcription factor binding sites (Figure 35).[186, 187] Region 1 contains not only SNPs 
with high conservation rates (rs1563469, phylogenic conservation score (PCS) = 0.843) 
across 17 species[203, 204], but also SNPs that lie in Short Interspersed Elements (SINE) 
(rs897620, rs2445620), in DNA repeat elements (rs2842910), long terminal repeat (LTR) 
(rs2842911), and Long Interspersed Elements (LINE) elements (rs750786, rs897630) 
(Appendix 72). Genetic conservation describes the amount and distribution of genetic 
diversity within species and evolutionary diversity among species as well as the retention 
of variants within and among populations in order to maintain long-term evolutionary 
potential.[203] 
5.4.2 Region 29 
 ENCODE analysis for region 29 shows potential for several dense DNaseI 





information. Regulatory regions in general and promoters in particular, tend to be DNase 
sensitive. There does not appear to be noticeable elevations in enhancer- and promoter-
associated histone marks (either H3K4Me1 or H3K4Me1) (Figure 36).[186, 187] Region 
29 contains two SNPs with a PCS of 1 indicating extremely high cross-species 
conservation (rs7831215, rs16939439). This region also houses SNPs that lie in SINEs, 
DNA repeat elements, LTRs, and LINEs (Appendix 72). 
5.4.3 Region 46 
In region 46, we see a large amount of evidence for functional elements. In 
particular, there are several large elevations in enhancer- and promoter-associated histone 
marks (H3K4Me1) in the positions approximately +30kb and to a lesser extent -45kb 
from the index SNP. These areas also coincide with many dense DNaseI hypersentivity 
clusters and transcription factor binding sites (Figure 37).[186, 187] Region 46 contains 
many SNPs that are in SINEs or LTRs. This evidence on a whole is suggestive of 
potential functional consequences of genetic variation in these particular regions – 
suggesting that further functional characterization is warranted.[186, 187] 
Taken as a whole, bioinformatic evidence from these regions provide indications 
of a potential regulatory effect of genetic regions involved in G x E interactions related to 
depressive symptoms. Typically, regulatory areas modulate gene expression in response 
to developmental, tissue specific or environmental signals. Influences on gene expression 
from developmental signals may lay down a basis for methylation across the life course 
and consequently lead to higher (or lower) depressive symptoms later in life. The 





successfully (or unsuccessfully) adapt to chemical stimuli, while these regulatory regions 
may also influence how the body responds, at a molecular level, to neighborhood stimuli.  
This novel work in examining the impact of G x E interactions on depressive 
symptoms, across multiple gene regions, environment definitions, and ethnicities was 
possible through innovative gene-environment set association test techniques, and 
through detailed assessments of individual-level psychosocial environment and objective 
neighborhood dimensions. These methods permit an examination of genes/SNP sets 
across ethnicities, where individual SNPs may not replicate across ethnicities due to 
ethnicity-specific patterns of linkage disequilibrium or differences in allele frequencies 
across ethnic groups.[173-175] Future work should focus on examining the functional 
elements in these regions as well as incorporating methods to examine complex diseases 
over time in repeated measures models.  
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Table 20 Gene-environment set associations tests (GESAT) interaction results for chronic burden x 
SNP-set and social support x SNP-set 
 
Chronic Burden Social Support 
Region AA EA CA HA AA EA CA HA 
 
p p p p p p p p 
1 9.91E-01 6.93E-02 3.53E-02 6.96E-01 3.25E-01 9.65E-01 3.69E-01 7.14E-01 
2 7.61E-01 3.18E-01 3.94E-01 7.82E-01 9.22E-01 8.95E-01 6.97E-01 6.86E-01 
3 7.64E-01 4.10E-01 8.35E-01 6.98E-01 7.73E-01 5.50E-01 5.00E-01 8.70E-01 
4 3.20E-01 6.93E-01 9.20E-01 9.51E-01 3.89E-01 7.61E-01 4.19E-01 9.88E-01 
5 1.73E-01 5.58E-01 9.03E-01 9.66E-01 6.87E-01 7.63E-01 4.28E-01 9.67E-01 
6 1.95E-01 6.10E-01 8.54E-01 9.50E-01 5.46E-01 7.82E-01 7.40E-01 9.60E-01 
7 1.27E-01 3.58E-01 5.32E-01 6.80E-01 3.67E-01 3.73E-01 3.42E-01 5.34E-02 
8 3.41E-01 6.46E-01 6.10E-01 5.72E-01 1.91E-01 5.73E-01 3.55E-01 2.83E-02 
9 1.57E-01 1.33E-01 1.43E-01 5.71E-01 2.09E-01 2.51E-01 1.82E-01 6.78E-01 
10 4.62E-01 6.41E-01 4.93E-01 5.95E-01 4.75E-01 9.23E-01 7.62E-01 1.74E-01 
11 4.69E-01 3.28E-01 3.70E-01 2.40E-01 8.98E-01 8.61E-01 9.95E-01 9.86E-01 
13 1.85E-01 3.21E-01 2.63E-01 1.27E-02 6.40E-02 4.06E-01 2.15E-01 9.78E-01 
14 5.52E-01 3.45E-01 9.77E-02 8.59E-01 6.63E-01 6.88E-02 5.79E-01 9.08E-01 
16 2.91E-01 4.50E-01 6.68E-01 3.88E-01 4.27E-01 3.69E-01 -- 7.12E-01 
17 3.62E-01 -- 1.81E-01 5.45E-01 6.37E-01 4.53E-01 2.90E-01 7.30E-01 
19 9.54E-01 7.82E-01 5.03E-01 2.86E-01 1.55E-01 4.13E-02 8.99E-01 9.91E-01 
20 1.75E-01 3.10E-01 6.17E-01 6.15E-01 2.41E-01 2.89E-01 3.12E-01 7.64E-01 
21 5.33E-01 8.92E-01 1.24E-01 8.89E-01 9.43E-01 8.37E-01 7.78E-01 8.00E-01 
22 5.57E-01 6.42E-01 7.20E-01 1.87E-01 2.69E-01 4.34E-01 8.66E-01 2.73E-01 
23 6.51E-01 9.66E-01 2.91E-01 4.12E-01 5.67E-01 4.28E-01 6.56E-01 9.19E-01 
24 6.87E-01 4.45E-01 2.29E-01 6.67E-01 8.18E-01 7.81E-01 7.50E-01 5.25E-01 
26 7.65E-01 7.75E-01 7.49E-01 4.42E-01 6.06E-01 5.26E-02 9.44E-01 2.49E-01 
27 6.32E-01 8.78E-01 8.40E-01 4.30E-01 4.82E-01 8.63E-02 9.44E-01 2.50E-01 
28 5.62E-01 7.60E-01 2.28E-01 4.98E-01 3.37E-01 1.72E-01 7.52E-01 4.59E-01 
29 3.81E-01 7.51E-01 5.90E-01 4.25E-01 4.19E-02 4.20E-02 3.99E-01 9.08E-01 
30 6.67E-01 5.84E-01 4.62E-01 2.40E-01 4.98E-01 9.20E-01 9.05E-01 9.62E-01 
32 7.93E-02 6.63E-01 6.07E-01 9.51E-01 1.68E-01 8.85E-01 5.84E-01 9.72E-01 
33 5.12E-01 6.52E-01 4.92E-01 1.74E-01 1.53E-01 7.13E-01 3.16E-01 2.56E-01 
34 6.98E-01 1.26E-01 5.31E-01 2.90E-01 9.02E-01 2.18E-01 1.02E-01 5.54E-01 
35 1.34E-01 9.77E-01 4.25E-01 7.62E-01 8.64E-01 9.12E-01 3.43E-01 7.91E-01 
38 8.42E-01 7.33E-01 9.18E-02 5.40E-01 8.92E-01 9.65E-01 4.38E-01 2.57E-02 
40 8.45E-01 4.14E-01 2.11E-01 2.10E-01 1.04E-01 9.94E-01 6.35E-01 6.47E-01 
41 9.65E-01 5.94E-01 5.25E-01 2.28E-01 5.29E-01 9.08E-01 4.44E-01 7.26E-01 
42 2.11E-01 4.60E-01 1.89E-01 3.83E-01 2.67E-01 6.96E-01 3.62E-01 7.62E-01 
43 6.09E-01 5.35E-01 7.45E-01 1.24E-01 1.10E-01 5.01E-01 8.86E-01 8.45E-01 
44 5.95E-01 6.46E-02 9.17E-02 6.42E-01 5.78E-01 8.73E-01 6.79E-01 9.88E-02 
46 7.61E-01 7.12E-01 6.51E-01 9.15E-01 7.23E-01 4.94E-01 7.55E-01 7.84E-01 
Only regions with significant joint effects were investigated in the interaction analysis. 
-- Indicates a model that did not converge. 
AA: African American, EA: European Americans, CA: Chinese Americans, HA: Hispanic Americans, p: p-
value. P-values ≤ 0.10 are bolded 





Table 21 Gene-environment set associations tests (GESAT) interaction results for Neighborhood 
Index Score and SNP-set, by ethnicity 
 AA EA CA HA 
 
 AA EA CA HA 
 Region p p p p 
 
Region  p p p p 
1 8.61E-01 4.91E-01 6.07E-01 1.06E-01 
 
23 9.59E-01 4.53E-01 1.98E-02 3.97E-01 
2 8.84E-01 5.71E-01 6.81E-01 8.88E-01 
 
24 3.71E-01 4.25E-01 9.58E-01 3.21E-01 
3 2.12E-01 8.40E-01 7.56E-01 1.08E-01 
 
26 9.18E-01 6.75E-01 3.96E-01 2.93E-01 
4 4.68E-01 6.74E-01 4.66E-01 4.69E-01 
 
27 8.36E-01 7.32E-01 5.28E-01 6.11E-02 
5 7.31E-01 3.84E-01 5.36E-01 5.82E-01 
 
28 6.80E-01 9.01E-01 2.29E-01 1.06E-01 
6 5.76E-01 3.61E-01 6.07E-01 5.51E-01 
 
29 2.80E-01 2.07E-01 6.14E-01 6.42E-02 
7 3.98E-01 6.08E-01 9.34E-01 9.61E-01 
 
30 6.50E-01 6.48E-01 8.94E-01 8.76E-01 
8 2.28E-01 4.58E-01 8.49E-01 9.18E-01 
 
32 3.55E-01 9.52E-02 4.57E-01 4.98E-01 
9 1.91E-01 1.49E-01 3.62E-01 2.57E-01 
 
33 9.02E-01 8.81E-01 3.43E-01 1.28E-01 
10 3.69E-01 2.58E-01 5.55E-01 7.98E-02 
 
34 1.63E-01 8.34E-01 6.96E-01 1.41E-02 
11 6.08E-02 9.63E-01 6.24E-01 5.37E-01 
 
35 3.62E-01 7.10E-01 2.39E-01 4.70E-01 
13 4.33E-01 7.36E-01 1.21E-01 4.52E-01 
 
38 3.22E-01 2.75E-01 4.65E-01 5.91E-03 
14 8.03E-01 9.52E-01 5.51E-01 3.41E-01 
 
40 8.77E-01 8.38E-02 5.98E-01 5.49E-01 
16 9.42E-01 2.40E-01 -- 1.77E-01 
 
41 5.16E-01 2.84E-01 3.37E-01 3.59E-01 
17 3.99E-01 3.82E-01 1.46E-01 3.82E-01 
 
42 3.15E-01 6.07E-01 4.55E-01 2.72E-01 
19 6.44E-01 7.97E-01 7.83E-02 4.56E-01 
 
44 7.45E-01 4.43E-01 5.79E-01 8.34E-01 
20 6.18E-02 3.46E-01 1.02E-01 4.64E-01 
 
46 6.25E-01 2.05E-01 2.28E-01 8.49E-01 
21 6.77E-01 5.33E-01 3.22E-01 6.56E-01 
 
47 4.23E-02 2.57E-02 4.97E-01 3.94E-03 
22 1.62E-01 9.15E-01 2.06E-01 7.78E-01 
      Only regions with significant joint effects were investigated in the interaction analysis. -- Indicates a model that did not converge, 
AA: African American, EA: European Americans, CA: Chinese Americans, HA: Hispanic Americans. p: p-value,  












Figure 27 Fisher's combined –log10(p-values) for each SNP x environment (chronic burden) 
interaction in region 1 plotted against genomic position 
SNPs with Fisher’s combined p-value < 0.001 are identified by rs number. Colors indicate the number of 
ethnicities that were used in calculating the Fisher’s combined p-value. Only SNPs with ethnicity-specific 
minor allele frequency > 5% were included in the Fisher’s combined analysis. 





Figure 28 Fisher's combined –log10(p-values) for each SNP x environment (chronic burden) 
interaction in region 44 plotted against genomic position 
 
SNPs with Fisher’s combined p-value < 0.001 are identified by rs number. Colors indicate the number of 
ethnicities that were used in calculating the Fisher’s combined p-value. Only SNPs with ethnicity-specific 





Figure 29 Fisher's combined –log10(p-values) for each SNP x environment (social support) 
interaction in region 29 plotted against genomic position 
SNPs with Fisher’s combined p-value < 0.001 are identified by rs number. Colors indicate the number of 
ethnicities that were used in calculating the Fisher’s combined p-value. Only SNPs with ethnicity-specific 





Figure 30 Fisher's combined –log10(p-values) for each SNP x environment (neighborhood index 
score) interaction in region 46 plotted against genomic position 
SNPs with Fisher’s combined p-value < 0.001 are identified by rs number. Colors indicate the number of 
ethnicities that were used in calculating the Fisher’s combined p-value. Only SNPs with ethnicity-specific 







Figure 31 Interaction plot for the SNP with the lowest Fisher's combined p-value for region 1 
 
Chronic burden divided into quartiles for plotting purposes, AA: African American, EA: European 







Figure 32 Interaction plot for the SNP with the lowest Fisher's combined p-value for region 44 
 
Chronic burden divided into quartiles for plotting purposes, AA: African American, EA: European 






Figure 33 Interaction plot for the SNP with the lowest Fisher's combined p-value for region 29 
 
Social support divided into quartiles for plotting purposes. AA: African American, EA: European 








Figure 34 Interaction plot for the SNP with the lowest Fisher's combined p-value for region 46 
 
Neighborhood Index Score divided into quartiles for plotting purposes, NIS: Neighborhood Index Score, 
AA: African American, EA: European Americans, CA: Chinese Americans, HA: Hispanic Americans, 


















































This dissertation explored genetic and environmental interplay in the context of 
depressive symptom scores across four genetically distinct ethnicities. This chapter will 
address strengths and limitations within each analytic chapter, as well as future directions 
for this research. In chapter III (Comparing genome-wide association studies (GWAS) 
across different phenotype modeling approaches, and across ethnicities), the goal was to 
investigate the association of single nucleotide polymorphisms (SNP) and depressive 
symptom scores in a longitudinal setting to elucidate genetic predictors across four 
ethnicities (African American (AA), European American (EA), Chinese American (CA), 
and Hispanic American (HA)). This was accomplished through the use of three different 
approaches of defining a depressive symptom phenotype. In the analysis investigating 
ethnicity-specific genetic associations using a baseline measure approach, one SNP in 
Hispanic Americans was identified at a genome-wide significance level (α = 5 x 10
-8
). 
Within each ethnicity, several novel variants were also discovered at a genome-wide 
suggestive level (α = 5 x 10
-6
), particularly in the repeated measures approach. In 
combining p-values across the four ethnicities for the repeated measures approach using 
meta-analysis, several genome-wide suggestive SNPs were implicated as potential cross-
ethnicity genetic predictors of depressive symptoms. Additionally, a SNP previously 





depressive symptom GWAS showed evidence of replication across the ethnicities in the 
Multi-Ethnic Study of Atherosclerosis (MESA).[120] This analysis indicates that a more 
complete characterization of longitudinal phenotypes provides a powerful platform for 
analyzing genetic associations of complex traits.  
Chapter IV continues the investigation of genetic predictors of depressive 
symptoms but moves into the framework of SNP-set-level inference. Using the meta-
analysis results from the averaged depressive symptom score GWAS across ethnicities, 
sequence kernel association testing (SKAT) and an extension of SKAT (MetaSKAT) 
were used to find and meta-analyze SNP-set results across ethnicities. Four SNP-set 
regions with significant associations for averaged depressive symptoms were discovered 
across ethnicities. This analysis used innovative techniques to identify genetic signals 
from a set of SNPs that were not apparent with the individual SNP GWAS. These 
methods also allowed a combination of genetic associations across ethnicities at the SNP-
set level. Importantly, these findings provide justification for moving away from 
performing solely individual SNP-based GWAS and into the addition of regional/gene-
level analysis when examining a phenotype across multiple ethnicities. 
Finally, in chapter V, SNP-set by environment interactions using both individual- 
and neighborhood-level environments were investigated to elucidate modifications of the 
genetic associations with depressive symptoms by environments. Four genetic regions 
had significant SNP-set x environment interactions with depressive symptoms (two 
regions had significant interactions with chronic burden (CB), one region had a 
significant interaction with social support (SS), and one region with neighborhood index 





environment interactions for SS and NIS, combined p-values across ethnicities for 
individual SNPs showed evidence of additive SNP x environment interactions.  
This dissertation represents an important contribution to life sciences in several 
ways: first, this is the first analyses that incorporates SKAT, MetaSKAT, and GESAT 
with depressive symptoms; second, through the analysis of common variants as opposed 
to rare variants in SKAT; third, through the investigation of the association of genetic 
variants and depressive symptoms across multiple ethnicities; fourth, through a detailed 
comparison of how longitudinal data can be used to define a mental health phenotype in 
the context of genetic studies; and finally through the use of both individual- and 
neighborhood-level interactions with genetic information at both an individual SNP level 
and a region level. This work contributes to the fields of epidemiology, genetics, and 
psychiatry. 
6.2 Depressive symptoms phenotype 
Depressive symptom score measured by the Center for Epidemiologic Studies – 
Depression (CES-D) is the primary outcome in this dissertation. The CES-D scale 
assesses several aspects of depression described in the DSM-IV: depressed mood, 
feelings of guilt and worthlessness, feelings of helplessness and hopelessness, 
psychomotor retardation, loss of appetite, and sleep disturbance.[7] It was developed by 
the Center for Epidemiologic Studies for use in general population surveys.[14, 19]  
Unfortunately, the CES-D is not a diagnostic interview but a screening measure 
used to help identify individuals at risk for depression. It may fail to separate depression 
from generalized anxiety or from depression secondary to other diagnoses. The CES-D 





participant’s depressive symptoms are a result of bereavement, medication side effects, 
drugs and alcohol, or physical illness. However, the CES-D scale has high internal 
consistency, acceptable test-retest stability, excellent validity by clinical and self-report 
criteria, and substantial evidence of construct validity.[14]  
Other diagnostic interviews may provide a better characterization of depressive 
symptoms (even depression) that would aid in creating a more valid phenotypic measure 
for analysis. However, these interviews sometimes need to be administered by a clinician 
or a trained interviewer. The Structural Clinical Interview (SCID) – using DSM-III-R 
criteria for illness – is a diagnostic instrument that must be administered by a clinical 
interview. The SCID allows for major axis I diagnoses in modules adapted to assess 
particular illnesses (e.g. depression) in both current episode (past month) and for lifetime 
occurrence.[205, 206]  
A diagnostic interview that could be administered by a trained interviewer is the 
Composite International Diagnostic Interview (CIDI). It has been used since its 
development by the World Health Organization (WHO) in 1990 as an expansion of the 
Diagnostic Interview Schedule to evaluate mental health with specific modules for Major 
Depression.[25, 207] The CIDI was primarily developed to be based on the WHO 
International Classification of Disease (ICD), rather than a diagnosis based on definitions 
and criteria from the Diagnostic and Statistical Manual (DSM) of Mental Disorders.[208] 
CIDI diagnoses are significantly related to independent clinical diagnosis, but there is 
some lack of concordance due partly to the unreliability of clinical interviews.[208] 
Kessler and Üstün highlight four methodological issues stemming from evaluations of the 





defined terms and multiple clauses, (2) some respondents may not understand tasks 
implied by the questions, (3) respondents may lack motivation to answer questions 
accurately due to the potentially embarrassing nature of the questions or stigmatizing 
experiences, and (4) some respondents may not have the ability to answer questions 
accurately due to difficulty in recall (e.g. age of onset, number of episodes, etc).[208] 
One of the major drawbacks of using the CIDI is that, while administration does not 
require a clinician, it does require a trained interviewer to conduct the assessment.[25]  
An alternative interview to the CES-D that can be administered by a lay 
interviewer is the Beck Depression Inventory (BDI).[209] The BDI is a list of 21 
symptoms and attitudes that are rated in terms of intensity. It can be taken in 5 – 10 
minutes and is scored by summing the ratings of the 21 items. It was originally designed 
to be administered by a trained interviewer but is generally self-administered.[209] This 
may be a more acceptable instrument since it is targeted at depression and can 
differentiate between depression and anxiety. 
Since no reliable biomarker or physiological measure of depression has been 
established, clinician diagnosis would be the ideal phenotype assessment for these 
studies, but is not practical due to time and monetary constraints. Accessing electronic 
medical records for clinical diagnosis of depression may be possible in the future, but 
currently it is unavailable for MESA participants.  
While still using depressive symptoms, perhaps measured by the CES-D, an 
alternative phenotype may be created using depressive symptom trajectories. Potential 
overall patterns of depression over the life course have not yet been established, and it is 





high depression, lifetime low depression, increasing depression over time, decreasing 
depression over time). Characterizing depressive illness using trajectories may be a 
pertinent avenue to pursue in future research.  
Despite the drawbacks of the CES-D, it has often been used to indicate the 
prevalence of depression in the literature – however, the CES-D assesses depressive 
symptoms, which may be a different phenotype than depression. The power to detect 
genetic variants associated with depression has been shown to increase when assessing 
depression quantitatively—as opposed to using a dichotomous definition or cutoff point 
to indicate “depression” —and better captures the phenotypic variations and subclinical 
depression in those who do not report enough symptoms to be categorized as suffering 
from depression.[24]  
6.3 Genome-wide association studies 
 Genome-wide association studies are typically designed to identify germline 
genetic variants associated with the risk of developing human diseases. The method 
searches the genome for small variants, SNPs that occur more frequently in individuals 
with a particular disease compared to individuals without the disease. Since this method 
examines the entire genome, it represents a promising way to study complex diseases 
which may have many genetic variants that contribute to disease risk. GWAS has been 
successful in identifying and validating common genetic variants (those with minor allele 
frequencies (MAF) > 1%) for a variety of human diseases (e.g. type 2 diabetes, coronary 
heart disease, breast cancer, and asthma).[210-212] 
 Since the early 2000s, both the Human Genome Project and the International 





perform extensive GWAS with these databases that contain references to the human 
genome sequence as well as a map of human genetic variation both quickly and 
accurately.[213, 214] Genotype chips, like the Affymetrix Genome-Wide Human SNP 
Array 6.0 used in MESA, allow for about 906,000 SNPs to be directly typed in a blood 
sample from an individual. Imputation methods allow for the identification of roughly 2.5 
million SNPs total from those (and including those) that are directly genotyped. The 
genotyping and imputation also include different types of genetic information including 
rare variants and copy number variants. One reason we may not have found any 
significant SNPs that were predictive of depressive symptoms in the ethnicity-specific 
GWAS is that we did not investigate rare variants or copy number variants that were part 
of the genotyping panel or imputation used in these studies. Imputation is not 100% 
accurate, nor is direct typing using genotype chips. Because of this, filtering methods are 
often employed to eliminate SNPs that are genotyped with poor quality. Filtering variants 
by removing SNPs with SNP-level call rate <95%, individual call rate <95%, and 
removing monomorphic SNPs allowed for the elimination of SNPs with poor quality 
from the analyses.  
To obtain the most accurate ethnicity-specific imputation, HapMap Phase I and II 
CEU + YRI + CHB + JPT (release #22 – NCBI Build 36), commonly called the 
“cosmopolitan panel,” was used as the reference panel for the African American, Chinese 
and Hispanic participants and HapMap Phase I and II – CEU was used as the reference 
panel (release #24 – NCBI Build 36) for Europeans. These panels are based on 
populations that were specifically defined. For the YRI (Yoruba), donors were required to 





required to have at least three of four Han Chinese grandparents. For the JPT (Japanese), 
donors were simply told that the aim was to collect samples from persons whose 
ancestors were from Japan. The criteria used to assign membership in the CEPH 
population (the CEU panel) have not been specified, except that all donors were residents 
of Utah. Using ethnicity-specific imputation panels allows us to more accurately match 
population patterns in SNP frequencies in each ethnicity for imputation – to account for 
homogeneity within and heterogeneity across ethnicities. The ability to obtain accurate 
genotype data on multiple ethnic populations allows for the characterization of genetic 
risk of disease across populations. This is one of the primary strengths of this dissertation. 
The vast majority of GWAS to date has been performed only in European subsamples 
which do not allow for comparison across genetically distinct ethnic groups limiting the 
applicability of study findings beyond European populations. 
It is known that allelic effects often differ according to their genetic and 
environmental context.[215, 216] Quantifying an individual SNP effect is difficult as 
both genetic and environmental backgrounds of individuals vary greatly.[216] GWAS 
attempt to reduce genetic heterogeneity by evaluating isolated population groups with 
higher degrees of genetic homogeneity compared to non-isolated populations (where 
isolated refers to the lack of out-breeding for many generations).[216] This is done by 
selecting populations that have similar ancestral backgrounds and analyzing them 
separately. The four genetically distinct populations in MESA were analyzed separately 
to address genetic and environmental heterogeneity. That is, that different ethnic groups 





While this dissertation included individuals from four genetically distinct 
populations, subdivisions within these populations may exhibit different risk profiles of 
depressive symptoms associated with different genetic variants. For instance, a paper 
published in 2012 used ~60,000 SNPs selected for minimal linkage disequilibrium to 
perform population structure analysis on the self-reported Hispanic participants in 
MESA. The authors showed that the Hispanic sample could be further divided into 
subgroups with very specific ancestries stemming from Central America, Cuba, the 
Dominican Republic, Mexico, Puerto Rico, and South America.[217] Though these are 
important ancestral and cultural differences, the sample sizes of each of these subgroups 
simply do not allow for powerful analysis using only MESA data. This is generally 
referred to as population substructure, which is known to be a potential source of 
confounding in genetic association studies.  
Admixture – the joining of two genetically distinct “parent” populations in recent 
history – will cause confounding of the association between a SNP and the trait of 
interest if: (1) the allele frequencies of the SNP vary with admixture proportions, (2) the 
admixture proportions vary among study participants, and (3) the mean value of the trait 
varies with admixture proportions.[218] Both African American and Hispanic American 
populations are considered admixed populations due to substantial allelic contributions 
from European and African ancestors. To account for both population substructure and 
admixture in each of the four ethnic groups under analysis, principal components 
calculated within each ethnicity were used as covariates. 
Though GWAS have been used for over a decade, most variants identified for 





explaining less than 1% of the variance of quantitative traits.[219] Because of the small 
effect sizes, very large sample sizes are required to reach adequate power to detect 
genetic effects and produce reliable inferences.[220] Most studies alone are 
underpowered to detect these variants and often collaboration across many studies, 
involving meta-analysis, are used to increase sample size, and thus power.[212, 219] 
Preliminary steps have been taken to analyze depressive symptoms in European samples 
from multiple studies, but in order to harmonize outcomes across studies, only baseline 
measures were considered.[120] Though this framework is frequently used for common 
traits with standard measures, it is exceedingly difficult to find studies measuring 
depressive symptoms using the CES-D in multiple ethnicities, across time.  
  Once GWAS for depressive symptoms were performed within each ethnicity in 
MESA, the question became how to compare across ethnicities. Traditional replication – 
where SNPs with the lowest p-values are “looked up” in an independent sample to 
determine if the direction of effect is consistent with the current findings and if the 
replication sample also has a significant effect – has been shown to have less power than 
a joint analysis method.[221] In a joint analysis, results from two GWAS in two different 
samples are combined using meta-analysis. There are several different choices of meta-
analysis methods that could have been used for these analyses including: p-value meta-
analysis, fixed effects, random effects, Bayesian approach and multivariate 
approaches.[222] Meta-analysis allows us to address the question: are the alleles at a 
particular marker associated with the disease status across studies (or in this case, ethnic 
groups). Weighting can improve power and reduce genetic heterogeneous effects. 





separate ethnicities) using weights.[153] We utilized the approach in which the direction 
of effect and p-value observed from each study are converted to Z-scores. Highly 
negative Z-scores are indicative of small p-values and associations between the coded 
allele and lower depressive symptom scores while large positive Z-scores are indicative 
of small p-values and associations between coded alleles and higher depressive symptom 
scores. The Z-scores are then combined across studies using a weighted sum, where the 
weights are proportional to the square root of the sample sizes from each study or ethnic 
subsample.[153, 223]  
 Ultimately, fixed effects meta-analysis methods using METAL were selected due 
to the ability of this method to synthesize the effect sizes, and because METAL is easily 
utilized and implemented. Other methods, such as p-value meta-analysis (i.e. Fisher’s 
combined method), random effects, Bayesian approaches and multivariate approaches 
introduce too many analytical issues such as not accounting for direction of effects, 
spuriously large summary effect estimates with selection biases, and computationally 
intense implementation.[222]  
6.4 SNP-set association analyses 
 Many complex diseases are influenced by the joint effects of genetic variation. A 
large number of group-wise association tests have been developed recently to evaluate 
SNP sets and their joint association with disease.[2, 3, 201, 202, 224-229] Group-wise 
testing has been shown to alleviate problems with intensive computation and multiple 
testing as well as lead to more stable results and more biologically relevant 





burden, and variance-component testing (including SKAT) have all been proposed as 
methods to evaluate the joint effect of SNPs on a disease.[2, 227, 234-236]  
PCA is a dimension reduction approach which is often used in genetic analysis to 
reduce redundant information.[234, 237] The idea is to transform p original variables into 
a set of new predictor variables, k, which are made up of a linear combination of the 
original variables. In using PCA, since many SNPs are in high linkage disequilibrium, the 
first few eigenvalues are able to capture much of the information in SNP sets. These 
eigenvalues are then regressed onto the outcome in linear or logistic models.[238]  
While PCA may have heavy loadings on important SNPs, meaning that PCA 
potentially could result in more biologically interpretable findings than other methods, 
PCA is not without limitations.[238] Latent variables identified in PCA are not 
necessarily related to the outcome resulting in reduced power for SNP set-based analysis 
because of the inclusion of SNPs unrelated to the disease.[234] PCA additionally requires 
a SNP screening step, using all SNPs to create the principal components which may be 
computationally intensive. Test power from PCA is also affected by the number of PCs 
included in the analysis.[239] 
SKAT has several advantages over other group-wise testing methods. First, 
SKAT does not assume individual SNPs have similar direction or magnitude of effect 
within a region and allows for individual variant effects to vary from a mean of zero in 
either direction. Second, SKAT is a more powerful method, even when sample sizes are 
small.[3] Importantly, SKAT allows for the adjustment of joint SNP effects by 
covariates. In addition to the ability to adjust for covariates, SKAT can be extended from 





unweighted linear kernel. Since these analyses did not focus on rare variants, the ability 
to specify an unweighted linear kernel was particularly important.  
MetaSKAT allows our investigation of SNP sets across multiple ethnicities by 
addressing two particular issues that may limit the ability for an individual SNP to 
replicate across multiple ethnicities: (1) that there are different underlying patterns of 
linkage disequilibrium and (2) there are differences in allele frequencies across 
ethnicities.[174, 175, 177] One drawback of current methods is the inability to assess 
outcomes in a repeated measures framework, accounting for correlation in the outcome 
within an individual using robust standard errors. Very recently a method for GEE-based 
SNP set association tests for continuous and discrete traits in family-based association 
studies has been published which could plausibly be extended to repeated measures.[240] 
One potential limitation of this work is the choice of region size in our SNP set 
analysis. SNP set regions were chosen based on results from the averaged depressive 
symptoms phenotype from the meta-analysis across ethnicities using the top 5,000 
ethnicity-specific SNPs. The region itself represents all SNPs within ±20 kilobases (kb) 
of an index SNP from the above analysis – for a total region size of 40kb. While this 
region represents an average LD block,[176] some of the regions created overlapped with 
other regions. This may be an indication that these particular regions represented a larger 
LD block than what we would have expected to see. Future research should include 
conditional analysis to see if the identified regions represent one block with a single “hit” 
in LD with many SNPs in that region or multiple “hits”. Some work has suggested that 
regions be defined based on LD blocks,[239] while other work has suggested using genes 





more biologically relevant than the regions that were used in these analyses. However, if 
regions in this analysis were defined as genes (even perhaps as LD blocks), potentially 
important functional areas, as were identified in chapters four and five, would have been 
missed. One potential solution is to use a sliding window approach across the entire 
genome. This approach suffers from several limitations including selection of an 
appropriate window size and the fact that this method produces myriad tests which suffer 
from the same multiple testing issues as individual SNP testing.[241] The sliding window 
approach is not generally valid if it is not known a priori that a trend exists and if no 
correction for multiple testing is applied.[242] Future work may consider investigating all 
known genes across the genome. 
6.5 Gene x environment association analyses 
 For decades, we have known that failure to assess both genetic and environmental 
factors together weaken observed associations between true risk factors and disease. 
Associations from these factors separately combine susceptible and non-susceptible 
persons and observed associations tend to be shifted toward the null.[243, 244] Identified 
variants from GWAS have only explained a small proportion of variation in complex 
diseases. The unexplained variation could be due partly to gene by environment (G x E) 
interactions, particularly in complex illnesses like depressive symptoms which are 
thought to have considerable interplay between genetics and the environment.  
 In epidemiological studies the term ‘interaction’ often has several 
meanings.[245] Statistical interaction: a departure from a pure main effects model with 
either additive or multiplicative effects for a disease risk or natural or logarithmic effects 





effects of one predictor have the same direction at differing levels of another factor but 
differ in magnitude, qualitative interaction: a statistical interaction where effects go in 
opposite directions at different levels of a second variable,[247, 248] synergism: where 
the burden of disease can be attributed to exposure of two or more factors that is greater 
than the sum of the risk from each factor alone.[249] In the analyses presented in this 
dissertation, models are testing for statistical interactions in terms of departure from 
additivity and synergism. G x E studies in general often suffer from several challenges 
which are discussed in detail below: exposure assessment, sample size and power, and 
study design.[246, 250]  
6.5.1 Exposure assessment 
 Few genetic studies have detailed measures of environment, let alone measures of 
environment at different time points across the life course. Since environmental factors 
may be multidimensional and vary over time, it is important to be able to capture 
temporal changes. MESA is unique in that the study has taken great care to assess 
multiple environments carefully across all exams. Particularly with the MESA 
neighborhood environments, extreme efforts have been made to produce objective 
measures of neighborhood factors by using individuals outside of the original MESA 
survey and synthesizing the results. Misclassification of exposure information in general 
can be large and could lead to unpredictable biases, especially when exposures differ with 
respect to disease status, which can ultimately induce spurious interactions.[251] It is also 
possible that we are not measuring the ‘right’ environments. Important environmental 
determinants of disease may be missed because we either do not know exactly what to 





an individual’s genetics are too far removed from physiologic or biochemical processes 
that result from environmental exposures.[244] 
6.5.2 Sample size and power 
 In analyzing G x E interactions, considerable sample sizes are needed to have 
enough statistical power to detect effects. As a rule of thumb, it has been suggested that 
detections of interactions require sample sizes at least four times as large as those 
required for detection of main effects with comparable magnitudes.[252] In GWA studies 
(essentially the main effect models), sample sizes of tens of thousands of cases are 
usually required to produce enough power to detect effects based on stringent 
significance levels and sample sizes in the thousands of cases are typically required for G 
x E analyses in studies where a few candidate genes are to be studied.[250] Though 
MESA has several thousand participants, genetic heterogeneity among the four ethnic 
groups resulted in the decision to analyze these groups separately. Sample sizes within 
each ethnicity fall short of the thousands of individuals recommended for G x E studies. 
Future research will include efforts to add Health and Retirement Study (HRS) 
participants while harmonizing environmental measures to enhance the sample size in 
these analyses. 
 Other considerations in determining the power to detect effects in G x E studies 
include the distribution of exposure, allele frequency, and significance level. The inability 
for some G x E results to replicate may have to do with underpowered discovery or 
replication samples.[253-255] To counter some of these issues, these analyses eliminated 
any SNPs within a region that had MAF < 5% (including monomorphic SNPs) from 





investigated if there is not a marginal effect[256], a range of interaction effect sizes can 
be detected even when marginal effects are not detectable.[250] The significance level 
was set to α = 0.20 from the marginal effect for the region to be included in the 
interaction analysis and α = 0.05 for interaction effects. These significance levels were 
based on previous findings that genetic effects can be apparent solely in groups with 
relevant environmental exposures – where environmental factors affect only those with a 
particular susceptibility genotype.[247, 248] 
6.5.3 Study design 
 MESA is a prospective cohort study of unrelated individuals. Choice of the type 
of study to analyze G x E interactions (as well as main effects) often includes the 
consideration of the temporal sequence of exposure and disease, control of confounding 
and other biases, and data quality.[250] Many study designs are available and most have 
been employed to analyze G x E interactions including classic epidemiologic designs 
(e.g. cohort, case-control, case-only, randomized trial, crossover trials, etc.), hybrid 
designs (e.g. nested case-control, case-cohort, two-phase case-control, counter-matching, 
etc), family-based designs (e.g. case-sibling, case-cousin, case-parent triad, twin studies, 
etc.), and designs specifically developed for genetic studies (e.g. two-stage genotyping, 
two-step interaction analysis, DNA pooling).[250] 
 Cohort designs allow for the comparison of incidents of new cases across groups 
that are defined by both genes and environments. The particular advantages of using a 
cohort design for G x E studies is that cohorts are free from most biases and allow for a 
clear temporal sequence of cause and effect. Though this is true of most cohort designs, 





(CES-D scores) and several of the environmental factors (chronic burden and social 
support) do not allow for such a clear temporal sequence. CES-D is assessed as 
symptoms occurring in the last seven days, while the scales for chronic burden and social 
support are measured over varying time frames (e.g. ongoing for more than six months). 
It is not feasible to define the temporality of cause and effect for our study, so these 
events are treated more as concurrent occurrences. A primary disadvantage of cohort 
studies is the need for long follow-up periods which often leads to loss-to-follow-up, 
particularly in elderly cohorts. However; the response rate (of participants alive) for 
MESA has been excellent: exam 1 (n=6,814), exam 2 (n=6,239, 92%), exam 3 (n=5,946, 
89%), exam 4 (n=5,704, 87%). 
Several of the non-traditional designs mentioned above have particular 
advantages for interaction investigation, most notably family-based association tests. 
Family-based association tests, including case-parent triads[257], case-sibling 
designs[258], and designs using family pedigrees[259] avoid bias from population 
stratification, which is particularly relevant when exploring G x E interactions within 
different ethnicities. Family-based study designs would allow for the separation of 
genetic and shared environment contributions to disease risk and allows for assessment of 
heritability – estimated to be around 30 to 50% for depression based on twin studies.[86] 
Though there are some advantages to family-based designs, there are several issues that 
would arise in using these designs to study depressive symptoms and the environments 
which were analyzed in these analyses. First, family-based association tests are generally 
less powerful for testing main effects than studies using unrelated individuals.[258] Since 





design with unrelated individuals was a more powerful choice. Second, family-based 
studies are more powerful for testing G x E interactions if relatives’ exposures are not too 
highly correlated. It is plausible that recruiting families using neighborhood of residence 
to define environments may produce exposures that are highly correlated within families. 
Finally, case-parent triads require that surviving parents are genotyped. This dissertation 
investigates depressive symptoms in participants who are on average 62.2 years old. It is 
not likely that all participants would have living parents that could contribute genetic 
information. 
 Though there may be some methodological issues that arise when investigating G 
x E interactions, the MESA cohort, with careful attention to data quality, relatively large 
samples sizes for multiple ethnicities, and prospective cohort design, makes an ideal 
sample for these analyses. The MESA cohort information for this dissertation has 
included four exams spanning 10 years, three of which measured depressive symptoms 
using the CES-D, as well as objective neighborhood information created by surveying 
individuals who reside in the same areas as MESA participants. MESA has excellent 
response rates with minimal loss-to-follow-up.  
6.6 Future directions 
This work is a novel investigation of the extent to which individual- and 
neighborhood-level social exposures interact with genetic predispositions to affect levels 
of depressive symptoms in population-based samples. Though it has extensively used 
new statistical methods to investigate individual SNPs, SNP sets and SNP set interactions 
in the context of G x E analysis at both an individual- and neighborhood-level, as well as 





6.6.1 Repeated measures methods 
 Extending methods used in this dissertation to allow for repeated measures for an 
individual in both the SNP set and SNP set x environment analyses will increase the 
power to detect genetic effects of depressive symptoms. At the time of analysis, no 
validated methods existed to allow for a repeated measures framework, though several 
promising methods are either in press or have been recently been published.[240] 
6.6.2 Epistasis 
 Neither SNP x SNP interactions nor SNP set x SNP set interactions were 
investigated in this dissertation. While epistasis – a phenomenon where the expression of 
one gene depends on the presence of one or more 'modifier genes'[260] – is an important 
avenue for investigation of genetic effects, it was simply beyond the scope of the research 
question for these analyses. If we consider the 37 SNP sets that were investigated in the 
interaction models, there would be 1,081 two-way interactions and 16,215 three-way 
interactions. The number of tests can skyrocket quite quickly, involving much 
computational power. Even when limiting the scope of SNP sets to only those with what 
were considered marginal main effects (p-value < 0.20), the dimensionality of the 
interactions is burdensome. Including three (or more) environments only compounds the 
multiple testing issues. A more comprehensive model for disease with multiple genes and 
multiple environmental risk factors ought to also consider G x G interactions.[246, 261] 
6.6.3 Pathway based analysis: Mediation through epigenetics and other functional 
mechanisms 
 One potentially fruitful avenue for future research is to investigate pathway based 





in gene expression, epigenetic processes, somatic mutations, and interference by small 
RNAs – may mediate genetic and environmental effects.[262-264] This is incredibly 
relevant to these analyses since many of our strongest gene-level results did not fall in 
established gene regions, but rather in areas with potential functional regulatory regions 
(chapter V). Few studies have embarked on this trajectory,[262] and none – to the 
author’s knowledge – in depressive symptoms. The basic idea of pathway-based analysis 
methods stems from observations that monozygotic twins, who begin life with identical 
methylation patters, over the life course are exposed to different environments which may 
provide mechanisms at the genetic level that result in differing patterns of disease.[265] 
This type of analysis requires in-depth (and often expensive) measurements of genetic 
information, such as methylation and expression data, which is slowly gaining popularity 
in large cohort studies as prices decrease.  
6.6.4 Next-generation sequencing and rare variants 
 Individual SNP analysis has been used to find many disease-associated loci, but 
region-based analysis has been shown to possess much higher power. In order for the 
most accurate genetic measures to be analyzed, high quality genotypes must be obtained. 
Given developments in next generation sequencing technologies and haplotype assembly 
algorithms – which allow for analysis of very specific genotype patterns and disease risk 
– we are entering an era where finer and finer genetic information is becoming available. 
Though not widely implemented (partially due to cost and massive data storage 
requirements), next generation sequencing methods are making it possible to sequence 
suspect portions of the genome at an extremely detailed level in subsamples of 





<1% – are gaining attention as these variants may account for some of the unexplained 
variance in disease.[250] This sequencing could help to make the analysis of rare 
variants, in combination with methods designed to up-weight the effects of rare variants 
so that they are not masked by other variants in a region (e.g. SKAT[2]), more standard 
practice in genetic association studies. 
6.6.5 Consortia efforts 
 Consortia efforts combine many studies with like samples and similar measures to 
increase sample sizes. Given the extremely large sample size requirements to obtain 
adequate power for genetic studies due to multiple testing issues, consortia efforts are 
almost mandatory in genetic studies. The problem with consortia studies is in finding 
studies with well-defined and comparable measures. The analyses in this dissertation 
present a complex problem for consortia, mainly the use of multiple ethnicities and 
highly detailed measures of environment. While previous consortia efforts for studying 
depressive symptoms in European ancestry individuals have reached over 50,000 
individuals (replication sample size = 51,258), only 34,549 individuals had depressive 
symptoms assessed with the CES-D. The other individuals used in replication had 
depressive symptoms defined through other instruments (e.g. Geriatric Depression Scale, 
Patient Health Questionnaire, Beck Depression Inventory-II, Maastricht Questionnaire). 
Since depressive symptoms can be assessed using a wide variety of instruments, which 
are often highly correlated (between 0.77 and 0.86), it may be possible to produce large 
sample sizes for consortia in these ethnicities if researchers are willing to slightly relax 
the phenotype definitions. This does; however, bring into question whether these efforts 





heterogeneity in measurement. Future studies should strive to evaluate both depressive 
symptoms and environmental factors using consistent measures.  
6.6.6 Public health and personal medicine 
 Depression will soon be second only to cardiac ischemia in terms of disease-
related morbidity.[5] Depression is a complex disorder made up of symptoms outlined in 
the Diagnostic and Statistical Manual – Mental Health.[7] These symptoms are influences 
not only by clinical, psychosocial and environmental contributors but also by genes. 
Insight from G x E interactions may have important policy implications for targeted 
intervention[266], treatment selection[267], and even environmental health 
standards.[268] Genes and gene regions identified in this study may prove to be parts of 
important pathways in the development of depression. Ultimately, identifying these 
pathways could lead to improved pharmacological efforts targeted specifically at certain 
genetic profiles. Knowledge of a patient’s genetic and environmental profiles based on 
exposure to chronic burden, social support, or neighborhood structure may serve as 
warning signs to clinicians when presenting in a clinical setting. This may assist health 
care professionals in identifying depression and identifying strategies to reduce 
deleterious exposures. Finally, this study provides evidence that living in poorer quality 
neighborhoods (those with low social cohesion, aesthetic quality, or low perceived 
safety) put individuals with certain genetic variants at higher risk for more depressive 
symptoms. Though idealistic, it may be possible to reduce depressive symptoms if public 
policies for cleaning up neighborhoods, improving relationships across neighbors, and 





scientific understanding about G x E interactions into risk assessment and prevention 
policies has been limited.[269] 
6.7 Concluding remarks 
 Genetic factors, stressors operating over the life-course, and various aspects of 
social context (including neighborhood environments) clearly play a role in the etiology 
of depressive symptoms. This evaluation of the joint effects of these factors as well as 
their interactions has found preliminary evidence of several genetic regions with 
implications for depressive symptoms across multiple ethnicities as main effects and also 
in interactions with environments. Future work should focus on clinically evaluated 
quantitative outcomes as well as replication efforts not only in European Americans, but 
















Appendix 2 QQ plot of p-values from SNP association with baseline depressive symptom score from 
African American GWA analyses adjusted for age, sex, study site and top four principal components, 







Appendix 3 QQ plot of p-values from SNP association with averaged depressive symptom score from 
African American GWA analyses adjusted for age, sex, study site and top four principal components, 






Appendix 4 QQ plot of p-values from SNP association with repeated measures depressive symptom 
score from African American GWA analyses adjusted for age, sex, study site and top four principal 






Appendix 5 QQ plot of p-values from SNP association with baseline depressive symptom score from 
European GWA analyses adjusted for age, sex, study site and top four principal components, minor 






Appendix 6 QQ plot of p-values from SNP association with averaged depressive symptom score from 
European GWA analyses adjusted for age, sex, study site and top four principal components, minor 






Appendix 7 QQ plot of p-values from SNP association with repeated measures depressive symptom 
score from European GWA analyses adjusted for age, sex, study site and top four principal 





Appendix 8 QQ plot of p-values from SNP association with baseline depressive symptom score from 
Chinese GWA analyses adjusted for age, sex, study site and top four principal components, minor 






Appendix 9 QQ plot of p-values from SNP association with averaged depressive symptom score from 
Chinese GWA analyses adjusted for age, sex, study site and top four principal components, minor 






Appendix 10 QQ plot of p-values from SNP association with repeated measures depressive symptom 
score from Chinese GWA analyses adjusted for age, sex, study site and top four principal 





Appendix 11 QQ plot of p-values from SNP association with baseline depressive symptom score from 
Hispanic GWA analyses adjusted for age, sex, study site and top four principal components, minor 






Appendix 12 QQ plot of p-values from SNP association with averaged depressive symptom score 
from Hispanic GWA analyses adjusted for age, sex, study site and top four principal components, 







Appendix 13 QQ plot of p-values from SNP association with repeated measures depressive symptom 
score from Hispanic GWA analyses adjusted for age, sex, study site and top four principal 






Appendix 14 Manhattan plots for baseline depressive symptoms score (top), averaged depressive 
symptom score (middle), and repeat measures depressive symptom score (bottom) from the African 





Appendix 15 Manhattan plots for baseline depressive symptoms score (top), averaged depressive 
symptom score (middle), and repeat measures depressive symptom score (bottom) from the 





Appendix 16 Manhattan plots for baseline depressive symptoms score (top), averaged depressive 
symptom score (middle), and repeat measures depressive symptom score (bottom) from the Chinese 






Appendix 17 Manhattan plots for baseline depressive symptoms score (top), averaged depressive 
symptom score (middle), and repeat measures depressive symptom score (bottom) from the Hispanic 





Appendix 18 QQ plot of p-values from SNP association with repeated measures depressive symptom 
score from African American GWA analyses adjusted for age, sex, and top four principal 





Appendix 19 QQ plot of p-values from SNP association with repeated measures depressive symptom 
score from European GWA analyses adjusted for age, sex, and top four principal components, minor 








Appendix 20 Manhattan plots for repeated measures depressive symptom score from the African 
















































































































































































































































































































































































































































Appendix 68 Fisher's combined p-values and ethnicity-specific p-values for each SNP in region 1 
   




n p n p n p n p X2 df X2 pvalue 
rs897630 2784009 A 1397 4.22E-01 2374 1.81E-03 747 1.19E-01 1379 5.89E-01 19.68 8 4.23E-03 
rs897620 2777567 C 1396 9.84E-01 2374 1.41E-03 - - 1379 - 13.15 4 4.59E-03 
rs2842910 2779832 C 1397 8.46E-01 2374 3.59E-03 747 1.41E-01 1379 - 15.51 6 6.44E-03 
rs2606406 2779766 A 1397 5.07E-01 2374 2.34E-03 747 1.88E-01 1378 5.38E-01 18.06 8 7.35E-03 
rs2842914 2812006 A 1397 6.88E-01 2374 2.38E-03 746 1.24E-01 1379 5.99E-01 18.04 8 7.40E-03 
rs750786 2795967 A 1397 9.97E-01 2374 2.34E-03 747 1.94E-01 1379 5.32E-01 16.67 8 1.16E-02 
rs1456465 2783092 A 1397 8.34E-01 2374 3.59E-03 747 1.59E-01 1379 5.30E-01 16.57 8 1.20E-02 
rs2842911 2799428 C 1397 6.45E-01 2374 3.59E-03 747 1.64E-01 1379 7.34E-01 16.37 8 1.27E-02 
rs3100865 2807281 G 1397 7.41E-01 2374 1.86E-02 747 9.32E-01 1379 3.28E-02 15.55 8 1.65E-02 
rs897631 2784330 C 1397 4.58E-01 2372 2.90E-02 747 1.34E-01 1376 - 12.67 6 1.78E-02 
rs10909793 2787716 G 1396 4.46E-01 2374 4.32E-01 747 1.29E-02 1377 - 11.99 6 2.24E-02 
rs880725 2786479 A 1397 4.54E-01 2374 3.54E-02 747 2.05E-01 1379 - 11.43 6 2.69E-02 
rs11580768 2778968 C 1397 6.41E-01 2373 7.76E-01 747 1.38E-02 1377 - 9.96 6 4.26E-02 
rs6676289 2810832 C 1397 5.79E-01 2374 - 747 4.53E-02 1379 - 7.28 4 4.78E-02 
rs2445620 2791319 C 1397 7.88E-01 2370 1.54E-02 747 7.37E-01 1378 - 9.43 6 4.98E-02 
rs1563474 2801674 A 1397 3.74E-01 2373 8.55E-01 746 2.97E-02 1378 - 9.31 6 5.15E-02 
rs6673503 2808493 C 1395 9.05E-01 2374 5.26E-01 746 1.00E-02 1376 7.53E-01 11.25 8 5.35E-02 
rs1563472 2796750 A 1397 8.36E-01 2373 8.55E-01 746 1.89E-02 1377 - 8.61 6 6.26E-02 
rs10797342 2785861 C 1395 8.68E-01 2374 8.54E-01 744 2.05E-02 1376 - 8.37 6 6.67E-02 
rs2168531 2788317 C 1397 7.90E-01 2374 8.33E-01 745 1.24E-02 1378 8.28E-01 10.00 8 7.02E-02 
rs12091184 2813319 C 1397 7.62E-01 2373 7.02E-01 746 2.16E-01 1379 9.86E-01 4.34 8 9.72E-02 
rs2045333 2776005 C 1397 7.25E-01 2373 4.77E-01 747 - 1379 - 2.12 6 9.75E-02 
rs12063033 2813185 A 1387 8.68E-01 2336 9.10E-01 720 4.35E-02 1369 - 6.74 6 9.76E-02 
rs897615 2787126 C 1396 6.70E-01 2374 9.99E-01 746 5.63E-02 1378 5.53E-01 7.74 8 1.01E-01 
rs12035436 2789340 G 1396 7.52E-01 2373 7.02E-01 747 2.05E-01 1379 8.01E-01 4.89 8 1.06E-01 
rs10910019 2784411 C 1397 5.16E-01 2365 9.60E-01 747 8.30E-02 1377 7.62E-01 6.93 8 1.08E-01 
rs1563469 2812608 A 1396 3.64E-01 2374 8.84E-01 747 1.19E-01 1379 9.22E-01 6.69 8 1.10E-01 
rs2124661 2788136 C 1397 7.33E-01 2374 5.47E-01 747 5.34E-01 1379 - 3.09 6 1.27E-01 
Region 1 is located on Chromosome 1, αBonferroni = 0.001, - indicates a model that did not converge 
Only SNPs with ethnicity-specific minor allele frequency > 5% were included in the Fisher’s combined analysis, SNP: single nucleotide polymorphism, BP: basepair position in kilobases, AA: African 








Appendix 69 Fisher's combined p-values and ethnicity-specific p-values for each SNP in region 29 
   











rs10086664 78211979 C 1402 3.55E-02 2376 4.57E-03 745 1.09E-01 1378 8.45E-01 22.23 8 8.27E-05 
rs1452832 78236750 C 1402 1.85E-02 2376 1.15E-02 747 1.23E-01 1378 9.58E-01 21.19 8 1.33E-04 
rs10093959 78213199 A 1402 5.48E-02 2376 5.07E-03 747 1.53E-01 1378 6.21E-01 21.09 8 1.39E-04 
rs9657123 78243575 C 1400 2.43E-02 2376 1.57E-02 747 1.64E-01 1378 9.14E-01 19.53 8 2.80E-04 
rs1993196 78211752 A 1402 2.91E-02 2376 1.61E-02 747 1.53E-01 1378 9.54E-01 19.18 8 3.28E-04 
rs10102542 78243564 C 1402 3.19E-02 2376 1.57E-02 747 1.64E-01 1378 9.39E-01 18.94 8 3.65E-04 
rs10504647 78220362 C 1402 3.19E-02 2376 1.57E-02 747 1.64E-01 1378 9.39E-01 18.94 8 3.65E-04 
rs12680110 78225266 C 1402 3.19E-02 2376 1.57E-02 747 1.64E-01 1378 9.39E-01 18.94 8 3.65E-04 
rs7016358 78246553 A 1402 3.19E-02 2376 1.57E-02 747 1.64E-01 1378 9.39E-01 18.94 8 3.65E-04 
rs10957840 78235557 C 1402 3.33E-02 2376 1.61E-02 747 1.53E-01 1378 9.55E-01 18.91 8 3.70E-04 
rs13250484 78245009 A 1402 3.33E-02 2376 1.61E-02 747 1.53E-01 1378 9.55E-01 18.91 8 3.70E-04 
rs13269867 78219857 A 1402 3.33E-02 2376 1.61E-02 747 1.53E-01 1378 9.55E-01 18.91 8 3.70E-04 
rs7821262 78208512 G 1402 3.33E-02 2376 1.61E-02 747 1.53E-01 1378 9.55E-01 18.91 8 3.70E-04 
rs13439699 78220079 C 1402 3.70E-02 2376 7.14E-02 747 1.97E-01 1378 8.87E-01 15.36 8 1.77E-03 
rs12056492 78225217 A 1402 4.36E-02 2376 6.26E-02 747 1.97E-01 1378 8.78E-01 15.32 8 1.81E-03 
rs1377248 78232477 C 1402 3.70E-02 2376 6.99E-02 747 2.11E-01 1378 9.03E-01 15.23 8 1.88E-03 
rs13259366 78225474 A 1402 4.16E-02 2376 7.14E-02 747 1.97E-01 1378 8.99E-01 15.1 8 1.99E-03 
rs12056333 78212369 C 1402 4.76E-02 2376 7.14E-02 747 1.97E-01 1378 8.78E-01 14.88 8 2.18E-03 
rs10282777 78237061 C 1402 2.22E-02 2376 5.96E-02 747 5.61E-01 1378 8.64E-01 14.7 8 2.36E-03 
rs7832753 78242401 A 1402 1.19E-02 2376 1.35E-01 747 8.00E-01 1378 7.57E-01 13.86 8 3.39E-03 
rs11996389 78226809 C 1402 3.85E-02 2376 1.42E-01 747 6.66E-01 1378 5.27E-01 12.51 8 6.01E-03 
rs1377247 78222909 A 1402 2.25E-02 2376 1.83E-01 747 7.02E-01 1378 7.09E-01 12.39 8 6.32E-03 
rs1377249 78232429 A 1402 2.25E-02 2376 1.83E-01 747 7.02E-01 1378 7.09E-01 12.39 8 6.32E-03 
rs1545508 78208756 A 1402 3.82E-02 2376 1.92E-01 747 7.16E-01 1378 5.23E-01 11.8 8 8.08E-03 
rs9298293 78211752 A 1402 4.38E-02 2376 1.83E-01 747 7.02E-01 1378 5.22E-01 11.67 8 8.53E-03 
rs10504645 78230921 G 1402 4.32E-02 2376 1.83E-01 747 7.16E-01 1378 5.23E-01 11.65 8 8.60E-03 
rs7831215 78236862 C 1402 4.32E-02 2376 1.83E-01 747 7.16E-01 1378 5.23E-01 11.65 8 8.60E-03 
rs1452808 78228511 A 1402 4.75E-01 2376 6.99E-02 747 2.11E-01 1378 4.62E-01 11.47 8 9.26E-03 
rs16939434 78227485 A 1402 1.63E-01 2376 2.63E-01 747 2.74E-01 1377 5.23E-01 10.19 8 1.56E-02 








rs6991979 78243575 A 1402 8.76E-02 2376 8.25E-01 747 5.90E-01 1378 2.07E-01 9.46 8 2.09E-02 
rs16939442 78242401 C 1393 8.11E-01 2369 1.67E-01 740 2.49E-01 1368 2.88E-01 9.26 8 2.26E-02 
rs7836772 78221169 C 1402 9.92E-02 2376 1.83E-01 747 7.02E-01 1378 8.15E-01 9.14 8 2.37E-02 
rs7842403 78211521 G 1402 9.92E-02 2376 1.83E-01 747 7.02E-01 1378 8.15E-01 9.14 8 2.37E-02 
rs7833179 78226180 C 1402 4.53E-01 2376 6.91E-02 747 8.88E-01 1378 4.26E-01 8.87 8 2.63E-02 
rs16939440 78208512 A 1402 8.27E-01 2376 2.29E-01 747 2.74E-01 1378 3.44E-01 8.05 8 3.60E-02 
rs16939441 78236862 C 1402 8.27E-01 2376 2.29E-01 747 2.74E-01 1378 3.44E-01 8.05 8 3.60E-02 
rs16939435 78230951 A 1402 8.27E-01 2376 2.29E-01 747 2.74E-01 1378 3.69E-01 7.91 8 3.79E-02 
rs16939436 78209886 A 1402 8.27E-01 2376 2.29E-01 747 2.74E-01 1378 3.69E-01 7.91 8 3.79E-02 
rs16939437 78213269 A 1402 8.27E-01 2376 2.29E-01 747 2.74E-01 1378 3.69E-01 7.91 8 3.79E-02 
rs16939439 78239201 A 1402 8.27E-01 2376 2.29E-01 747 2.74E-01 1378 3.69E-01 7.91 8 3.79E-02 
rs10095652 78208734 C 1402 7.70E-01 2376 2.32E-01 747 1.57E-01 1378 7.08E-01 7.83 8 3.90E-02 
rs7015723 78248131 G 1402 7.74E-01 2376 2.32E-01 747 1.57E-01 1378 7.08E-01 7.82 8 3.92E-02 
rs1470834 78231269 A 1402 8.57E-01 2376 2.23E-01 747 3.05E-01 1378 3.44E-01 7.82 8 3.92E-02 
rs16939447 78234373 A 1402 8.57E-01 2376 2.23E-01 747 3.05E-01 1378 3.44E-01 7.82 8 3.92E-02 
rs16939448 78243802 C 1402 8.57E-01 2376 2.23E-01 747 3.05E-01 1378 3.44E-01 7.82 8 3.92E-02 
rs16939450 78226180 A 1402 8.57E-01 2376 2.23E-01 747 3.05E-01 1378 3.44E-01 7.82 8 3.92E-02 
rs16939433 78214528 A 1402 8.74E-01 2376 2.29E-01 747 2.74E-01 1378 3.69E-01 7.8 8 3.95E-02 
rs7813218 78234605 C 1402 9.71E-01 2376 2.23E-01 747 3.05E-01 1378 3.43E-01 7.57 8 4.30E-02 
rs10097260 78224651 A 1399 3.44E-01 2376 2.00E-01 747 7.16E-01 1376 7.68E-01 6.55 8 6.19E-02 
rs17378611 78221169 A 1401 6.98E-01 2375 5.05E-01 747 - 1378 8.13E-01 2.5 6 1.81E-01 
rs10113852 78239301 C 1402 7.65E-01 2376 - 747 - 1378 5.58E-01 1.7 4 2.14E-01 
Region 29 is located on Chromosome 8, - indicates a model that did not converge 
Only SNPs with ethnicity-specific minor allele frequency > 5% were included in the Fisher’s combined analysis 
SNP: single nucleotide polymorphism, BP: basepair position in kilobases, AA: African American, EA: European American, CA: Chinese American, HA: Hispanic American, 
n: sample size, p: p-value, df: degrees of freedom 











Appendix 70 Fisher's combined p-values and ethnicity-specific p-values for each SNP in region 44 
   






n p n p n p n p X2 df X2 pvalue 
rs16970495 77131187 A 1397 1.73E-02 2373 4.27E-01 747 1.89E-01 1379 7.79E-02 18.25 8 6.90E-03 
rs3816282 77129277 A 1396 5.62E-01 2374 1.86E-02 747 5.53E-02 1379 . 14.92 6 8.01E-03 
rs7183818 77159468 C 1397 9.05E-02 2373 2.22E-01 747 4.75E-02 1379 2.64E-01 16.58 8 1.19E-02 
rs12911829 77165876 C 1397 2.84E-01 2374 4.26E-03 747 5.01E-01 1379 4.27E-01 16.52 8 1.21E-02 
rs744059 77146560 C 1397 2.28E-01 2374 2.89E-02 747 4.24E-01 1379 4.28E-01 13.47 8 3.03E-02 
rs736827 77145921 A 1397 6.36E-01 2374 7.13E-03 747 4.86E-01 1379 5.64E-01 13.38 8 3.10E-02 
rs6495367 77163186 A 1397 2.02E-01 2373 2.52E-01 747 1.51E-01 1377 2.49E-01 12.51 8 3.92E-02 
rs6495366 77162402 C 1397 1.03E-01 2373 2.85E-01 747 1.29E-01 1379 6.35E-01 12.06 8 4.40E-02 
rs2009197 77137895 C 1397 9.57E-01 2374 5.46E-01 747 9.77E-01 1379 . 1.34 6 5.74E-02 
rs755362 77157055 A 1397 2.04E-01 2374 2.07E-01 747 1.00E-01 1379 9.95E-01 10.94 8 5.74E-02 
rs4778879 77154848 A 1397 3.32E-01 2374 2.20E-01 745 8.92E-02 1379 7.48E-01 10.65 8 6.13E-02 
rs12443101 77130589 A 1397 7.65E-01 2369 4.19E-01 746 4.04E-01 1371 4.02E-02 10.51 8 6.31E-02 
rs13380104 77127099 C 1397 1.75E-01 2374 2.53E-01 747 1.22E-01 1379 9.78E-01 10.48 8 6.35E-02 
rs744060 77146329 C 1397 6.48E-01 2374 9.11E-02 747 3.87E-01 1379 2.57E-01 10.28 8 6.63E-02 
rs6495365 77160732 C 1397 3.74E-01 2374 8.23E-02 747 5.43E-01 1379 . 8.18 6 7.00E-02 
rs6495364 77156751 C 1397 6.08E-01 2374 6.55E-02 747 5.35E-01 1379 . 7.70 6 7.89E-02 
rs8030257 77138231 A 1397 6.23E-01 2373 5.86E-01 747 4.04E-02 1379 6.88E-01 9.18 8 8.18E-02 
rs11072824 77131471 C 1397 7.45E-01 2374 1.34E-01 747 3.58E-01 1379 3.53E-01 8.75 8 8.78E-02 
rs16970524 77145850 A 1397 8.41E-01 2374 4.58E-01 747 9.38E-01 1379 . 2.04 6 9.38E-02 
rs11634225 77139747 A 1396 5.26E-01 2374 7.08E-01 747 9.61E-01 1379 . 2.05 6 9.42E-02 
rs729650 77146365 C 1396 7.52E-01 2374 5.44E-01 746 8.73E-01 1379 . 2.06 6 9.47E-02 
rs987057 77134426 C 1397 8.30E-01 2373 3.11E-01 747 7.11E-01 1379 5.71E-01 4.51 8 1.00E-01 
rs11629697 77149214 A 1396 8.17E-01 2373 3.13E-01 746 1.49E-01 1378 . 6.54 6 1.02E-01 
rs894784 77142996 G 1391 2.33E-01 2372 2.10E-01 747 8.48E-01 1377 . 6.37 6 1.05E-01 
rs997285 77134521 G 1397 4.44E-01 2373 8.77E-01 747 7.94E-01 1379 . 2.34 6 1.06E-01 
rs7174521 77149145 A 1397 9.52E-01 2374 7.69E-01 747 6.29E-02 1378 . 6.15 6 1.09E-01 
rs12911414 77139194 A 1397 7.45E-01 2373 2.22E-01 747 5.69E-01 1379 4.28E-01 6.42 8 1.11E-01 
rs12440502 77143686 G 1397 3.46E-01 2373 9.40E-01 747 2.80E-01 1379 6.66E-01 5.60 8 1.11E-01 
rs7166032 77152835 A 1397 3.21E-01 2372 9.95E-01 747 2.66E-01 1379 7.09E-01 5.62 8 1.11E-01 








rs16970502 77137679 A 1396 9.79E-02 2373 6.58E-01 747 8.43E-01 1378 . 5.83 6 1.15E-01 
rs4778626 77135967 C 1396 3.31E-01 2374 1.70E-01 747 - 1378 . 5.76 6 1.16E-01 
rs4778861 77159930 C 1397 4.14E-01 2374 3.62E-01 747 9.57E-01 1379 . 3.88 6 1.35E-01 
rs747109 77163656 C 1397 6.69E-01 2374 3.35E-01 747 . 1379 . 2.99 4 1.68E-01 
rs4778857 77136392 C 1391 7.57E-01 2367 3.16E-01 744 . 1378 . 2.86 4 1.71E-01 
rs998031 77134521 C 1397 7.59E-01 2374 5.14E-01 747 . 1379 . 1.88 4 1.84E-01 
Region 44 is located on Chromosome 15 
Only SNPs with ethnicity-specific minor allele frequency > 5% were included in the Fisher’s combined analysis 
SNP: single nucleotide polymorphism, BP: basepair position in kilobases, AA: African American, EA: European American, CA: Chinese American, HA: Hispanic American, 
n: sample size, p: p-value, df: degrees of freedom 
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rs4800653 21458098 A 1100 2.38E-02 1930 1.53E-02 538 2.30E-01 976 2.27E-03 30.95 8 1.47E-06 
rs1840444 21472831 A 1100 3.33E-02 1930 1.21E-02 538 2.56E-01 976 1.09E-02 27.41 8 7.65E-06 
rs2728504 21468660 A 1098 4.04E-02 1927 1.65E-02 538 2.50E-01 976 1.20E-02 26.24 8 1.32E-05 
rs1811520 21485642 A 1100 4.92E-02 1930 1.55E-02 538 2.50E-01 976 1.20E-02 25.97 8 1.49E-05 
rs2592062 21480858 G 1100 4.92E-02 1930 1.55E-02 538 2.50E-01 976 1.20E-02 25.97 8 1.49E-05 
rs2728509 21471994 G 1100 4.92E-02 1930 1.55E-02 538 2.50E-01 976 1.20E-02 25.97 8 1.49E-05 
rs1840445 21484484 C 1100 9.18E-01 1930 3.47E-03 538 2.30E-01 976 4.83E-03 25.1 8 2.22E-05 
rs2568474 21492261 C 1099 3.38E-01 1930 9.78E-03 538 2.12E-01 976 1.60E-02 22.79 8 6.41E-05 
rs2568476 21492275 C 1100 1.80E-01 1930 1.55E-02 538 1.97E-01 976 2.50E-02 22.39 8 7.69E-05 
rs979166 21460370 A 1100 2.62E-01 1929 6.17E-03 538 2.16E-01 976 4.63E-02 22.06 8 8.94E-05 
rs9950413 21462007 A 1100 9.44E-01 1929 1.04E-02 538 1.59E-01 974 1.68E-02 21.09 8 1.39E-04 
rs4800652 21455858 A 1100 4.02E-01 1930 8.38E-03 538 2.52E-01 976 3.64E-02 20.77 8 1.60E-04 
rs1455185 21493500 C 1100 9.92E-01 1930 1.26E-02 538 3.33E-01 976 1.41E-02 19.48 8 2.87E-04 
rs1840439 21462799 A 1100 5.37E-01 1930 1.23E-02 538 2.12E-01 976 4.81E-02 19.21 8 3.24E-04 
rs1840438 21480604 A 1100 9.74E-01 1930 1.26E-02 538 3.33E-01 976 1.69E-02 19.16 8 3.31E-04 
rs2019917 21487395 C 1099 5.10E-01 1930 5.04E-02 538 3.89E-01 976 7.20E-03 19.07 8 3.45E-04 
rs1840437 21464405 C 1099 7.30E-01 1930 4.76E-02 538 3.36E-01 976 7.68E-03 18.64 8 4.18E-04 
rs2728505 21477104 A 1100 5.11E-01 1930 6.85E-02 538 4.00E-01 976 7.34E-03 18.37 8 4.71E-04 
rs273770 21474070 A 1096 3.61E-02 1922 2.09E-01 538 2.86E-01 976 4.81E-02 18.35 8 4.75E-04 
rs2604482 21478474 C 1100 9.90E-01 1929 2.06E-02 538 3.33E-01 976 1.74E-02 18.09 8 5.34E-04 
rs2604480 21481587 C 1100 5.46E-01 1930 6.85E-02 538 3.90E-01 976 8.31E-03 18.03 8 5.48E-04 
rs2604481 21479877 C 1100 5.46E-01 1930 6.85E-02 538 3.90E-01 976 8.31E-03 18.03 8 5.48E-04 
rs1840435 21465750 A 1098 9.67E-01 1930 1.67E-02 538 3.24E-01 975 2.36E-02 17.99 8 5.58E-04 
rs2592061 21468780 C 1100 8.92E-01 1930 6.85E-02 538 3.15E-01 976 9.07E-03 17.31 8 7.54E-04 
rs274231 21455049 A 1099 2.28E-01 1925 2.58E-01 535 2.52E-01 970 3.72E-02 15 8 2.07E-03 
rs8087975 21469911 A 1100 8.08E-03 1930 . 538 . 976 5.45E-01 10.85 4 2.20E-03 
rs273772 21479486 A 1100 2.29E-01 1930 3.25E-01 538 2.74E-01 976 5.29E-02 13.66 8 3.69E-03 
rs9965027 21492262 C 1100 2.19E-02 1930 . 538 . 976 3.69E-01 9.64 4 4.03E-03 
rs1579854 21456605 C 1100 4.70E-02 1929 2.22E-01 538 9.02E-01 976 3.30E-01 11.55 8 8.96E-03 








rs11663205 21454353 A 1099 1.54E-01 1929 9.53E-01 538 1.68E-01 976 1.74E-01 10.91 8 1.17E-02 
rs12458367 21481019 C 1099 3.91E-01 1928 1.74E-01 537 7.01E-01 976 1.21E-01 10.32 8 1.48E-02 
rs9957023 21487592 A 1100 4.98E-02 1930 . 538 . 976 7.11E-01 6.68 4 1.77E-02 
rs11873662 21466728 G 1099 5.36E-01 1926 8.93E-01 536 1.67E-02 974 9.88E-01 9.69 8 1.91E-02 
rs12454499 21485419 A 1100 4.84E-01 1930 2.51E-01 538 6.00E-01 976 1.27E-01 9.37 8 2.16E-02 
rs273768 21470808 A 1100 2.33E-01 1930 2.19E-01 538 5.93E-01 975 4.21E-01 8.73 8 2.77E-02 
rs273766 21474112 A 1100 2.40E-01 1930 2.19E-01 538 5.93E-01 975 4.21E-01 8.67 8 2.84E-02 
rs1947098 21484544 C 1100 8.02E-02 1930 5.57E-01 538 3.40E-01 976 9.24E-01 8.53 8 3.00E-02 
rs9966851 21482557 A 1100 1.68E-01 1930 5.61E-01 538 3.21E-01 976 6.92E-01 7.72 8 4.07E-02 
rs273773 21454669 A 1100 1.97E-01 1930 2.96E-01 538 9.68E-01 976 4.36E-01 7.41 8 4.56E-02 
rs1823940 21465721 C 1100 1.71E-01 1930 4.55E-01 538 9.26E-01 976 4.71E-01 6.76 8 5.75E-02 
rs273764 21472082 A 1100 6.82E-01 1930 5.08E-01 538 6.08E-01 976 5.70E-01 4.24 8 1.27E-01 
rs1598310 21484743 G 1100 6.99E-01 1930 4.09E-01 538 8.90E-01 976 5.61E-01 3.89 8 1.39E-01 
rs9952296 21458701 A 1100 6.66E-01 1930 4.72E-01 538 5.41E-01 976 9.28E-01 3.69 8 1.46E-01 
Region 46 is located on Chromosome 18 
Only SNPs with ethnicity-specific minor allele frequency > 5% were included in the Fisher’s combined analysis 
SNP: single nucleotide polymorphism, BP: basepair position in kilobases, AA: African American, EA: European American, CA: Chinese American, HA: Hispanic American, 
n: sample size, p: p-value, df: degrees of freedom 










Appendix 72 Phylogenic conservation score from hg18 for Vertebrate Multiz Alignment & Conservation (17 Species) for each analyzed SNP within regions 1, 
30 and 46 
Region 1 Region 29 Region 46 
SNP PCS SNP PCS SNP PCS SNP PCS SNP PCS 
rs1563469
a
















 0.000 rs7821262 0.060 rs273768
d
 0.001 rs2604482 0.000 
rs10910019 0.000 rs7832753
e
 0.000 rs10957840 0.003 rs12454499
e
 0.000 rs2592062 0.000 




 0.004 rs2568476 0.002 









 0.465 rs2568474 0.000 





rs6676289 0.007 rs1993196 0.000 rs1470834
e
 0.001 rs1823940 0.000 rs2019917
d
 0.001 






















rs11580768 0.000 rs16939434 0.000 rs7016358 0.142 rs11663205 0.000 rs1455185 0.006 
rs2045333 0.001 rs16939435 0.000 rs17378611 0.001 rs9950413 0.002 rs1840439
e
 0.134 
rs3100865 0.000 rs16939436 0.000 rs10113852 0.000 rs9952296 0.001 rs9957023 0.000 
rs2445620
b
 0.000 rs13259366 0.000 rs6991979
c
 0.001 rs2592061 0.000 rs979166 0.000 
rs1456465 0.000 rs13269867 0.000 rs16939447
f
 0.006 rs1947098 0.000 rs4800653 0.130 
rs2842910
c







 0.000 rs10504645 0.001 rs10102542 0.001 rs2728504 0.000 rs1840444 0.000 
rs2842914 0.003 rs7831215 1.000 rs7836772 0.000 rs2604480 0.001 rs9965027 0.000 
rs2606406 0.003 rs16939439 1.000 rs9657123 0.000 rs2604481 0.001 rs1840445 0.005 







 0.000     







 0.000     
rs880725 0.000 rs12056333 0.000 rs16939450 0.763     
rs897631 0.000 rs16939442
d
 0.001       
SNPs with PCS greater than 0.1 are bolded. 
SNP: single nucleotide polymorphism, PCS: Phylogenic Conservation Score – estimates the probability that each nucleotide belongs to a conserved element, based on the multiple  
alignments. aAnother 2bp SNP overlaps this SNP (rs72543806), bSNP is in a SINE element, cSNP is in a DNA repeat element, dSNP is in a LTR,  






1. Mair, C., et al., Cross-sectional and longitudinal associations of neighborhood 
cohesion and stressors with depressive symptoms in the multiethnic study of 
atherosclerosis. Ann Epidemiol, 2009. 19(1): p. 49-57. 
2. Lee, S., M.C. Wu, and X. Lin, Optimal tests for rare variant effects in sequencing 
association studies. Biostatistics, 2012. 13(4): p. 762-75. 
3. Wu, M.C., et al., Rare-variant association testing for sequencing data with the 
sequence kernel association test. Am J Hum Genet, 2011. 89(1): p. 82-93. 
4. Cassano, P. and M. Fava, Depression and public health: an overview. Journal of 
psychosomatic research, 2002. 53(4): p. 849-857. 
5. Organization, W.H., Depression, 2010. 
6. Greenberg, P.E., et al., The economic burden of depression in the United States: 
how did it change between 1990 and 2000? The Journal of clinical psychiatry, 
2003. 64(12): p. 1465-1475. 
7. American Psychiatric, A., Diagnostic and Statistical Manual of Mental disorders, 
Fourth Edition. Vol. 4th. 1994, Washington, DC: American Psychiatric 
Association. 886. 
8. Kessler, R.C. and P.S. Wang, The descriptive epidemiology of commonly 
occurring mental disorders in the United States. Annual Review of Public Health, 
2008. 29: p. 115-129. 
9. Muglia, P., et al., Genome-wide association study of recurrent major depressive 
disorder in two European case-control cohorts. Molecular psychiatry, 2010. 
15(6): p. 589-601. 
10. Shyn, S.I., et al., Novel loci for major depression identified by genome-wide 
association study of Sequenced Treatment Alternatives to Relieve Depression and 
meta-analysis of three studies. Molecular psychiatry, 2011. 16(2): p. 202-215. 
11. Shi, J., et al., Genome-wide association study of recurrent early-onset major 
depressive disorder. Molecular psychiatry, 2011. 16(2): p. 193-201. 
12. Lewis, C.M., et al., Genome-wide association study of major recurrent depression 
in the U.K. population. The American Journal of Psychiatry, 2010. 167(8): p. 949-
957. 
13. Rietschel, M., et al., Genome-wide association-, replication-, and neuroimaging 
study implicates HOMER1 in the etiology of major depression. Biological 
psychiatry, 2010. 68(6): p. 578-585. 
14. Radloff, L., The CES-D scale: A self-report depression scale for research in the 
general population. Applied psychological measurement, 1977. 1: p. 385-401. 
15. Kendler, K.S. and C.O. Gardner, Jr., Boundaries of major depression: an 
evaluation of DSM-IV criteria. The American Journal of Psychiatry, 1998. 




16. Beekman, A.T., et al., Criterion validity of the Center for Epidemiologic Studies 
Depression scale (CES-D): results from a community-based sample of older 
subjects in The Netherlands. Psychological medicine, 1997. 27(1): p. 231-235. 
17. Harlow, S.D., E.L. Goldberg, and G.W. Comstock, A longitudinal study of the 
prevalence of depressive symptomatology in elderly widowed and married 
women. Arch Gen Psychiatry, 1991. 48(12): p. 1065-8. 
18. Kuchibhatla, M.N., et al., Trajectory classes of depressive symptoms in a 
community sample of older adults. Acta Psychiatr Scand, 2012. 125(6): p. 492-
501. 
19. Comstock, G.W. and K.J. Helsing, Symptoms of depression in two communities. 
Psychological medicine, 1976. 6(4): p. 551-563. 
20. Breslau, N., Depressive symptoms, major depression, and generalized anxiety: a 
comparison of self-reports on CES-D and results from diagnostic interviews. 
Psychiatry research, 1985. 15(3): p. 219-229. 
21. Boyd, J.H., et al., Screening for depression in a community sample. 
Understanding the discrepancies between depression symptom and diagnostic 
scales. Archives of General Psychiatry, 1982. 39(10): p. 1195-1200. 
22. Roberts, R.E. and S.W. Vernon, The Center for Epidemiologic Studies Depression 
Scale: its use in a community sample. The American Journal of Psychiatry, 1983. 
140(1): p. 41-46. 
23. Fechner-Bates, S., J.C. Coyne, and T.L. Schwenk, The relationship of self-
reported distress to depressive disorders and other psychopathology. Journal of 
consulting and clinical psychology, 1994. 62(3): p. 550-559. 
24. van der Sluis, S., et al., Power in GWAS: lifting the curse of the clinical cut-off. 
Mol Psychiatry, 2013. 18(1): p. 2-3. 
25. Organization, W.H., Composite International Diagnostic Interview, Version 1.0, 
1990, World Health Organization: Geneva. 
26. Beck, A.T., et al., An inventory for measuring depression. Arch Gen Psychiatry, 
1961. 4: p. 561-71. 
27. Ayuso-Mateos, J.L., et al., From depressive symptoms to depressive disorders: 
the relevance of thresholds. Br J Psychiatry, 2010. 196(5): p. 365-71. 
28. Holmes, T.H. and R.H. Rahe, The Social Readjustment Rating Scale. J 
Psychosom Res, 1967. 11(2): p. 213-8. 
29. Brown, G.W. and T. Harris, Social origins of depression: a reply. Psychol Med, 
1978. 8(4): p. 577-88. 
30. Dohrenwend, B.P. and B.S. Dohrenwend, Social and cultural influences on 
psychopathology. Annu Rev Psychol, 1974. 25: p. 417-52. 
31. Lazarus, R.S. and S. Folkman, Stress, Appraisal and Coping. 1984, New York: 
Springer. 
32. Pearlin, L.I., The sociological study of stress. J Health Soc Behav, 1989. 30(3): p. 
241-56. 
33. Thoits, P.A., Stress, coping, and social support processes: where are we? What 
next? J Health Soc Behav, 1995. Spec No: p. 53-79. 
34. Miech, R.A., W.W. Eaton, and K. Brennan, Mental health disparities across 
education and sex: a prospective analysis examining how they persist over the life 




35. Murphy, J.M., et al., Depression and anxiety in relation to social status. A 
prospective epidemiologic study. Arch Gen Psychiatry, 1991. 48(3): p. 223-9. 
36. Ulbrich, P.M., G.J. Warheit, and R.S. Zimmerman, Race, socioeconomic status, 
and psychological distress: an examination of differential vulnerability. J Health 
Soc Behav, 1989. 30(1): p. 131-46. 
37. Bruce, M.L., D.T. Takeuchi, and P.J. Leaf, Poverty and psychiatric status. 
Longitudinal evidence from the New Haven Epidemiologic Catchment Area study. 
Archives of General Psychiatry, 1991. 48(5): p. 470-474. 
38. Stansfeld, S.A. and M.G. Marmot, Social class and minor psychiatric disorder in 
British Civil Servants: a validated screening survey using the General Health 
Questionnaire. Psychological medicine, 1992. 22(3): p. 739-749. 
39. Breslau, N. and G.C. Davis, Chronic stress and major depression. Archives of 
General Psychiatry, 1986. 43(4): p. 309-314. 
40. Brown, G.W., Genetic and population perspectives on life events and depression. 
Social Psychiatry and Psychiatric Epidemiology, 1998. 33(8): p. 363-372. 
41. Bruce, M.L., Psychosocial risk factors for depressive disorders in late life. 
Biological psychiatry, 2002. 52(3): p. 175-184. 
42. Chi, I. and K.L. Chou, Social support and depression among elderly Chinese 
people in Hong Kong. International journal of aging & human development, 2001. 
52(3): p. 231-252. 
43. Everson, S.A., et al., Epidemiologic evidence for the relation between 
socioeconomic status and depression, obesity, and diabetes. Journal of 
psychosomatic research, 2002. 53(4): p. 891-895. 
44. Maty, S.C., S.A. James, and G.A. Kaplan, Life-course socioeconomic position 
and incidence of diabetes mellitus among blacks and whites: the Alameda County 
Study, 1965-1999. Am J Public Health, 2010. 100(1): p. 137-45. 
45. Maty, S.C., et al., Childhood socioeconomic position, gender, adult body mass 
index, and incidence of type 2 diabetes mellitus over 34 years in the Alameda 
County Study. Am J Public Health, 2008. 98(8): p. 1486-94. 
46. Kaplan, G.A., S.J. Shema, and C.M. Leite, Socioeconomic determinants of 
psychological well-being: the role of income, income change, and income sources 
during the course of 29 years. Ann Epidemiol, 2008. 18(7): p. 531-7. 
47. Berkman, L.F. and L. Breslow, Health and ways of living: the Alameda County 
Study. 1983, New York: Oxford University Press. 
48. Roberts, R.E., J.M. Stevenson, and L. Breslow, Symptoms of depression among 
blacks and whites in an urban community. The Journal of nervous and mental 
disease, 1981. 169(12): p. 774-779. 
49. Kaplan, G.A., et al., Psychosocial predictors of depression. Prospective evidence 
from the human population laboratory studies. American Journal of 
Epidemiology, 1987. 125(2): p. 206-220. 
50. Toussaint, L.L., et al., Forgiveness and health: age differences in a US 
probability sample. J Adult Dev, 2001. 8: p. 249-57. 
51. Williams, D.R., et al., Racial differences in physical and mental health: 





52. Salonen, J.T., Is there a continuing need for longitudinal epidemiologic research? 
The Kuopio Ischaemic Heart Disease Risk Factor Study. Annals of Clinical 
Research, 1988. 20(1-2): p. 46-50. 
53. Kendler, K.S., L.M. Karkowski, and C.A. Prescott, Stressful life events and major 
depression: risk period, long-term contextual threat, and diagnostic specificity. 
The Journal of nervous and mental disease, 1998. 186(11): p. 661-669. 
54. Bulik, C.M., P.F. Sullivan, and K.S. Kendler, Heritability of binge-eating and 
broadly defined bulimia nervosa. Biol Psychiatry, 1998. 44(12): p. 1210-8. 
55. Hammen, C., Stress and depression. Annual review of clinical psychology, 2005. 
1: p. 293-319. 
56. Bruce, M.L. and R.A. Hoff, Social and physical health risk factors for first-onset 
major depressive disorder in a community sample. Social psychiatry and 
psychiatric epidemiology, 1994. 29(4): p. 165-171. 
57. Dohrenwend, B.P., Psychology, psychologists, and psychiatric epidemiology. 
Acta Psychiatr Scand Suppl, 1994. 385: p. 13-20; discussion 21-4. 
58. Swindle, R.W., Jr., R.C. Cronkite, and R.H. Moos, Life stressors, social 
resources, coping, and the 4-year course of unipolar depression. Journal of 
abnormal psychology, 1989. 98(4): p. 468-477. 
59. Paykel, E.S. and Z. Cooper, Life events and social stress, in Handbook of 
Affective Disorders, E.S. Paykel, Editor. 1992, Guilford: New York. p. 149-170. 
60. Hammen, C., et al., Psychiatric history and stress: predictors of severity of 
unipolar depression. Journal of abnormal psychology, 1992. 101(1): p. 45-52. 
61. Hammen, C., J.H. Shih, and P.A. Brennan, Intergenerational transmission of 
depression: test of an interpersonal stress model in a community sample. Journal 
of consulting and clinical psychology, 2004. 72(3): p. 511-522. 
62. McGonagle, K.A. and R.C. Kessler, Chronic stress, acute stress, and depressive 
symptoms. American Journal of Community Psychology, 1990. 18(5): p. 681-706. 
63. Kessler, R.C., R.H. Price, and C.B. Wortman, Social factors in psychopathology: 
stress, social support, and coping processes. Annual Review of Psychology, 
1985. 36: p. 531-572. 
64. Langford, C.P., et al., Social support: a conceptual analysis. J Adv Nurs, 1997. 
25(1): p. 95-100. 
65. Bamigbade, T.A., et al., Actions of tramadol, its enantiomers and principal 
metabolite, O-desmethyltramadol, on serotonin (5-HT) efflux and uptake in the 
rat dorsal raphe nucleus. Br J Anaesth, 1997. 79(3): p. 352-6. 
66. Henderson, A.S., et al., The course of depression in the elderly: a longitudinal 
community-based study in Australia. Psychological medicine, 1997. 27(1): p. 119-
129. 
67. Forsell, Y. and B. Winblad, Incidence of major depression in a very elderly 
population. International journal of geriatric psychiatry, 1999. 14(5): p. 368-372. 
68. Mair, C., A.V. Roux, and S. Galea, Are neighbourhood characteristics associated 
with depressive symptoms? A review of evidence. British medical journal, 2008. 
62(11): p. 940-6. 
69. Mair, C., et al., Factors associated with CD4 lymphocyte counts in HIV-negative 




70. Mair, C., A.V. Diez Roux, and S. Galea, Are neighbourhood characteristics 
associated with depressive symptoms? A review of evidence. J Epidemiol 
Community Health, 2008. 62(11): p. 940-6, 8 p following 946. 
71. Aneshensel, C.S., et al., Urban neighborhoods and depressive symptoms among 
older adults. The journals of gerontology.Series B, Psychological sciences and 
social sciences, 2007. 62(1): p. S52-9. 
72. Mulvaney, C. and D. Kendrick, Depressive symptoms in mothers of pre-school 
children--effects of deprivation, social support, stress and neighbourhood social 
capital. Social psychiatry and psychiatric epidemiology, 2005. 40(3): p. 202-208. 
73. Yen, I.H., et al., Perceived neighborhood problems and quality of life, physical 
functioning, and depressive symptoms among adults with asthma. American 
Journal of Public Health, 2006. 96(5): p. 873-879. 
74. la Gory, M. and K. Fitzpatrick, The effects of environmental context on elderly 
depression. Journal of aging and health, 1992. 4: p. 459-79. 
75. Kubzansky, L.D., et al., Neighborhood contextual influences on depressive 
symptoms in the elderly. American Journal of Epidemiology, 2005. 162(3): p. 
253-260. 
76. Hybels, C.F., et al., Sociodemographic characteristics of the neighborhood and 
depressive symptoms in older adults: using multilevel modeling in geriatric 
psychiatry. The American Journal of Geriatric Psychiatry : Official Journal of the 
American Association for Geriatric Psychiatry, 2006. 14(6): p. 498-506. 
77. Gutman, L.M. and A.J. Sameroff, Continuities in depression from adolescence to 
young adulthood: contrasting ecological influences. Development and 
psychopathology, 2004. 16(4): p. 967-984. 
78. Latkin, C.A. and A.D. Curry, Stressful neighborhoods and depression: a 
prospective study of the impact of neighborhood disorder. J Health Soc Behav, 
2003. 44(1): p. 34-44. 
79. Curry, A.D. and C.A. Latkin, Gender differences in street economy and social 
network correlates of arrest among heroin injectors in Baltimore, Maryland. J 
Urban Health, 2003. 80(3): p. 482-93. 
80. Aneshensel, C.S. and C.A. Sucoff, The neighborhood context of adolescent 
mental health. Journal of health and social behavior, 1996. 37(4): p. 293-310. 
81. Simons, R.L., et al., Discrimination, crime, ethnic identity, and parenting as 
correlates of depressive symptoms among African American children: a multilevel 
analysis. Development and psychopathology, 2002. 14(2): p. 371-393. 
82. Galea, S., et al., Urban built environment and depression: a multilevel analysis. J 
Epidemiol Community Health, 2005. 59(10): p. 822-7. 
83. Yen, I.H. and G.A. Kaplan, Poverty area residence and changes in depression 
and perceived health status: evidence from the Alameda County Study. 
International journal of epidemiology, 1999. 28(1): p. 90-94. 
84. Cutrona, C.E., et al., Neighborhood context, personality, and stressful life events 
as predictors of depression among African American women. J Abnorm Psychol, 
2005. 114(1): p. 3-15. 
85. Mujahid, M.S., et al., Assessing the measurement properties of neighborhood 





86. Rice, F., The genetics of depression in childhood and adolescence. Current 
psychiatry reports, 2009. 11(2): p. 167-173. 
87. Plomin, R., J.C. DeFries, and J.C. Loehlin, Genotype-environment interaction and 
correlation in the analysis of human behavior. Psychol Bull, 1977. 84(2): p. 309-
22. 
88. Monroe, S.M. and A.D. Simons, Diathesis-stress theories in the context of life 
stress research: implications for the depressive disorders. Psychol Bull, 1991. 
110(3): p. 406-25. 
89. Belsky, J., Variation in susceptibility to rearing influences: An evolutionary 
argument. Psychological Inquiry, 1997. 8: p. 182-186. 
90. Belsky, J., Theory testing, effect-size evaluation, and differential susceptibility to 
rearing influence: the case of mothering and attachment. Child Dev, 1997. 68(4): 
p. 598-600. 
91. Kendler, K.S. and L.J. Eaves, Models for the joint effect of genotype and 
environment on liability to psychiatric illness. Am J Psychiatry, 1986. 143(3): p. 
279-89. 
92. Jaffee, S.R. and T.S. Price, Gene-environment correlations: a review of the 
evidence and implications for prevention of mental illness. Mol Psychiatry, 2007. 
12(5): p. 432-42. 
93. Belsky, J. and M. Pluess, Beyond diathesis stress: differential susceptibility to 
environmental influences. Psychol Bull, 2009. 135(6): p. 885-908. 
94. Caspi, A., et al., Role of genotype in the cycle of violence in maltreated children. 
Science, 2002. 297: p. 851-853. 
95. Caspi, A., et al., Influence of Life Stress on Depression: Moderation by a 
Polymorphism in the 5-HTT Gene. American Association for the Advancement of 
Science, 2003. 
96. Lengua, L.J., et al., The additive and interactive effects of parenting and 
temperament in predicting adjustment problems of children of divorce. J Clin 
Child Psychol, 2000. 29(2): p. 232-44. 
97. Kim-Cohen, J., et al., MAOA, maltreatment, and gene-environment interaction 
predicting children's mental health: new evidence and a meta-analysis. Molecular 
psychiatry, 2006. 11(10): p. 903-913. 
98. Eley, T.C., et al., Gene-environment interaction analysis of serotonin system 
markers with adolescent depression. Molecular psychiatry, 2004. 9(10): p. 908-
915. 
99. Kendler, K.S. and J.H. Baker, Genetic influences on measures of the environment: 
a systematic review. Psychol Med, 2007. 37(5): p. 615-26. 
100. Rutter, M., Gene-environment interdependence. Developmental science, 2007. 
10(1): p. 12-18. 
101. Rutter, M., Gene-environment interplay. Depression and anxiety, 2010. 27(1): p. 
1-4. 
102. Rutter, M., T.E. Moffitt, and A. Caspi, Gene-environment interplay and 
psychopathology: multiple varieties but real effects. Journal of child psychology 
and psychiatry, and allied disciplines, 2006. 47(3-4): p. 226-261. 
103. Plomin, R., Behavioral genetics in the postgenomic era. 2003, Washington, DC: 




104. Thapar, A., et al., The contribution of gene-environment interaction to 
psychopathology. Development and psychopathology, 2007. 19(4): p. 989-1004. 
105. Caspi, A. and T.E. Moffitt, Gene-environment interactions in psychiatry: joining 
forces with neuroscience. Nat Rev Neurosci, 2006. 7(7): p. 583-90. 
106. Gottesman, II and T.D. Gould, The endophenotype concept in psychiatry: 
etymology and strategic intentions. Am J Psychiatry, 2003. 160(4): p. 636-45. 
107. Tsuang, M.T., et al., Gene-environment interactions in mental disorders. World 
Psychiatry, 2004. 3(2): p. 73-83. 
108. Karg, K. and S. Sen, Gene x Environment interaction models in psychiatric 
genetics. Curr Top Behav Neurosci, 2012. 12: p. 441-62. 
109. Risch, N., et al., Interaction between the serotonin transporter gene (5-HTTLPR), 
stressful life events, and risk of depression: a meta-analysis. JAMA : the journal 
of the American Medical Association, 2009. 301(23): p. 2462-2471. 
110. Munafo, M.R., et al., Gene X environment interactions at the serotonin 
transporter locus. Biological psychiatry, 2009. 65(3): p. 211-219. 
111. Karg, K., et al., The Serotonin Transporter Promoter Variant (5-HTTLPR), 
Stress, and Depression Meta-analysis Revisited Evidence of Genetic Moderation. 
Archives of General Psychiatry, 2011. 68(5): p. 444-454. 
112. Bukh, J.D., et al., Interaction between genetic polymorphisms and stressful life 
events in first episode depression. Journal of Affective Disorders, 2009. 119(1-3): 
p. 107-115. 
113. Kohli, M.A., et al., The neuronal transporter gene SLC6A15 confers risk to major 
depression. Neuron, 2011. 70(2): p. 252-65. 
114. Major Depressive Disorder Working Group of the Psychiatric, G.C., A mega-
analysis of genome-wide association studies for major depressive disorder. 
Molecular psychiatry, 2013(4): p. 497-511. 
115. Morgenthaler, S. and W.G. Thilly, A strategy to discover genes that carry multi-
allelic or mono-allelic risk for common diseases: a cohort allelic sums test 
(CAST). Mutat Res, 2007. 615(1-2): p. 28-56. 
116. Sjoberg, R.L., et al., Development of depression: sex and the interaction between 
environment and a promoter polymorphism of the serotonin transporter gene. The 
international journal of neuropsychopharmacology / official scientific journal of 
the Collegium Internationale Neuropsychopharmacologicum (CINP), 2006. 9(4): 
p. 443-449. 
117. Uddin, M., et al., Gender differences in the genetic and environmental 
determinants of adolescent depression. Depression and anxiety, 2010. 
118. Bild, D.E., et al., Multi-ethnic study of atherosclerosis: objectives and design. Am 
J Epidemiol, 2002. 156(9): p. 871-81. 
119. Levy, D., et al., Evidence for a gene influencing blood pressure on chromosome 
17. Genome scan linkage results for longitudinal blood pressure phenotypes in 
subjects from the framingham heart study. Hypertension, 2000. 36(4): p. 477-483. 
120. Hek, K., et al., A Genome-Wide Association Study of Depressive Symptoms. Biol 
Psychiatry, 2013. 
121. Setiawan, V.W., et al., Two estrogen-related variants in CYP19A1 and 
endometrial cancer risk: a pooled analysis in the Epidemiology of Endometrial 




publication of the American Association for Cancer Research, cosponsored by the 
American Society of Preventive Oncology, 2009. 18(1): p. 242-247. 
122. Sun, Y.V., P.A. Peyser, and S.L. Kardia, A common copy number variation on 
chromosome 6 association with the gene expression level of endothelin 1 in 
transformed B lymphocytes from three racial groups. Circulation.Cardiovascular 
genetics, 2009. 2(5): p. 483-488. 
123. Purcell, S., et al., PLINK: a tool set for whole-genome association and 
population-based linkage analyses. Am J Hum Genet, 2007. 81(3): p. 559-75. 
124. Purcell, S., PLINK 1.07. 
125. Team, R.D.C., R: A language and environment for statistical computing, in R 
Foundation for Statistical Computing2008: Vienna, Austria. 
126. Bromberger, J.T. and K.A. Matthews, A longitudinal study of the effects of 
pessimism, trait anxiety, and life stress on depressive symptoms in middle-aged 
women. Psychol Aging, 1996. 11(2): p. 207-13. 
127. Investigators, E., Enhancing Recovery in Coronary Heart Disease (ENRICHD) 
study intervention: rationale and design. Psychosom Med, 2001. 63(5): p. 747-55. 
128. Inc., S.I., SAS/STAT, 2008: Cary, NC, USA. 
129. Pollitt, R.A., K.M. Rose, and J.S. Kaufman, Evaluating the evidence for models of 
life course socioeconomic factors and cardiovascular outcomes: a systematic 
review. BMC public health, 2005. 5: p. 7. 
130. Lemelin, E.T., et al., Life-course socioeconomic positions and subclinical 
atherosclerosis in the multi-ethnic study of atherosclerosis. Soc Sci Med, 2009. 
68(3): p. 444-51. 
131. St. Clair, P., et al., RAND HRS Data Documentation, Version H, 2008, Labor & 
Population Program, RAND Center for the Study of Aging: Santa Monica, CA. 
132. Clarke, P., et al., Guide to Content of the HRS Psychosocial Leave-Behind 
Participant Lifestyle Questionnaires: 2004 & 2006 2007, University of Michigan: 
Ann Arbor, MI. p. 1-48. 
133. National Institute on Aging, Using Genome-Wide Association Studies (GWAS) to 
Explore Fundamental Questions About Aging in the Health and Retirement Study 
(HRS) Sample, 2010, Committee on Population, National Academy of Sciences. 
134. Quality Control Report for Genotypic Data. 
135. Kessler, R.C., et al., Prevalence, severity, and comorbidity of 12-month DSM-IV 
disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry, 
2005. 62(6): p. 617-27. 
136. Wray, N.R., et al., Genome-wide association study of major depressive disorder: 
new results, meta-analysis, and lessons learned. Mol Psychiatry, 2012. 17(1): p. 
36-48. 
137. Craddock, N. and L. Forty, Genetics of affective (mood) disorders. Eur J Hum 
Genet, 2006. 14(6): p. 660-8. 
138. Fairweather-Schmidt, A.K., K.J. Anstey, and A.J. Mackinnon, Is suicidality 
distinguishable from depression? Evidence from a community-based sample. Aust 
N Z J Psychiatry, 2009. 43(3): p. 208-15. 
139. Sullivan, P.F., M.C. Neale, and K.S. Kendler, Genetic epidemiology of major 
depression: Review and meta-analysis. American Journal of Psychiatry, 2000. 




140. Farmer, A., et al., Cardiff depression study. A sib-pair study of life events and 
familiality in major depression. Br J Psychiatry, 2000. 176: p. 150-5. 
141. Pergadia, M.L., et al., A 3p26-3p25 genetic linkage finding for DSM-IV major 
depression in heavy smoking families. Am J Psychiatry, 2011. 168(8): p. 848-52. 
142. Breen, G., et al., A genome-wide significant linkage for severe depression on 
chromosome 3: the depression network study. Am J Psychiatry, 2011. 168(8): p. 
840-7. 
143. Huang, J., et al., Cross-disorder genomewide analysis of schizophrenia, bipolar 
disorder, and depression. The American Journal of Psychiatry, 2010. 167(10): p. 
1254-1263. 
144. McMahon, F.J., et al., Meta-analysis of genome-wide association data identifies a 
risk locus for major mood disorders on 3p21.1. Nature genetics, 2010. 42(2): p. 
128-131. 
145. Bosker, F.J., et al., Poor replication of candidate genes for major depressive 
disorder using genome-wide association data. Molecular psychiatry, 2010. 
146. Sullivan, P.F., et al., Genome-wide association for major depressive disorder: a 
possible role for the presynaptic protein piccolo. Molecular psychiatry, 2009. 
14(4): p. 359-375. 
147. Wray, N.R., et al., Genome-wide association study of major depressive disorder: 
new results, meta-analysis, and lessons learned. Molecular psychiatry, 2010. 
148. Hettema, J.M., et al., A population-based twin study of the relationship between 
neuroticism and internalizing disorders. The American Journal of Psychiatry, 
2006. 163(5): p. 857-864. 
149. Juster, F.T. and R. Suzman, An Overview of the Health and Retirement Study. 
Journal of Human Resources, 1995. 30: p. Page [S7] of S7-S56. 
150. Zeger, S.L. and K.Y. Liang, Longitudinal data analysis for discrete and 
continuous outcomes. Biometrics, 1986. 42(1): p. 121-30. 
151. Team, R.C., R: A Language and Environment for Statistical Computing, 2012: 
Vienna, Austria. 
152. Yan, J.H., S., Generalized Estimating Equation Package v. 1.1-6, 2012. 
153. Willer, C.J., Y. Li, and G.R. Abecasis, METAL: fast and efficient meta-analysis of 
genomewide association scans. Bioinformatics, 2010. 26(17): p. 2190-1. 
154. Devlin, B. and K. Roeder, Genomic control for association studies. Biometrics, 
1999. 55(4): p. 997-1004. 
155. Chauhan, S.C., et al., MUC13 mucin augments pancreatic tumorigenesis. Mol 
Cancer Ther, 2012. 11(1): p. 24-33. 
156. Chauhan, S.C., et al., Expression and functions of transmembrane mucin MUC13 
in ovarian cancer. Cancer Res, 2009. 69(3): p. 765-74. 
157. Gupta, B.K., et al., Increased expression and aberrant localization of mucin 13 in 
metastatic colon cancer. J Histochem Cytochem, 2012. 60(11): p. 822-31. 
158. Maher, D.M., et al., Mucin 13: structure, function, and potential roles in cancer 
pathogenesis. Mol Cancer Res, 2011. 9(5): p. 531-7. 
159. Moehle, C., et al., Aberrant intestinal expression and allelic variants of mucin 
genes associated with inflammatory bowel disease. J Mol Med (Berl), 2006. 




160. Samuels, T.L., et al., Mucin gene expression in human laryngeal epithelia: effect 
of laryngopharyngeal reflux. Ann Otol Rhinol Laryngol, 2008. 117(9): p. 688-95. 
161. Shimamura, T., et al., Overexpression of MUC13 is associated with intestinal-
type gastric cancer. Cancer Sci, 2005. 96(5): p. 265-73. 
162. Williams, S.J., et al., Muc13, a novel human cell surface mucin expressed by 
epithelial and hemopoietic cells. J Biol Chem, 2001. 276(21): p. 18327-36. 
163. Clark, H.F., et al., The secreted protein discovery initiative (SPDI), a large-scale 
effort to identify novel human secreted and transmembrane proteins: a 
bioinformatics assessment. Genome Res, 2003. 13(10): p. 2265-70. 
164. Kimura, K., et al., Diversification of transcriptional modulation: large-scale 
identification and characterization of putative alternative promoters of human 
genes. Genome Res, 2006. 16(1): p. 55-65. 
165. Sherry ST, et al., dbSNP: the NCBI database of genetic variation. Nucleic Acids 
Res, 2001 Jan 1 29(1): p. 308-11. 
166. Hix, L.M., et al., Tumor STAT1 transcription factor activity enhances breast 
tumor growth and immune suppression mediated by myeloid-derived suppressor 
cells. J Biol Chem, 2013. 288(17): p. 11676-88. 
167. Online Mendelian Inheritance in Man, O.  9/20/2013]; Available from: 
http://omim.org/. 
168. Xu, E., J. Zhang, and X. Chen, MDM2 expression is repressed by the RNA-
binding protein RNPC1 via mRNA stability. Oncogene, 2013. 32(17): p. 2169-78. 
169. Yan, W., et al., p73 expression is regulated by RNPC1, a target of the p53 family, 
via mRNA stability. Mol Cell Biol, 2012. 32(13): p. 2336-48. 
170. Demirkan, A., et al., Genetic risk profiles for depression and anxiety in adult and 
elderly cohorts. Mol Psychiatry, 2011. 16(7): p. 773-83. 
171. Mukherjee, S., et al., Gene-based GWAS and biological pathway analysis of the 
resilience of executive functioning. Brain Imaging Behav, 2013. 
172. Peng, G., et al., Gene and pathway-based second-wave analysis of genome-wide 
association studies. Eur J Hum Genet, 2010. 18(1): p. 111-7. 
173. Lander, E.S. and N.J. Schork, Genetic dissection of complex traits. Science, 1994. 
265(5181): p. 2037-48. 
174. Goddard, K.A., et al., Linkage disequilibrium and allele-frequency distributions 
for 114 single-nucleotide polymorphisms in five populations. Am J Hum Genet, 
2000. 66(1): p. 216-34. 
175. Bryc, K., et al., Colloquium paper: genome-wide patterns of population structure 
and admixture among Hispanic/Latino populations. Proc Natl Acad Sci U S A, 
2010. 107 Suppl 2: p. 8954-61. 
176. Shifman, S., et al., Linkage disequilibrium patterns of the human genome across 
populations. Hum Mol Genet, 2003. 12(7): p. 771-6. 
177. Lee, S., et al., General framework for meta-analysis of rare variants in 
sequencing association studies. Am J Hum Genet, 2013. 93(1): p. 42-53. 
178. Pruim, R.J., et al., LocusZoom: regional visualization of genome-wide association 
scan results. Bioinformatics, 2010. 26(18): p. 2336-7. 




180. Clark, S.L., et al., Genome-wide association study of patient-rated and clinician-
rated global impression of severity during antipsychotic treatment. 
Pharmacogenet Genomics, 2013. 23(2): p. 69-77. 
181. Kalsi, G., et al., A systematic gene-based screen of chr4q22-q32 identifies 
association of a novel susceptibility gene, DKK2, with the quantitative trait of 
alcohol dependence symptom counts. Hum Mol Genet, 2010. 19(12): p. 2497-506. 
182. Chambers, J.C., et al., Genome-wide association study identifies loci influencing 
concentrations of liver enzymes in plasma. Nat Genet, 2011. 43(11): p. 1131-8. 
183. Yuan, X., et al., Population-based genome-wide association studies reveal six loci 
influencing plasma levels of liver enzymes. Am J Hum Genet, 2008. 83(4): p. 520-
8. 
184. Oguri, M., et al., Assessment of a polymorphism of SDK1 with hypertension in 
Japanese Individuals. Am J Hypertens, 2010. 23(1): p. 70-7. 
185. Yoshida, T., et al., Association of genetic variants with hemorrhagic stroke in 
Japanese individuals. Int J Mol Med, 2010. 25(4): p. 649-56. 
186. Consortium, E.P., et al., An integrated encyclopedia of DNA elements in the 
human genome. Nature, 2012. 489(7414): p. 57-74. 
187. Kent, W.J., et al., The human genome browser at UCSC. Genome Res, 2002. 
12(6): p. 996-1006. 
188. Koenen, K.C., et al., Modification of the association between serotonin 
transporter genotype and risk of posttraumatic stress disorder in adults by 
county-level social environment. American Journal of Epidemiology, 2009. 
169(6): p. 704-711. 
189. Kendler, K.S., et al., The interaction of stressful life events and a serotonin 
transporter polymorphism in the prediction of episodes of major depression: a 
replication. Archives of General Psychiatry, 2005. 62(5): p. 529-535. 
190. Middeldorp, C.M., et al., Life events, anxious depression and personality: a 
prospective and genetic study. Psychological medicine, 2008. 38(11): p. 1557-
1565. 
191. Taylor, A. and J. Kim-Cohen, Meta-analysis of gene-environment interactions in 
developmental psychopathology. Dev Psychopathol, 2007. 19(4): p. 1029-37. 
192. Uher, R. and P. McGuffin, The moderation by the serotonin transporter gene of 
environmental adversity in the etiology of depression: 2009 update. Molecular 
psychiatry, 2010. 15(1): p. 18-22. 
193. Marazziti, D., et al., Metabolic syndrome and major depression. CNS Spectr, 
2013: p. 1-12. 
194. Felger, J.C. and F.E. Lotrich, Inflammatory cytokines in depression: 
neurobiological mechanisms and therapeutic implications. Neuroscience, 2013. 
246: p. 199-229. 
195. Krishnan, V. and E.J. Nestler, The molecular neurobiology of depression. Nature, 
2008. 455(7215): p. 894-902. 
196. Pariante, C.M. and S.L. Lightman, The HPA axis in major depression: classical 
theories and new developments. Trends Neurosci, 2008. 31(9): p. 464-8. 





198. Verhoeven, V.J., et al., Genome-wide meta-analyses of multiancestry cohorts 
identify multiple new susceptibility loci for refractive error and myopia. Nat 
Genet, 2013. 45(3): p. 314-8. 
199. Hysi, P.G., et al., A genome-wide association study for myopia and refractive 
error identifies a susceptibility locus at 15q25. Nat Genet, 2010. 42(10): p. 902-5. 
200. Lin, X., et al., Test for interactions between a genetic marker set and environment 
in generalized linear models. Biostatistics, 2013. 14(4): p. 667-81. 
201. Madsen, B.E. and S.R. Browning, A groupwise association test for rare mutations 
using a weighted sum statistic. PLoS Genet, 2009. 5(2): p. e1000384. 
202. Neale, B.M., et al., Testing for an unusual distribution of rare variants. PLoS 
Genet, 2011. 7(3): p. e1001322. 
203. Moritz, C., Defining 'Evolutionarily Significant Units' for conservation. Trends 
Ecol Evol, 1994. 9(10): p. 373-5. 
204. Margulies, E.H., et al., Identification and characterization of multi-species 
conserved sequences. Genome Res, 2003. 13(12): p. 2507-18. 
205. Spitzer, R.L., et al., The Structured Clinical Interview for DSM-III-R (SCID). I: 
History, rationale, and description. Arch Gen Psychiatry, 1992. 49(8): p. 624-9. 
206. Williams, J.B., et al., The Structured Clinical Interview for DSM-III-R (SCID). II. 
Multisite test-retest reliability. Arch Gen Psychiatry, 1992. 49(8): p. 630-6. 
207. Robins, L.N., et al., National Institute of Mental Health Diagnostic Interview 
Schedule. Its history, characteristics, and validity. Arch Gen Psychiatry, 1981. 
38(4): p. 381-9. 
208. Kessler, R.C. and T.B. Ustun, The World Mental Health (WMH) Survey Initiative 
Version of the World Health Organization (WHO) Composite International 
Diagnostic Interview (CIDI). Int J Methods Psychiatr Res, 2004. 13(2): p. 93-121. 
209. Beck, A., R. Steer, and M. Garbin, Psychometric properties of the Beck 
Depression Inventory: Twenty-five years of evaluation. Clinical Psychology 
Review, 1988. 8: p. 77-100. 
210. Morris, A.P., et al., Large-scale association analysis provides insights into the 
genetic architecture and pathophysiology of type 2 diabetes. Nat Genet, 2012. 
44(9): p. 981-90. 
211. Manolio, T.A., Genomewide association studies and assessment of the risk of 
disease. N Engl J Med, 2010. 363(2): p. 166-76. 
212. McCarthy, M.I. and J.N. Hirschhorn, Genome-wide association studies: past, 
present and future. Hum Mol Genet, 2008. 17(R2): p. R100-1. 
213. International HapMap, C., The International HapMap Project. Nature, 2003. 
426(6968): p. 789-96. 
214. Project, U.S.D.o.E.H.G. Human Genome Project. Available from: 
http://www.ornl.gov/hgmis. 
215. Thornton-Wells, T.A., J.H. Moore, and J.L. Haines, Genetics, statistics and 
human disease: analytical retooling for complexity. Trends Genet, 2004. 20(12): 
p. 640-7. 
216. Flint, J. and T.F. Mackay, Genetic architecture of quantitative traits in mice, flies, 
and humans. Genome Res, 2009. 19(5): p. 723-33. 
217. Manichaikul, A., et al., Population structure of Hispanics in the United States: the 




218. Hoggart, C.J., et al., Control of confounding of genetic associations in stratified 
populations. Am J Hum Genet, 2003. 72(6): p. 1492-1504. 
219. de Bakker, P.I., et al., Practical aspects of imputation-driven meta-analysis of 
genome-wide association studies. Hum Mol Genet, 2008. 17(R2): p. R122-8. 
220. Roberts, R., et al., The genome-wide association study--a new era for common 
polygenic disorders. J Cardiovasc Transl Res, 2010. 3(3): p. 173-82. 
221. Skol, A.D., et al., Joint analysis is more efficient than replication-based analysis 
for two-stage genome-wide association studies. Nat Genet, 2006. 38(2): p. 209-
13. 
222. Zeggini, E. and J.P. Ioannidis, Meta-analysis in genome-wide association studies. 
Pharmacogenomics, 2009. 10(2): p. 191-201. 
223. Stouffer, S.A.S., E.A.; DeVinney, L.C.; Star, S.A., The American Soldier: 
Adjustment during Army Life. 1949, Princeton, NJ: Princeton University Press. 
224. Lee, S., et al., Optimal unified approach for rare-variant association testing with 
application to small-sample case-control whole-exome sequencing studies. Am J 
Hum Genet, 2012. 91(2): p. 224-37. 
225. Han, F. and W. Pan, A data-adaptive sum test for disease association with 
multiple common or rare variants. Hum Hered, 2010. 70(1): p. 42-54. 
226. Ionita-Laza, I., et al., A new testing strategy to identify rare variants with either 
risk or protective effect on disease. PLoS Genet, 2011. 7(2): p. e1001289. 
227. Ionita-Laza, I., et al., Sequence Kernel Association Tests for the Combined Effect 
of Rare and Common Variants. Am J Hum Genet, 2013. 
228. Price, A.L., et al., Pooled association tests for rare variants in exon-resequencing 
studies. Am J Hum Genet, 2010. 86(6): p. 832-8. 
229. Tzeng, J.Y., et al., Studying gene and gene-environment effects of uncommon and 
common variants on continuous traits: a marker-set approach using gene-trait 
similarity regression. Am J Hum Genet, 2011. 89(2): p. 277-88. 
230. Qiao, B., et al., Genome-wide gene-based analysis of rheumatoid arthritis-
associated interaction with PTPN22 and HLA-DRB1. BMC Proc, 2009. 3 Suppl 
7: p. S132. 
231. Buil, A., et al., A new gene-based association test for genome-wide association 
studies. BMC Proc, 2009. 3 Suppl 7: p. S130. 
232. Lo, S.H., et al., Discovering interactions among BRCA1 and other candidate 
genes associated with sporadic breast cancer. Proc Natl Acad Sci U S A, 2008. 
105(34): p. 12387-92. 
233. Beyene, J., et al., Gene- or region-based analysis of genome-wide association 
studies. Genet Epidemiol, 2009. 33 Suppl 1: p. S105-10. 
234. Gauderman, W.J., et al., Testing association between disease and multiple SNPs 
in a candidate gene. Genet Epidemiol, 2007. 31(5): p. 383-95. 
235. Chen, X., et al., Supervised principal component analysis for gene set enrichment 
of microarray data with continuous or survival outcomes. Bioinformatics, 2008. 
24(21): p. 2474-81. 
236. Gao, Q., et al., Gene- or region-based association study via kernel principal 
component analysis. BMC Genet, 2011. 12: p. 75. 
237. Ma, S. and Y. Dai, Principal component analysis based methods in bioinformatics 




238. Cai, M., et al., SNP set association analysis for genome-wide association studies. 
PLoS One, 2013. 8(5): p. e62495. 
239. Zhao, Y., et al., Association test based on SNP set: logistic kernel machine based 
test vs. principal component analysis. PLoS One, 2012. 7(9): p. e44978. 
240. Wang, X., et al., GEE-Based SNP Set Association Test for Continuous and 
Discrete Traits in Family-Based Association Studies. Genetic Epidemiology, 
2013: p. n/a-n/a. 
241. Mathias, R.A., et al., A graphical assessment of p-values from sliding window 
haplotype tests of association to identify asthma susceptibility loci on 
chromosome 11q. BMC Genet, 2006. 7: p. 38. 
242. Schmid, K. and Z. Yang, The trouble with sliding windows and the selective 
pressure in BRCA1. PLoS One, 2008. 3(11): p. e3746. 
243. Khoury, M.J., M.J. Adams, Jr., and W.D. Flanders, An epidemiologic approach to 
ecogenetics. Am J Hum Genet, 1988. 42(1): p. 89-95. 
244. Khoury, M.J. and S. Wacholder, Invited commentary: from genome-wide 
association studies to gene-environment-wide interaction studies--challenges and 
opportunities. Am J Epidemiol, 2009. 169(2): p. 227-30; discussion 234-5. 
245. Koopman, J.S., Causal models and sources of interaction. Am J Epidemiol, 1977. 
106(6): p. 439-44. 
246. Thomas, D., Methods for investigating gene-environment interactions in 
candidate pathway and genome-wide association studies. Annu Rev Public 
Health, 2010. 31: p. 21-36. 
247. Gilliland, F.D., et al., Effects of glutathione S-transferase M1, maternal smoking 
during pregnancy, and environmental tobacco smoke on asthma and wheezing in 
children. Am J Respir Crit Care Med, 2002. 166(4): p. 457-63. 
248. Martinez, F.D., Gene-environment interactions in asthma: with apologies to 
William of Ockham. Proc Am Thorac Soc, 2007. 4(1): p. 26-31. 
249. Gianfagna, F., et al., A systematic review of meta-analyses on gene 
polymorphisms and gastric cancer risk. Curr Genomics, 2008. 9(6): p. 361-74. 
250. Thomas, D., Gene--environment-wide association studies: emerging approaches. 
Nat Rev Genet, 2010. 11(4): p. 259-72. 
251. Holmans, P., et al., Gene ontology analysis of GWA study data sets provides 
insights into the biology of bipolar disorder. Am J Hum Genet, 2009. 85(1): p. 
13-24. 
252. Smith, P.G. and N.E. Day, The design of case-control studies: the influence of 
confounding and interaction effects. Int J Epidemiol, 1984. 13(3): p. 356-65. 
253. Burton, P.R., et al., Size matters: just how big is BIG?: Quantifying realistic 
sample size requirements for human genome epidemiology. Int J Epidemiol, 2009. 
38(1): p. 263-73. 
254. Ioannidis, J.P., T.A. Trikalinos, and M.J. Khoury, Implications of small effect 
sizes of individual genetic variants on the design and interpretation of genetic 
association studies of complex diseases. Am J Epidemiol, 2006. 164(7): p. 609-
14. 
255. Matullo, G., M. Berwick, and P. Vineis, Gene-environment interactions: how 




256. Clayton, D. and P.M. McKeigue, Epidemiological methods for studying genes 
and environmental factors in complex diseases. Lancet, 2001. 358(9290): p. 1356-
60. 
257. Schaid, D.J., Case-parents design for gene-environment interaction. Genet 
Epidemiol, 1999. 16(3): p. 261-73. 
258. Gauderman, W.J., J.S. Witte, and D.C. Thomas, Family-based association 
studies. J Natl Cancer Inst Monogr, 1999(26): p. 31-7. 
259. Laird, N.M. and C. Lange, Family-based designs in the age of large-scale gene-
association studies. Nat Rev Genet, 2006. 7(5): p. 385-94. 
260. Cordell, H.J., Epistasis: what it means, what it doesn't mean, and statistical 
methods to detect it in humans. Hum Mol Genet, 2002. 11(20): p. 2463-8. 
261. Cordell, H.J., Detecting gene-gene interactions that underlie human diseases. Nat 
Rev Genet, 2009. 10(6): p. 392-404. 
262. Miller, R.L. and S.M. Ho, Environmental epigenetics and asthma: current 
concepts and call for studies. Am J Respir Crit Care Med, 2008. 177(6): p. 567-
73. 
263. Salk, J.J., E.J. Fox, and L.A. Loeb, Mutational heterogeneity in human cancers: 
origin and consequences. Annu Rev Pathol, 2010. 5: p. 51-75. 
264. Zeisel, S.H., Epigenetic mechanisms for nutrition determinants of later health 
outcomes. Am J Clin Nutr, 2009. 89(5): p. 1488S-1493S. 
265. Fraga, M.F., et al., Epigenetic differences arise during the lifetime of monozygotic 
twins. Proc Natl Acad Sci U S A, 2005. 102(30): p. 10604-9. 
266. Shostak, S., Locating gene-environment interaction: at the intersections of 
genetics and public health. Soc Sci Med, 2003. 56(11): p. 2327-42. 
267. Need, A.C., A.G. Motulsky, and D.B. Goldstein, Priorities and standards in 
pharmacogenetic research. Nat Genet, 2005. 37(7): p. 671-81. 
268. Cullen, A.C., et al., The application of genetic information for regulatory 
standard setting under the clean air act: a decision-analytic approach. Risk Anal, 
2008. 28(4): p. 877-90. 
269. Perera, F.P., Molecular epidemiology: on the path to prevention? J Natl Cancer 
Inst, 2000. 92(8): p. 602-12. 
270. Siepel, A. and D. Haussler, Combining phylogenetic and hidden Markov models 
in biosequence analysis. J Comput Biol, 2004. 11(2-3): p. 413-28. 
271. Siepel, A. and D. Haussler, Phylogenetic hidden Markov models, in Statistical 
Methods in Molecular Evolution, R. Nielsen, Editor. 2005, Springer: New York. 
p. 325-351. 
 
 
